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Abstract
In bovine milk the highly phosphorylated cleavage fragment of osteopon-
tin (OPN1-149) is capable of stabilising high concentrations of calcium
phosphate ions by formation of calcium phosphate nanoclusters (CPN).
Here OPN1-149 isolated from bovine milk is characterised by a range of
biophysical techniques as adopting an intrinsically disordered conforma-
tion in solution. The transient ensemble of conformations sampled by
OPN1-149 is characterised by small angle X-ray scattering (SAXS) in
combination with the ensemble optimisation method. Formation of CPN
by OPN1-149 is characterised using dynamic light scattering and small
angle neutron scattering (SANS). The dynamics of the protein and the ef-
fects of sequestration on the molecular ﬂuctuations are quantiﬁed on the
nanosecond-angstrom resolution by elastic incoherent neutron scattering.
The molecular ﬂuctuations of the free phosphopeptide are found to repre-
sent a highly ﬂexible protein. Upon sequestration of calcium phosphate,
stiﬀening of OPN1-149 is reﬂected in molecular ﬂuctuations more closely
resembling those characteristic of globular proteins. The quantiﬁcation
of the eﬀects provides a handle for future comparisons and classiﬁcation
of molecular ﬂuctuations. The formed OPN1-149 calcium phosphate nan-
oclusters are characterised according to a core shell model using SANS and
static light scattering. The structure of the core is probed using neutron
and X-ray diﬀraction. The results bring insight into the modulation of
the activity of OPN1-149 and phosphopeptides with a role in the control
of biomineralisation.
A recombinant human fragment (hOPN1-157) equivalent to OPN1-149
is produced and characterised in order to extend the work further to-
wards the human regulatory system. The eﬀects of phosphorylation, a
key requirement for sequestration of calcium phosphate, on the structure
and dynamics are determined using SAXS and elastic incoherent neutron
scattering. The results indicate that phosphorylation of the protein has
limited impact on both the structure and dynamics of hOPN1-157
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Chapter 1
Introduction - Biological background
1.1 Fundamentals of biomineralisation
Mineralised tissue is characterised by the presence of deposited mineral such as hy-
droxyapatite (HA), which has the chemical formula Ca5(PO4)3(OH). Healthy soft
tissue, on the other hand, is characterised by a lack of mineral content and the de-
position of minerals in soft tissue is often detrimental to health [1]. In vertebrates
the most abundant mineralised tissue is that of bone, from which the skeleton is con-
structed. The most important property of bone material is its high resilience through
which it fulﬁls its fundamental function of providing form and strength to the mam-
malian body. The high resilience is due to the nanoscale hierarchical structure, where
a mineral, often HA, is deposited within in an organic matrix such as collagen [2].
The hierarchical structure of bone is shown in Figure 1.1. In mammalian bone crys-
talline HA is deposited within an organic matrix consisting of long strands of collagen
protein [3, 4]. The strength aﬀorded to mineralised tissue depends on the nanoscale
on not only the amount of HA deposited but also on the interaction between HA and
collagen [5].
In vivo soft and hard tissue are often in contact with each-other and certain biological
ﬂuids can permeate both tissue types. For example teeth contain large amounts of
tissue mineralised by crystalline calcium phosphate. In the mouth teeth are constantly
exposed to saliva which due to its acidic pH would be expected to increase the rate
1
Figure 1.1: Illustration of bone structure at different resolutions, on the atomic scale bone
consists of deposits of crystalline HA within an organic matrix of collagen. Image taken
from Nair et al [3]
of tooth demineralisation [6, 7, 8]. In order to maintain the integrity of the tooth
mineralised tissue, mammals produce saliva containing a high contents of calcium
and phosphate [9]. Saliva is in almost constant contact with the tooth surface and
therefore the mineral contents of tooth is constantly replenished [9]. The same is
true for other biological ﬂuids which are in contact with mineral fronts, such as those
found in the extracellular matrix of bone. Milk contains the highest concentration of
calcium phosphate of all bioﬂuids [10]. The high concentration of calcium phosphate
is required in order to provide the neonate with suﬃcient calcium and phosphate to
develop and maintain it’s skeletal structure [11]. Milk is transported from the mother
to the neonate through the soft tissue present in the mammary gland, the calciﬁcation
of which is rare [11]. A consequence of this is the almost paradoxical observation that
biological ﬂuids are supersaturated with respect to hydroxyapatite yet do not contain
precipitate and the diﬀerent soft tissues which they permeate remain unmineralised
[12, 13, 14, 15].
At levels of supersaturation calcium phosphate is expected to precipitate out of solu-
tion. At physiological pH the precipitate does not directly form the most thermody-
namically stable phase of HA, instead it passes through a number of diﬀerent calcium
phosphate phases of decreasing solubility. The process can be described by Ostwald’s
rule of stages which states that nucleation will occur with the formation of a critical
2
nucleus with the lowest possible surface energy and not the lowest energy phase [16].
This means that in general the least stable phase crystallises ﬁrst and consequently
increasingly stable crystalline phases form. During the precipitation of calcium phos-
phate in a supersaturated solution the ﬁrst phase encountered is that of a highly
unstable and short-lived amorphous calcium phosphate (ACP-1) which is followed by
a second amorphous phase (ACP-2) [17]. Subsequently, crystalline octacalcium phos-
phate (OCP) is formed, which matures into the most stable hydroxyapatite phase,
this process is represented in Figure 1.2 [14, 17, 18]. It is the HA mineral phase which
is often deposited at sites of ectopic calciﬁcation and in sites of required calciﬁcation
such as the collagen matrix [19, 20, 21, 22].
Figure 1.2: Schematic of the calcium phosphate phase separation leading to the forma-
tion of HA. The process proceeds via several transient intermediate crystalline and semi
crystalline calcium phosphate phases. Based on an image taken from Holt et al . [23]
.
Biological ﬂuids are complex aqueous suspensions that contain a range of diﬀerent
types of organic and inorganic constituents. Including biological macromolecules (pro-
teins, lipids and carbohydrates), exogenous substances (e.g. drugs and microorgan-
isms) and ionic species [9, 24]. This is because most biological ﬂuids perform several
functions. A good example of this is saliva the functions of which include facilitating
the taste and nutrient content of food, maintaining tooth homoeostasis as well as
3
defending the host from bacteria and other exogenous pathogens [9].
As previously mentioned saliva also contains signiﬁcant concentrations of diﬀerent
ionic species including calcium and phosphate, which are required to maintain the
integrity of tooth enamel [9]. For an ionic species in solution there exists a physical
limit of the amount that can be dissolved before the solution is considered saturated.
Typically a saturated solution will form either a precipitate of solid or gas.
The saturation level of diﬀerent biological ﬂuids can be calculated with respect to
diﬀerent solid phases and it can be determined whether a solution is considered sta-
ble, metastable or unstable. The stability of a biological ﬂuid can be determined by
using thermodynamic principles, by calculation of the thermodynamic equilibrium
constant. In solution, ionic compounds disassociate into their respective constituent
species. In classical thermodynamics, an equilibrium can be established between a
solid phase and the solution, in the case of calcium phosphate ions forming a solid
HA phase:
Ca5(PO4)3(OH)(s) −−⇀↽− OH
−
(aq) + 3PO
3−
4 (aq) + 5Ca
2+
(aq)
The solubility of the formed solid phases is given by the solubility constant, KS
which can be obtained as a product of all ion activities in the solution. For HA the
ion activity product is expressed as :
KS =
{
OH−(aq)
}{
PO 3−4 (aq)
}2 {
Ca2+(aq)
}3
The brackets around the ions correspond to the activities of the ions, for ideal
solutions these are equal to their concentrations, but for concentrated solutions like
bioﬂuids the ion activities are signiﬁcantly smaller then their concentrations. When a
solution is in equilibrium with the solid phase the ion activity value is invariant [10].
The ion activity product of a solid phase forming is dependent on the stochiometry, for
example for a dicalcium phosphate the ion activity product is expressed as {Ca2+}1 ·{
HPO2−4
}1, compared to that of a tricalcium phosphate, {Ca2+}3 · {PO3−4 }2. For
4
these two examples the ion activities take the same form however their magnitudes
diﬀer due to the exponent, so that each calcium phosphate phase has a characteristic
ion activity product. In a solid phase in equilibrium with a solution the ion activity
does not change even when the composition of the solution changes. Therefore, if a
invariant ion activity product is found in the solution, then the structure of the solid
phase can be determined.
The calculation of ion equilibria in biological ﬂuids is now well established [10], and
has been applied to several biological ﬂuids [10]. The model developed by Holt allows
for the activities of each ionic species to be determined and from this the activity
products of diﬀerent crystalline phases can be obtained [10]. The state of equilibrium
can then be determined by dividing the ion activity product (IAP) by the solubility
product of the solid phase (KS), yielding the saturation index deﬁned as Log(S). If
Log(S) > 1 the solution is supersaturated with respect to the solid phase and hence
unstable. On the other hand if Log(S) < 1 the solution is undersaturated with respect
to the solid phase and hence stable.
Thus by calculating Log(S) from experimental data on the composition and ionic
strength of diﬀerent bodily ﬂuids it is straightforward to determine the level of su-
persaturation with respect to HA or any other mineral phase. Such calculations have
been performed by Holt et al . [10] on the supersaturation of diﬀerent bodily ﬂuids
with respect to HA. The results are shown in Table 1.1, they indicate that several
biological ﬂuids are supersaturated with respect to HA. In Figure 1.3 the supersat-
uration of diﬀerent samples of milk calculated with respect to diﬀerent solid phases
of calcium phosphate are shown. It shows that milk is supersaturated with HA but
undersaturated with respect to an amorphous calcium phosphate phase [10].
Unwanted mineralisation of soft tissues, known as ectopic calciﬁcation, is often detri-
mental to mammalian health [25, 26]. Ectopic calciﬁcation can occur in several dif-
ferent organs including the lungs, circulatory tissues and kidneys [1, 27, 28, 29, 30,
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Table 1.1: Salt composition (mM), ionic strength, free ion concentrations (mM) and state
of saturation with respect to calcium phosphate (Log(S)) of human artificial urine and
ultrafiltrates of serum, saliva and milk (Table adapted from Holt et al . [10]).
Serum Urine Saliva Milk
Calcium 1.8 4.1 0.8 7.3
Magnesium 0.6 2.9 - 0.9
Sodium 144.9 148.4 31.6 2.2
Potassium 4.4 42.0 31.0 13.3
Phosphate 1 20.5 2.5 2.2
Chloride 151.8 177.4 58.0 24.1
Citrate - 2.3 - 2.1
Ionic strength 150 187 65.6 35.3
pH 7.4 5.9 7.4 6.8
Ca2+ 1.1 1.8 0.5 4.7
Mg2+ 0.4 1.4 - 0.6
Log(S) 7.74 3.77 7.85 10.02
31, 32]. In humans one of the most prevalent types of ectopic calciﬁcation is that of
the aortic valve, known as aortic stenosis [33, 34]. Calciﬁcation of the aortic valve
leads to a reduction of the function [33, 35]. The risk factors and schematic progress
of aortic calciﬁcation are shown in Figure 1.4 [36].
The likelihood of developing aortic stenosis increases with age [37], consequently the
disease is especially prevalent in the elderly population. The known increased risk
factor is caused by build up of calcium phosphate deposits within the aortic valve
over prolonged time periods [38]. The impact of aortic stenosis on national health in
western countries is increasing as the ageing population increases [39]. Aortic steno-
sis and other diseases of mineralisation are caused by a defect in the system which
regulates biomineralisation. All ectopic calciﬁcations are a result of the precipitation
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Figure 1.3: Calculated log(S) of various samples of bovine milk with respect to different
calcium phosphate phases. Image taken from Holt et al . [10]
of calcium phosphate at unwanted locations within soft tissue. Despite this bioﬂuids
do not readily precipitate calcium phosphate, it is thought that inhibitors of precipi-
tation such as magnesium ions, citrate and most powerfully secreted phosphoproteins
regulate the supersaturation [23, 40]. Examples of inhibitory phosphopeptides include
caseins in milk and osteopontin (OPN) which is present in all bioﬂuids [23, 41]. A
fundamental understanding of the regulatory system(s) involved is essential to sup-
port the design of new materials and therapies, and this a strong motivation for the
work described in this thesis.
1.1.1 The role of phosphoproteins in biomineralisation
Depending upon the type and level of post-translational modiﬁcations present OPN
can either inhibit or increase the rate of hydroxyapatite growth [42, 43, 44]. It is
for example known that sequences of 8 or more phosphorylated residues, such as
those found in the C-terminal half of OPN, can in fact promote the maturation of
amorphous calcium phosphate [45].
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Figure 1.4: Aortic stenosis risk factors, known to increase the chance of developing aortic
valve calcification. Image taken from Rajamannan et al [36]
Due to their levels of saturation with respect to hydroxyapatite, artiﬁcially created
mimetic biological ﬂuids with the same ionic strength and pH of those produced in
vivo are highly unstable and readily precipitate calcium phosphate [46, 47, 48]. In
order for soft and mineralised tissue to coexist a regulatory system must exist which
inhibits ectopic calciﬁcation. One of the major regulatory roles involves of highly
phosphorylated proteins and the control they exert on solutions supersaturated with
respect to HA [23, 45, 49].
Osteopontin and Fetuin A, for example, can inﬂuence the rate of the calcium phos-
phate phase transformation, from the formation of a fresh precipitate of calcium phos-
phate all the way through to the formation of HA [50, 51, 52, 53, 54, 55]. Highly phos-
phorylated proteins including OPN and bone sialoprotein II are also capable of bind-
ing to crystalline hydroxyapatite through densely phosphorylated regions [52, 56, 57].
Caseins are another family of well studied phosphoproteins that have been shown to
stabilise supersaturated milk by the sequestering high levels of calcium phosphate
within a structure known as the casein micelle [15, 58].
Examples demonstrating the importance of phosphorylated proteins in the regulation
of mineralisation can also be found in several other biological ﬂuids. For example in
urine and blood the widely expressed extracellular matrix proteins fetuin-A and OPN
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have been shown to play important roles in many aspects of mineralisation including
the inhibition of HA formation, the promotion of HA formation and the controlled
mineralisation of collagen [59, 44, 57, 60, 61, 62, 63, 64]. Highly phosphorylated pro-
teins such as Caseins, Fetuin-A and OPN can aﬀect the time period of every step in
the conversion of fresh precipitate of calcium phosphate to hydroxyapatite [43, 65, 66].
Highly phosphorylated regions are present in many proteins that regulate biominer-
alisation. If a protein containing such regions is present in suﬃcient molar concentra-
tion in a supersaturated solution then the calcium phosphate is sequestered within
so called calcium phosphate nanoclusters. Small-angle X-ray and neutron scatter-
ing studies have shown that the formed CPNs are core-shell particles with a core of
calcium phosphate surrounded by the sequestering protein [67]. The act of calcium
phosphate sequestration prevents the formation of hydroxyapatite. Evidence is now
accumulating which suggests that the sequestration of calcium phosphate is a general
regulatory mechanism which stabilises supersaturated biological ﬂuids [10, 68]. The
most well studied case of calcium phosphate sequestration is that found in bovine
milk. The function of milk is to facilitate the transport of large concentrations of
calcium phosphate from the mother to the neonate through soft tissue [11, 69]. Con-
sequently bovine milk is supersaturated with respect to HA, yet calciﬁcation of the
mammary gland is rare [23]. About two thirds of the calcium and half the phosphate
is associated with the casein family of proteins, which together form the larger casein
micelle structure [70, 71]. The casein family of proteins can be separated into the cal-
cium sensitive casein α, β and the non calcium sensitive κ-casein [71]. In milk calcium
phosphate is sequestered by the calcium sensitive β-casein resulting in the formation
of calcium phosphate nanoclusters (CPNs) [72, 67, 73]. The act of sequestration leads
to the formation of CPN and the stabilisation of the supersaturated bioﬂuid [67, 74].
β casein is a highly phosphorylated rheomorphoic or intrinsically disordered protein
[75, 76], in bovine milk, β casein contains a sequence of 4 consecutive serines which
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are phosphorylated [75, 76, 77, 78]. Holt et al . [45] described a number of examples of
these highly phosphorylated regions and named them as phosphate centers (PCs). A
PC is a short acidic sub-sequence in which three or more residues are phosphorylated.
A typical example from caseins is the sequence of the single PC of bovine β casein:
-E-pS-L-pS-pS-pS-E-E-, where pS is a phosphoseryl residue [45]. Other examples in-
clude sequences in OPN and other phosphoproteins from mineralised tissues including
the protein orchestin [45]. The non-phosphorylated acidic residues in PCs and their
ﬂanking sequences may also inﬂuence the strength of binding. The eﬀect of adding
Asp residues to a PC was explored by recombinant methods applied to casein-like
sequences [79]. Non-PC less highly phosphorylated sequences and unphosphorylated
acidic sequences can, for example, bind to crystalline calcium phosphates or inhibit
the maturation of ACP [52] but they have not, so far, been demonstrated to form
the equilibrium nanocluster complexes. Amino acid sequences can only be considered
phosphate centres if three or more of the potential sites of phosphorylation are phos-
phorylated. It is through these highly phosphorylated regions that β-caseins interact
with calcium phosphate and facilitates the formation of calcium phosphate nanoclus-
ters [67, 74, 23]. Other phosphate centre containing proteins including OPN have also
been shown to be able to sequester calcium phosphate in a similar manner [79, 45].
In order to understand the act of calcium phosphate sequestration a thermodynamic
description has been developed [72, 74].
1.1.2 A thermodynamic model of calcium phosphate seques-
tration
The formation of calcium phosphate nanoclusters can be understood in terms of a
thermodynamic model of calcium phosphate sequestration. Formation of stable equi-
librium core-shell nanoparticles can be divided into two parts, the energy of formation
of the core and the sequestration of ACP by the protein shell. The chemical potential
of a system is deﬁned by classical thermodynamics as a form of potential energy that
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is released or absorbed during a phase transition. In solution the variation of chemi-
cal potential is expressed by relating the quantities with the concentration. Classical
thermodynamics allows the calculation of the chemical potential of a species (µi) from
the activity of the species in solution (ai) so that:
µi = µ
std
i +RT ln ai (1.1)
where µstdi is the potential in a standard state, R is the Boltzmann constant and T the
temperature. In the case of calcium phosphate nanoclusters there exists a chemical
potential for both the protein monomer (µm) and the nanocluster form (µCPN).
µm = µ
std
m +RT ln am (1.2)
At equilibrium µm = µi then the Gibbs free energy is ∆G·i = µi − µm then if Ki is
the equilibrium constant for the nanocluster formation then:
∆G·i = −RT ln
(
ai
a1
)
= −RT lnKi (1.3)
The chemical potential of the calcium phosphate bulk phase is equal to the chemical
potential of the monomer in a saturated solution:
∆Gcore = RT ln as (1.4)
The Gibbs free energy of formation of an equilibrium complex between a core of
calcium phosphate and a sequestering phosphopeptide (∆Gcpn), can be divided into
the free energy of formation of the calcium phospahte core (∆Gcore) and the free
energy of sequestration of the shell of phosphopeptide (∆Gseq), to form the resulting
core-shell particle. For a complex containing imoles of calcium phosphate sequestered
by a shell containing j moles of phosphopeptide:
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∆Gcpn = i∆Gcore + j∆Gseq (1.5)
The CPN is then assumed to have a spherical structure, with the number of
phosphopeptides proportional to the surface of a sphere:
∆Gcpn = i∆Gcore + ki
2/3∆Gseq/A (1.6)
where k = (36πV 2acp)
1/3, A is the core surface area occupied by the sequestering
phosphopeptide, Vacp is the molar volume of ACP. The average modal core radius
(rcore) is then given by:
rcore ≈

 2kγ
3RTln
(
a1
as
)

(3Vcore
4π
) 1
3
(1.7)
where γ is the surface energy of the protein shell. Replacing the Gibbs free energy of
the core formation with the activity of ACP in solution (a1) containing the complex
(as) saturated with respect to the bulk ACP phase, is then:
rcore ≈
(
2k∆Gseq
−3Acore∆Gcore
)(
3Vcore
4π
) 1
3
(1.8)
If there is a reaction between the phospopeptide and the core surface then ∆Gseq
will be negative and hence a1 < as in which case the surface energy is negative and
the solution is undersaturated and hence stable. The above equation shows that the
radius of a calcium phosphate core varies inversely with the Gibbs free energy of the
calcium phosphate core, (∆Gcore). A crystalline core would have a much higher lattice
energy compared to an amorphous core, therefore decreasing the likelihood that the
core is crystalline.
Another condition for the formation of a stable calcium phosphate nanocluster is an
stoichiometric excess of phosphate centres, the fraction of reacted phosphate centres
12
(α) required for a stable solution is then [72]:
α =
[p]
f [pp]Rp
(1.9)
Where [p] is the molar concentration of phosphate, [pp] is the molar concentration of
phosphorylated peptides containing f phosphate centres and Rp is the stoichiometric
ratio from the empirical formula of a calcium phosphate nanocluster which is given
by:
CaRcaHRh(Pi)Rp(H2O)RwR−PC
For a solution to be stable α must be equal to or less then 1. Above an α value of 1
the solution can remain metastable but over time a precipitate will form.
Based on the model, calculations can be performed on biological ﬂuids to determine
the region of stability and the molar concentration of phosphate centers required to
stabilise the solution. The calculation is explained in detail by Holt [72], and requires
certain parameters shown in Table 1.2
Table 1.2: Parameters required for the calculation of stability of different biofluids, table
adapted from Lenton et al . [68].
Parameter Description
C1, C2, Cn Concentration of the n principal salts
RC1, RC2, RCn Molar ratio of each salt constituent to PC in the complex
[PC] Concentration of phosphate centres
y acidity of the calcium phosphate
Ks Solubility constant
v(C1, C2, Cn) Isotherm describing the aﬃnity of the salt to the PC
The theory of nanocluster formation and their ability to stabilise biological ﬂuids has
been tested experimentally [10]. Figure 1.5 shows that there is a close agreement
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between the predicted stability of a synthetic bioﬂuids and the observed stability.
Showing that suﬃcient concentration of phosphate centre containing proteins can
stabilise synthetic bioﬂuids, phosphate centre concentration is in stoichiometric excess
of the calcium phosphate ions.
Figure 1.5: Stability diagrams of artificial biofluids, using different phosphate centre con-
taining proteins. The calculated border of stability is indicated by a dashed line, the circles
indicate synthetic mimetic biofluids. Filled circles are samples which formed precipitate.
(A) Stabilisation of synthetic serum by β-casein isolated from milk. (B) Stabilisation of
serum by NaCPP another phosphopeptide. (C) Stabilisation of serum by OPNmix. (D)
Stabilisation of saliva by OPNmix. Image taken from Holt et al . [10].
1.2 The structure and function of osteopontin
Osteopontin (OPN) is a highly phosphorylated sialoprotein expressed in numerous
diﬀerent bodily tissues including brain, kidney and mineralised tissue [80]. In con-
trast to OPN function in bioﬂuids, the main function of OPN in the brain and kidney
is that of a signalling molecule [80]. Signiﬁcant concentrations of OPN have been
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found in all bodily ﬂuids where it has been sought including in milk and the ex-
tracellular matrix of bone and teeth [81, 82, 83]. OPN is a member of the small
integrin binding ligand, N-linked glycoproteins (SIBLING) family of proteins [84].
This group of proteins share several common features including a large degree of
post-translational modiﬁcation and a high level of ﬂexibility in the protein structure
[84]. Characteristically of SIBLING proteins OPN is extensively modiﬁed by post-
translational modiﬁcations including phosphorylation and glycosylation, resulting in
a distribution of diﬀerent OPN peptides with varying functional groups and molecular
masses [84, 85, 59, 86, 87]. Post-translational modiﬁcations of OPN are often tissue
dependent and allow OPN to mediate many diﬀerent cellular and biological processes
in vivo [88]. Procceses regulated by post-translational modiﬁcation of OPN include
bone remodelling [89], cell signalling [90] and regulation of the inﬂammation response
[91]. There are abundant examples of the functional relevance of phosphorylation
in OPN [88]. The process of bone remodelling and growth are greatly aﬀected by
the levels of phosphorylation of OPN. For example OPN promotes the attachment of
osteoclasts provided that the protein is phosphorylated [92], a condition that is also
essential to the ability in inhibiting hydroxyapatite formation [59, 44]. Likewise in
urine and soft tissues phosphorylation of OPN is required to inhibit crystallisation of
calcium phosphate [93, 94, 95]. The kinases responsible for phosphorylating secreted
osteopontin have been identiﬁed as Casein kinase IIα and FAM20C [96, 97, 98].
In humans OPN is expressed as a 300 amino acid sequence but matures into a 264
residue chain with a molecular mass of 42.9 kDa [86]. The mature human sequence
contains 36 sites of phosphorylation and 5 sites of glycosylation, compared with 28
and 3 respectively for bovine OPN (Figure 1.6) [99, 86]. OPN isolated from bovine
milk is known to bind calcium in several diﬀerent locations in the sequence in a non
phosphorylation dependent manner, with a slight increase in the association constant
observed upon phosphorylation of OPN [100]. This is thought to be due to the
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Figure 1.6: Sequence alignment of human and bovine OPN. Amino acid residues high-
lighted in red are conserved accross the species.
higher charge charge interaction introduced by the phosphorylated residues [100].
Upon going down the Hofmeister series the aﬃnity of OPN to diﬀerent ions decreases
signiﬁcantly proving that the association is a charge charge interaction and not due
to conformational space requirements [100]. The calcium binding locations in bovine
OPN have been identiﬁed, and are shown in Figure 1.7.
Figure 1.7: Sequence of full length bovine OPN with the 28 phosphorylation sites indi-
cated (blue circles) and acidic residues (yellow). Calcium binding sites proposed based on
experimental data are indicated by red circles representing Ca2+ ions. Image taken from
Kläning et al . [100].
The sequence of OPN is highly conserved across mammalian species (for example see
Figure 1.6) in particular regions containing motifs of serines and threonines [99]. The
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structures of OPN from diﬀerent species have been characterised using several dif-
ferent techniques. NMR studies of quail OPN determined a highly ﬂexible structure
of the protein and addition of calcium ions to the buﬀer did not induce structural
changes [101]. Other studies completed by one dimensional NMR on human OPN
from recombinant sources showed a similar high ﬂexibility and lack of secondary struc-
ture elements [84]. It is now generally accepted that the lack of a folded or globular
structure, along with the many post-translational modiﬁcations it undergoes, are cen-
tral to the functional diversity and speciﬁcity of OPN [50]. Many proteins involved in
the regulation and formation of biominerals in mammals are either known to have or
are predicted to have a large degree of disorder [102, 103]. These include the casein
family of proteins and more recently OPN. These proteins are capable of sequestering
calcium phosphate thereby forming stable calcium phosphate nanoclusters which pre-
vent supersaturated bioﬂuids from precipitating. It is believed that intrinsic protein
disorder is vital for the formation of these nanoclusters and hence the stabilisation of
many diﬀerent biological ﬂuids.
1.3 Intrinsically disordered proteins
It was previously thought that proteins require a well-deﬁned three dimensional struc-
ture to carry out their biological function, the so called structure function paradigm
[104]. In recent years, however, it has become increasingly obvious that there exists a
large group of proteins that are either completely disordered or contain large domains
of disorder, and that therefore well deﬁned three-dimensional structures are not nec-
essarily required for protein function [104]. Figure 1.8 schematically highlights this
dichotomy.
Disordered proteins or disordered protein regions are deﬁned as dynamic ensembles in
which atomic positions and Ramachandran angles vary signiﬁcantly over time without
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Figure 1.8: Structured regions and disordered regions are fundamental protein building
blocks. In recent years the idea of a disorder-function paradigm has become accepted. Many
proteins consist of a combination of both structured and unstructured regions and can be
classified by their amount of disorder. Image taken from Van der Lee et al . [105].
a well deﬁned equilibrium value, in contrast to folded proteins which only have small
amplitude thermally driven motions about an equilibrium position [105]. In recent
years it has become clear that intrinsically disordered proteins (IDPs) are involved
in many key biological regulatory processes including regulation of the cell cycle and
signal transduction [106]. It is now known that around 40% of the protein coding genes
in the human genome contain disordered regions of at least 30 amino acid residues
[107]. The traditional structure function paradigm states that proteins fold into a
well deﬁned three-dimensional structure due to the preferred thermodynamic stability.
The collapsed globular state of a folded protein is stabilised by several diﬀerent forces,
including the hydrophobicity of the amino acid residues in the core of the globular
protein and the formation of disulﬁde bridges. It is now clear that proteins can contain
structured or disordered regions and that both of these fundamentally diﬀerent types
of protein regions must be considered individually to study function.
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IDPs contain a diﬀerent distribution of amino acid composition compared to globular
proteins, often including large stretches of low complexity amino acid residues [108].
Low complexity regions are deﬁned as those containing little diversity in their amino
acid composition and often contain repeats of the same amino acid residues. The
evolution of largely disordered proteins diﬀers from that of their ordered counterparts
mainly due to the lack of structural constraints within the amino acid sequence [109]
resulting in a more rapid evolution of IDPs compared to globular proteins [110]. An
example of this is the linker region in a unstructured linker domain in RAP70 [111]
where the amino acid sequence conservation is low yet the disordered behaviour is
conserved across species. Due to their low sequence complexity, lack of hydrophobic
amino acids and tendency to be enriched in charged and polar amino acids it is
possible to analyse sequences and predict the tendency for protein disorder [112,
113]. A number of diﬀerent disorder predictors now exist based on several diﬀerent
techniques. Ab initio methods are one of the more popular methods used as they rely
only on the primary amino acid sequence of the protein [114]. For example IUpred
[115] predicts the disorder tendency of an amino acid sequence based on the capacity
of the sequence to form inter-residue interactions to stabilise the globular state [115].
1.3.1 The energy landscape of IDPs
A protein in solution samples a variety of conformations based on thermal ﬂuctua-
tions which can be described by the dependence of free energy on the amino acid
conﬁguration in three dimensional space, see Figure 1.9. Folded proteins are charac-
terised by a well deﬁned energy minimum within which the secondary and tertiary
structures of the globular protein are located. IDPs on the other hand, do not adopt
a well deﬁned tertiary structure, instead the structure of the protein ﬂuctuates within
a conformational ensemble [116]. The free energy landscape of IDPs is therefore best
described by a more featureless energy landscape with several local energy minima
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separated by low energy barriers (Figure 1.9) [117, 118]. Changes to the environmen-
tal conditions may therefore have a great eﬀect on the conformational ensemble of
an IDP present in solution. For example Figure 1.9 C shows the eﬀects of increasing
amounts of folding upon binding of an IDP to the sampled energy landscape [119].
Figure 1.9: Energy landscapes depicted for (A) A globular protein. (B) A IDP and (C)
Different degrees of folding upon binding of an IDP. Image taken from [119].
1.3.2 Post-translational modifications of IDPs
Amajor characteristic of IDPs is their increased tendency to undergo post-translational
modiﬁcations (PTMs) compared to globular proteins [120, 121]. Computational pre-
dictions have shown that there is a strong link between the amount of predicted
protein disorder and the extent of PTMs [122, 123]. PTMs are classiﬁed as chemical
changes inﬂicted upon a peptide chain after translation. Currently around 300 diﬀer-
ent types of post-translational modiﬁcations are known to occur under physiological
conditions [124]. The diﬀerent types of PTMs range from the addition of chemical
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groups, such as phosphates and carbohydrates, to the digestion of the amino acid
chain by proteolytic enzymes [124, 125]. The extent and amount of post-translational
modiﬁcations greatly aﬀect the structural and functional properties of proteins, in-
cluding the stability and localisation in the cell as well as the aﬃnity of proteins to
their ligands [126]. The nature of and amount of PTMs eﬀecting diﬀerent IDPs are
often highly cell speciﬁc which allows for tuning of the protein function for speciﬁc
cellular processes [88]. The reversible nature of certain PTMs (e.g. phosphorylation
and acteylation) provides a regulatory switch turning on and oﬀ speciﬁc biological
processes, this type of regulation is often found in signalling pathways [127]. For
example the circadian clock is highly regulated by diﬀerent types of kinase and phos-
phatase enzymes [128]. The higher rate of PTMs found in IDPs or IDP regions is
thought to be in part due to their increased ﬂexibility which allow for easy recognition
and consequent modiﬁcation by PTM enzymes, as more of the amino acid chain is
accessible to both solvent and the enzymes that undertake PTMs [122]. The rapid
turning on and of oﬀ IDP function by PTM enzymes makes them ideal for regulat-
ing cell signalling resulting in a high degree of IDP participation in these processes
[129, 130].
1.3.3 Mechanisms of IDP complex formation
One of the key features of IDPs is their ability to bind many diﬀerent types of pro-
teins or substrates, an ability which seems to be unique to IDPs and as mentioned
previously inﬂuenced by the amount and type of PTM [131]. IDPs that are capable
of interacting with many binding partners are known as hub proteins [132, 131]. The
conformational freedom of IDPs allows them to adopt diﬀerent conformational struc-
tures when bound to their partners which are often highly diverse [133]. The result is
a range of diﬀerent types of complexes with a wide range of structural and dynamical
features. The following is a non-exhaustive list of some of the key mechanisms that
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underpin IDP interactions with their partners. They can be broadly separated into
static disorder based complexes and dynamic disorder based complexes [134].
1.3.4 Static-disorder based complexes
This type of complex is based on the recognition and binding of a speciﬁc three
dimensional conformation of an IDP by an often globular partner. The formed com-
plexes are referred to as static because they can be described by a well deﬁned three
dimensional shape. The two main types of static-disorder based complexes are those
formed by conformational selection and those formed by binding induced folding.
Conformational selection states that the intrinsically disordered substrate protein
is ﬂuctuating through its heterogeneous ensemble in solution. The binding partner
selects one or several of the compatable heterogeneous conformations thereby shifting
the heterogeneous population towards a selected conformational state [135, 136]. The
model therefore suggests that the heterogeneous ensemble of structural conformations
contains structures that resemble the bound state [137]. In the case of IDPs this allows
one disordered protein to be a binding partner for multiple proteins, each selecting for
a diﬀerent structural conformation. Distributions of the heterogeneous ensemble of
conformations not only depends upon the amino acid sequence but also external eﬀects
such as post-translational modiﬁcations which are capable of shifting the structural
conformational ensemble towards one which is more favourable to binding [138, 139].
Classiﬁed as a disorder to order mechanism binding-induced folding states that folding
of certain IDPs takes place upon partner binding [140]. The ﬁrst step in binding-
induced folding is the recognition of a partner through a certain motif which is followed
by folding of the IDP partner [141, 142]. It is believed that by adopting an unfolded
conformation the protein has a larger capture radius allowing it to more rapidly
interact with the partner, but its biological function is completed once bound in the
folded state.
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1.3.5 Dynamic-disorder based complexes
Several IDPs contain regions within which their structural heterogeneity is conserved
upon complex formation. Increasing the rigidity or removing these regions aﬀects the
binding aﬃnity and speciﬁcity [143]. The maintenance of structural disorder upon
complex formation is termed fuzziness and the complexes formed are known as fuzzy
complexes. The maintenance of conformational heterogeneity in fuzzy complexes is
of critical importance and often the disordered regions provide sites for other proteins
to bind or post-translational modiﬁcations to occur [143].
1.3.6 Intrinsic disorder, osteopontin and biomineralisation
Intrinsically disordered proteins are proteins that do not feature any signiﬁcant sec-
ondary or tertiary structural elements. Therefore their crystal structure can not be
determined. However, the function of intrinsically disordered proteins may be related
to their structure in a similar manner to globular proteins. For example, all proteins
shown to sequester calcium phosphate thereby forming calcium phosphate nanoclus-
ters are shown to be intrinsically disordered. The ability to sample a large area of
conformational space and rapidly recognise binding partners is a major beneﬁt of
adopting an intrinsically disordered structure. The eﬃcient sampling of a large area
of conformational space also allows intrinsically disordered proteins to recognise and
bind a large subset of binding partners.
1.4 Scope of this thesis
In this thesis some of the questions of the role of intrinsic disorder in the sequestra-
tion of calcium phosphate are answered using a range of diﬀerent techniques. The
heterogeneous conformations of OPN1-149 in solution are determined by SAXS com-
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bined with the EOM method. The rigidity of OPN1-149 is then determined by elastic
incoherent neutron scattering and related to the heterogeneous structural ensemble
of OPN1-149. The eﬀects of sequestering calcium phosphate on the rigidity is also
determined by elastic incoherent neutron scattering, providing evidence that IDPs
can maintain a disordered structure but acquire diﬀerent dynamical properties. The
core-shell nature of calcium phosphate nanoclusters stabilised by OPN1-149 is con-
ﬁrmed by small-angle neutron scattering in combination with contrast variation. The
core of the calcium phosphate nanocluster is determined to have amorphous proper-
ties by neutron and X-ray diﬀraction. That the core is amorphous is important for
the biological function of the formed calcium phosphate nanoclusters, allowing them
to act as reservoirs of calcium phosphate for hard tissue mineralisation. Furthermore,
human osteopontin is prepared using recombinant methods in order to determine the
eﬀects of phosphorylation on the protein structure and dynamics. The results provide
further insight into the function of this regulatory protein in vivo.
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Chapter 2
Methods - theoretical background
The work within this thesis utilises a range of biophysical techniques to characterise the
structure and dynamics of different osteopontin peptides. This chapter aims to provide a
general, non-exhaustive, introduction to several of the key techniques employed. More detail
about the experiments performed are given in the corresponding results chapters.
2.1 Properties of the neutron
The neutron is a nuclear particle that decays into a proton, an electron and an electron
antineutrino. A neutron has no net negative charge and a slightly higher mass then
a proton, some of the fundamental properties of the neutron are shown in Table 2.1
and compared against those of the proton.
Neutrons can be described as waves with the wavenumber, K, deﬁned as
K =
2π
λ
(2.1)
Where λ is the neutron wavelength. The momentum of a neutron can be calculated
based on it’s mass mn and it’s velocity v by:
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Table 2.1: Properties of the neutron and the proton.
Neutron Proton
Mass 1.675 · 10−27 kg 1.672 · 10−27 kg
Charge 0 1
Spin 1/2 1/2
Magnetic moment 0.966 · 1026J · T 1 1.410 ·1026J · T 1
p = mnv = ~K (2.2)
Where ~ is Planck’s constant and v the neutron velocity. The kinetic energy (E) of
the neutron can then be calculated by:
E = (~2/2mn)K
2 (2.3)
The wavelength of a neutron is thus dependent on it’s energy, which in turn depends
upon temperature:
λ =
~
mnv
(2.4)
v =
E
~
(2.5)
E = KBT (2.6)
where KB is the Boltzmann constant and T the temperature. In order to study
matter neutrons with similar wavelengths to interatomic distances are required, cor-
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responding to energies on the order of meV. Neutrons emerging from either ﬁssion or
spallation sources have energies of an order of MeV. In order to produce neutrons of
lower energy the produced neutrons are slowed down by a moderator. A moderator
lowers the neutron energy by thermal equilibration typically by inelastic collisions
with light atoms. The resulting neutrons are characterised by their temperature and
corresponding wavelengths shown in Table 2.2. At the Institut Laue-Langevin neu-
trons are moderated to thermal energies using liquid D2O to cold temperatures.
Table 2.2: Neutron energies and corresponding properties.
Ultra cold Cold Thermal Epi-thermal
Energy (E) 0.25 µeV 1 meV 25 meV 1000 meV
Temperature (K) 3 mK 12 K 290 K 1000 K
Wavelength(λ) 57 nm 0.9 nm 0.18 nm 0.029 nm
Velocity (v) 6.9 ms−1 440 ms−1 2200 ms−1 1400 ms−1
2.2 The neutron scattering process
Neutrons interact with the atomic nuclei of many atoms in the sample. The scattering
per atom is given by the double diﬀerential cross section:
d2σ
dΩdEout
=
σs
4π~
·
Kin
Kout
· S(q, ω) (2.7)
where Kin and Kout are the incident beam and scattered beam, respectively, S(q, ω)
is the scattering cross section and ~ is Planck’s constant. The diﬀerence, between the
incident and scattered beam is then deﬁned as the scattering vector ~q, given by:
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~q = Kout −Kin (2.8)
This process is represented schematically in Figure 2.1 .
Kin
Kout
A
2θ
Kin
Kout
q
B
Figure 2.1: (A) The scattering process is described by two vectors the incident beam, Kin
and the scattered beam Kout (B) The momentum transfer (q) is defined Kin −Kout
The total scattering cross section, σtotS(q, ω), contains coherent and incoherent con-
tributions:
σtotS(q, ω) = [σcohScoh(q, ω) + σincSinc(q, ω)] (2.9)
where Scoh(q, ω) and Sinc(q, ω) are the coherent and incoherent scattering functions
and σcoh and σinc are the coherent and incoherent scattering cross sections. The
interaction of a neutron with the atomic nuclei of a sample can result in several
diﬀerent processes including diﬀraction, inelastic scattering and coherent inelastic
scattering.
During a diﬀraction type experiment the angular dependence of the scattered inten-
sity, deﬁned as S(q), is measured:
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S(q) =
∫
S(q, ω)dω (2.10)
A diﬀraction measurement reﬂects the spatial arrangement of atoms in the sample and
the scattering proﬁle depends upon this arrangement of atoms in 3-dimensional space.
In a crystalline material diﬀraction gives rise to Bragg peaks, in a semi crystalline
material the scattering is more diﬀuse and if the sample is in solution as is the case for
small-angle scattering experiments the resulting pattern is further diﬀused, examples
are shown in Figure 2.2.
Figure 2.2: Scattering function shown for three different types of sample. (A) Bragg
diffraction observed for crystalline material. (B) Diffuse scattering observed for semicrys-
talline material. (C) Small-angle scattering observed for a heterogeneous non crystalline
solution.
During a small-angle scattering experiment the angular dependency of the scattered
intensity (S(q)) is measured, which reﬂects the spatial rearrangement, (p(r)), of the
atoms. To remain independent of the wavelength (λ) of the incident radiation the
scattering patterns are usually represented as a function of q, deﬁned as:
q =
4π
λ
· sin(θ) (2.11)
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where the scattering angle between the incident beam and the recorded intensity is
2θ.
2.3 Small-angle scattering
Measurement of the scattered intensity as a function of scattered angle at small angles
can provide information about the structure of a particle in solution at low resolu-
tion. This technique is known as small-angle scattering. The information provided by
small-angle scattering depends on the sample studied and can range on structural in-
formation of individual particles to interactions between them. The exact length scale
studied depends upon the wavelength of the incident beam and the angle measured.
Both neutrons and X-rays can be produced at the appropriate range of wavelengths,
and the underlying principles for the analysis of the scattering data are similar. A
schematic diagram of a small-angle scattering experiment is shown in Figure 2.3.
During a basic SAS experiment a solution containing the biological sample is inserted
into a beam of monochromatic radiation (neutrons or X-rays) and the intensity of
the scattered bean is recorded as a function of the scattered angle. An identical mea-
surement is then performed on the buﬀer in which the sample was measured and is
subtracted from sample scattering, the diﬀerence in signal arising from scattering of
the biological macro-molecule this process is represented schematically in Figure 2.3.
In order to determine the structural properties of biological macromolecules dilute
solutions have to be measured where interparticle interactions are absent. This con-
centration normally lies around a few mg/ml. Typical protein samples measured by
SAS are two phase systems, with scattering contributions from the macromolecule
and from the solvent. The diﬀerence between the scattering of the sample and it’s
solvent is known as contrast. One of the major diﬀerences between SAXS and SANS
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Monochromatic beam
X-ray, neutron
sample
solvent
Kin
Kout
q
Figure 2.3: Schematic layout of a basic SAS experiment, the momentum transfer q is
defined as the incident beam (Kin) minus the scattered beam (Kout). The detector is
represented by the blue bar.
is the cause of contrast. For small-angle X-ray scattering the contrast arises due to
the diﬀerence in electron density between the sample and the solvent. If the sample
to be measured (M1) is present in a solute (M2) then the contrast (Dr) is deﬁned
as:
Dr = M1−M2 (2.12)
Because biological macromolecules are mainly constructed of lighter atoms this dif-
ference can be quite small, therefore experiments are often performed at synchrotron
radiation sources which provide a X-ray beam with high intensity and brightness.
For a SANS experiment depends upon the diﬀerence between the scattering length
of the sample (p(s)) and solvent (po). So that the contrast (S(q)) between the sample
and solvent is deﬁned as:
S(q) = p(s) − p
o (2.13)
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During a small-angle neutron scattering experiment the scattered intensity of the
incident beam depends upon the excess neutron scattering length of the atomic con-
stituents. Unlike electron density which increases with increasing molecular mass the
neutron scattering length is dependent on nuclear properties (spin, energy levels) and
there is no linear dependency of molecular mass, even isotopes of the same atom can
have diﬀerent neutron scattering lengths (Figure 2.4).
Figure 2.4: The variation of the coherent scattering length does not increase linearly with
atomic mass.
A useful feature of neutron scattering is the ability to alter the contrast of the solvent
using isotope replacement. For example deuterium has a neutron scattering length of
6.671fm compared to −3.742fm of hydrogen. Therefore it is possible to change the
scattering length of the solvent and match out scattering of diﬀerent constituents of
the sample. This phenomenon of varying the percentage of deuterium in the solvent
is known as contrast variation and is shown schematically in Figure 2.5.
2.3.1 Model independent analysis of small-angle scattering data
As previously mentioned during a SAS experiment the intensity of the scattered
beam is measured as a function of the angle (I(q)). The recorded spectra contains
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Figure 2.5: Average neutron scattering length densities for molecules commonly present
in biological molecules as a function of the percentage of D2O in solution. By altering the
concentration of deuterium in the solvent it is possible to match-out contributions from
different samples in the solution. For example at 40% D2O contributions from protein
scattering are matched out.
information about the size and shape of the particle on the size scale determined by
the measured q-range. Several model independent characteristics of the scattering
sample can be determined from the scattering spectra including the molecular mass,
the radius of gyration (RG) and the maximum particle diameter (Dmax). The most
straightforward model independent data analysis is the Guinier analysis developed
by Guinier in the 1930s [144]. The Guinier analysis allows for the extraction of the
(RG) and the forward scattering intensity (I(0)), by the Guinier equation:
I(q) = I(0)exp
(
−
1
3
R2Gq
2
)
(2.14)
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A linear ﬁt to the plot of lnI(q) against q2 therefore allows for the extraction of
the radius of gyration from the slope and I(0) from the intercept of the slope. The
Guinier approximation is only valid for low q regions for globular proteins this region
corresponds to q∗RG ≤ 1.3. A deviation from a linear behaviour in the Guinier region
deﬁned by q ∗ RG ≤ 1.3 is indicative of poor sample caused by either interparticle
interactions which can be caused by radiation damage induced by the incident beam.
Once it has been determined from the Guinier analysis that there is no radiation
damage or interparticle eﬀects the value of the forward scattering intensity (I(0)) can
be used to determine the molecular mass if a standard of known mass has also been
measured. According to the relationship [145]:
MP = I(0)p/Cp ·
Mst
I(0)st/Cst
(2.15)
Where MP and Mst are the molecular masses of the protein sample and the standard
respectively. I(0)p and I(0)st are the forward scattering intensities of the sample
and standard and Cp and Cst are the concentrations of the sample and standard, in
grams per litre. The accuracy of this analysis is limited (10 - 20 %) but is suﬁcient
to determine the oligomeric state of the protein [145].
Information about the compactness of the scattering particle can be obtained by
the Kratky plot (q2 ∗ I(q) against q). Where the Guinnier plot looks at structural
features at low q the Kratky plot emphasises structural features at higher values of q.
Examples of diﬀerent types of biological macromolecules and the corresponding shape
of the Kratky plot are shown in ﬁgure Figure 2.6. By the Kratky plot analysis it is
therefore relatively straightforward to determine whether the sample studied adopts
a globular or unfolded conformation in solution.
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Figure 2.6: Kratky plot of different biological macromolecules. Due to their well defined
globular shape folded proteins show a defined maxima, whereas natively unfolded proteins
increase at higher values of q. Image taken from Bernado et al. [146].
It is also possible to extract information on the size and shape of the particle through
indirect Fourier transform methods. A transform can be applied to the scattering data
to obtain the spherically averaged auto-correlation function of the excess scattering
density yielding the pair distribution function, p(r). The p(r) function essentially
provides a histogram of all distances between pairs of points in the scattering particle.
The p(r) function is deﬁned as:
p(r) =
1
2π2
∫
∞
0
srI(s)sin(sr)ds (2.16)
The p(r) is a function in real space, which is related to the measured scattering
intensity I(s) by an inverse transform:
I(s) = 4π
∫
∞
0
p(r)
sin(sr)
sr
dr (2.17)
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The value of p(r) reaches zero when the radius exceeds the maximum pair of distance
in the sample, a point known as Dmax. Therefore the upper limit on the inverse
transform can be replaced by Dmax (instead of inﬁnity). The p(r) function can then be
obtained indirectly from this inverse transform. This method, known as the indirect
Fourier transform method [147], assumes that p(r) can be represented by a linear
combination (K) of orthogonal functions (Wk) in the range 0 to Dmax, where Dmax
must be obtained.
p(r) =
K∑
K=1
ckφk(sk) (2.18)
The optimal value of ck is obtained by minimisation of
φ = χ2 + αP (p) (2.19)
where χ is a measure of the goodness of ﬁt between experimental and calculated data.
The calculated data is obtained by the following direct transform of the p(r) function.
The variable α provides a balance between the ﬁt of the curve to the data and the
smoothness of the curve, and P(p) smooths out the p(r) function (equation ahead):
χ2 =
1
N − 1
·
[
Iexp(SJ)− cIcalc(SJ)
σ(Sj)
]
(2.20)
where N is the number of data points, σ the standard deviation and c is the scaling
factor.
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P (p) =
∫ Dmax
0
[
P
′
]2
dp (2.21)
The p(r) distribution not only provides information about the maximum distance but
also on the shape of the particle, see Figure 2.7.
Figure 2.7: Distance distribution functions calculated for different geometrical shapes.
Image taken from Mertens [148].
The indirect Fourier transform program, GNOM, automatically performs the calcu-
lation and provides as output the p(r) function for a given solution [147].
2.3.2 Ab initio modelling
The p(r) function obtained by indirect Fourier-transform methods can be used to pro-
duce scattering envelopes of the biological sample. The most common used software
for ab initio modelling is the DAMMIN software provided by the ATSAS package
[149]. DAMMIN stands for dummy atom model minimisation, the software builds
model by assuming that each scattering particle is built up of a collection of beads
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within a spherical search volume which has a maximum size corresponding to the
Dmax. Each bead is randomly assigned to either solvent (black), or structure (yel-
low), in random positions (Figure 2.8). From the random starting position, the beads
are re-arranged, one at a time, and the ﬁt of the new model to the scattering curve
is determined and evaluated by χ2 in equation 2.20. Limits are applied to the model
including that all beads must be connected and that the resulting model must be
compact. The algorithm of DAMMIN is essentially as follows:
1. Start from a random position (X0)
2. Select a random atom, change it from solvent to sample (X2) and calculate the
change (δ = X2 −X0)
3. If δ =< 0 then X2 is the new position and move to next step, else repeat step 2
4. After T steps, if no change is observed for the movement of any atom then ﬁnish
modelling. Where T is given by the user.
There are several drawbacks to using ab initio methods to recover a low reso-
lution structure. Most important to remember is that using these methods a three
dimensional shape is being reconstructed from essentially a one dimensional data set.
2.3.3 Flexibility analysis of SAS data by ensemble optimisa-
tion methods
Highly ﬂexible systems such as intrinsically disordered proteins (IDPs) are not repre-
sented by a single molecule in solution. Instead these structures exist as a heteroge-
neous ensemble of diﬀerent conformational structures. Using SAS it is possible to gain
several diﬀerent types of data from IDPs some of which have already been discussed.
One of the most useful applications of small-angle scattering in terms of structure
determination is the possibility to asses the ﬂexibility of IDPs. Classical analysis of
small-angle scattering data results in a single scattering envelope which represents the
studied biological macromolecule and ﬁts to the experimentally determined scattering
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Figure 2.8: The ab initio modelling process using DAMMIN. (A) From the p(r) distri-
bution of the experimental curve a maximum spherical search volume is found. The fitting
procedure is then started until the calculated scattering curve matches the experimentally
determined curve. (B) Graphical depiction of the spherical search volume determined by
Dmax, with beads assigned going from the starting point to the final bead model. Image
taken from Mertens et al . [148]
curve. In reality ﬂexible systems exist as a large distribution of diﬀerent conforma-
tional structures. A method to analyse data based on this has been developed and is
known as the ensemble optimisation method (EOM). This method represents these
heterogeneous structures present in solution by an ensemble of structures containing
N diﬀerent conformations. The scattering from this ensemble can be calculated from
the average scattering of N structures present in the ensemble.
In order to pick an ensemble of structures ﬁrst a large pool (M) of structures is
generated at random based on the amino acid sequence of the protein. The amount
of structures in this pool is enough so that all areas of conformational space are
covered. From this large pool of structures a subset of conformations is picked that
best represents the experimental scattering curve. This is achieved by a Monte Carlo
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based search. If it is assumed that each of the diﬀerent conformational models are
uniformly populated, so that the intensity of a subset I(q) containing N conformers
is
I(q) =
1
N
N∑
n=1
In(q) (2.22)
Where In(q) is scattering from the n-th conformation and q is the momentum transfer
(as previously deﬁned). The scattering curve is calculated for each model according
to
χ2 =
1
K − 1
K∑
j=1
[
µI(qj)− Iexp(qj)
σ(qj)
]2
(2.23)
Where K is the number of experimental points on the scattering curve, Iexp(q) is
the experimentally determined scattering data, σ(q) is the error and µ is a scaling
factor. The conformations with the lowest χ2, and hence with the best ﬁt to the
data, are selected for further analysis. The ﬁnal conformation typically results in
around 50 structures, a far smaller amount then required to fully explain the ﬂexible
behaviour of a protein in solution that samples a large area of conformational space.
However these ensembles are suﬃcient to provide information on the overall properties
of ﬂexible proteins in terms of their size and shape. The structures produced by the
EOM method are not truly present in solution, instead the structures are said to
represent the population of conformational ensembles present in the solution. The
distributions of size in terms of Dmax and RG are representative. The EOM method is
able to ﬁnd minima in terms of distribution but not in terms of truly representative
conformations. A comparison can be drawn by comparing the truly random pool
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generated at the start of the algorithm with the selected ensemble. An example of
this type of analysis is shown in Figure 2.9.
Figure 2.9: The radius of gyration distribution determined by the EOM method applied to
three different proteins. The random pools are shown as black dashed lines and the selected
ensembles in colour. The distributions are skewed towards either extended structures (fH12-
13) or compact structures (fH10-14 and fH10-15). Image taken from Mertens et al . [148]
2.3.4 Instruments used for small-angle scattering experiments
Small-angle X-ray diffractometer BM29
BM29 is a pinhole geometry SAXS beamline located on the synchrotron light source
at the ESRF in Grenoble [150]. The beamline has been designed speciﬁcally for high
throughput protein solution scattering experiments. It contains a 2.867 m evacuated
tube with a Pilatus 1m detector. Unlike the SANS beamlines the detector is kept at
a ﬁxed position, the q-range is selected by altering the energy of the incident beam
between 7-15keV. Due to the much higher ﬂux available at synchrotron beamlines the
measurement time is considerably shorter for the same sample conditions. In order to
achieve a higher throughput of samples the BM29 beamline is ﬁtted with an biological
SAXS sample changer, developed by the EMBL [151]. This system automates the
measurement of samples and allows for a high trough put of biological samples.
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Figure 2.10: Schematic of BM29 the BIO-SAXS beamline at the ESRF. Image taken from
the BM29 website (www.esrf.eu/home/UsersAndScience/Experiments/MX/bm29.html)
2.3.5 Small-angle neutron diffractometer D33
D33 is a small-angle neutron scattering instrument at the Institut Laue-Langevin in
Grenoble [152]. The instrument can be run in either a time-of-ﬂight (TOF) mode or
in a monochromatic mode. In this thesis only the monochromatic mode was used. In
monochromatic mode neutrons of a speciﬁed energy are selected by a velocity selector
to provide the chosen q-range.The extended evacuated tube within which the detectors
are located mean that it can collect a large dynamic q-range even in monochromatic
mode, in TOF mode a much larger q-range can be collected in a single measurement
(Figure 2.11). The downside of measuring a large dynamic q-range in TOF mode is
the decrease of signal to noise at low q due to decreased delivery of neutrons from the
reactor at the corresponding wavelength. However this option is considered useful
for kinetic measurements of certain systems. In monochromatic mode it is however
possible to cover a large q-range by measurement of multiple sample to detector
distances, this is the typical set up for most biological measurements. The detector is
a large area helium 3 multi detector situated in a 20 meter evacuated tube, movement
of the detector to diﬀerent distances is controlled by computer.
42
Figure 2.11: Schematic drawing of the D33 instrument at the Institut Laue-Langevin,
taken from the ILL website
2.4 Elastic incoherent neutron scattering
Previously the information available from the coherent scattering length was ex-
plained. However, according to equation 2.9, the scattered neutrons also contain
incoherent contributions. The incoherent scattering length Binc is deﬁned as:
B2inc =
〈
B2
〉
− 〈B〉2 (2.24)
Whereas the coherent scattering length is the average scattering length of the el-
ement, the incoherent scattering length is the deviation from the average position
(〈B2〉 − 〈B〉2). Incoherent scattering therefore contains information about the dy-
namics of the atoms present in the studied sample. Measurement of energy resolved
neutron scattering spectra provides access to the study of protein motions on the pico
to nanosecond time-scale and on the angstrom length-scale. Where the exact time
scale studied depends upon the instrumental energy resolution, and the length-scale
dependent upon the accessible q-range. An example of a spectra obtained by a typi-
cal energy resolved incoherent neutron scattering experiment is shown in Figure 2.12.
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During a real experiment such spectra are collected as a function of the scattering
vector q. The spectra shows examples of elastic, quasi-elastic and incoherent scatter-
ing. At zero energy transfer there is a large elastic peak, these scattered neutrons do
not exchange with the sample. The intensities of the elastic peaks as a function of
the scattering vector q contain information about the motions of the sample studied.
When a neutron interacts with a sample the theoretical scattering function (Sth) can
be written as [153]:
Sth(q, ω) = e
−<x2>q2 ·
[
A0(q) · δ(ω) +
∑
n
An(q) · Ln(ω)
]
(2.25)
The equation contains several diﬀerent components, A0(q) is referred to as the elas-
tic incoherent structure factor, which contains information about the motion of the
sample studied. The delta function δ(ω) needs to be considered when there are mo-
tions in the sample slower than the resolution of the instrument. The second part
of the equation contains a sum of quasi elastic components, described by a sum of
Lorentzians (Ln(ω)) with the quasi elastic incoherent structure factor (An(q)). The
above equation is a simpliﬁcation of the theoretical scattering function which ignores
the presence of long range translational diﬀusion. Fast vibrational motions in the
sample are contained within the Debye-Waller factor (e−<x
2>q2).
2.4.1 Mean squared displacements determined by elastic in-
coherent neutron scattering
During a ﬁxed window elastic temperature scan the neutron intensity is measured at
zero energy transfer, from this data a model independent mean square displacement
can be obtained. The intermediate scattering function (I(q, t)inc) is deﬁned as the
Fourier transform of the Van Hove function, which contains a self and a distinct part.
The intermediate scattering function of a component containing N atoms is
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Figure 2.12: Example of a spectra obtained for a typical time-resolved incoherent scattering
experiment.
I(q, t)inc ≈
1
n
∑
i
exp(iq
[
r[i](0)− r[i](t)
]
(2.26)
where r[i](0) and −r[i](t) are position vectors at time = 0 and time = t. If it is as-
sumed that the distribution of atoms around their average position can be described
by a Gaussian approximation the expression can be simpliﬁed in a Gaussian approx-
imation. As q approaches zero, the approximation is also valid for motions following
a non Gaussian distribution so long as the motions are localised in the length and
time window of the spectrometer used. Under this assumption (I(q, t)inc = can be
simpliﬁed [154]:
I(q, t)inc ≈
1
n
e∑
i
xp
(
−
1
6
· q2
〈[
r[i](0)− r[i](t)
]2〉) (2.27)
The mean square displacement of each atom i, 〈U2i 〉, corresponding to the amplitude
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of motions present in the sample can then be introduced [155] :
〈
U2i
〉
=
〈[
r[i](0)− r[i](t)
]2〉 (2.28)
The incoherent scattering function S(q, 0)inc is then
S(q, 0)inc =
1
N
∑
i
eexp
(
−
1
6
· q2
〈
u2i
〉)
(2.29)
The average mean squared displacements of all incoherent scatterers in the sample
can then be obtained from the slope of the plot of log scattered intensities against q2.
〈
u2
〉
=
−3 ·∆lnS(q, 0)
∆q2
(2.30)
This approximation is similar to the Guinier approximation used in small-angle scat-
tering experiments [156]. The approximation is valid up until 〈u2〉 · q2 ≈ 2 [156].
By far the largest contributor to incoherent scattering in biological systems are hy-
drogen atoms. Hydrogens are spread quite evenly on the sidechains of amino acids
on the protein backbone. It can therefore by implied that the average movement of
hydrogens represents the average movement of the whole protein.
Often mean squared displacements are measured as a function of temperature in a so
called ﬁxed window elastic temperature scan. The intensities measured at zero energy
transfer are large and therefore this method allows for good statistics to be collected
in a relatively short period of time. An example of a ﬁxed window temperature scan
performed on the backscattering instrument IN16 at the ILL is shown in Figure 2.13.
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The Gaussian approximation linear ﬁt and the deviation thereof at higher q can be
seen in Figure 2.13 A.
Figure 2.13: Fixed window temperature scan performed on a hydrated protein powder on
IN16.(A) The Gaussian approximation applied with the linear fit applied to low q. (B) The
obtained mean squared displacements plotted as a function of temperature. Image taken
from Gallat et al . [157]
A mean force constant < k′ > can obtained from the dependence of the mean squared
displacement against temperature, shown in the inset in Figure 2.13 B [158]. Accord-
ing to Zaccai [158] the force constant can be described by:
< k′ >=
0.00276
d<u2>
dT
(2.31)
Where the top half of the fraction results in < k′ > in N/m. The mean force constant
obtained provides information about the rigidity of the protein sample and can be
compared across diﬀerent samples so long as the instrumental space and time window
remains constant [158].
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2.4.2 The relationship between instrumental resolution and
motion
Diﬀerent neutron scattering instruments have diﬀerent energy resolutions (∆E) with
a corresponding time resolution (∆T ):
∆T =
~
∆E
(2.32)
where ~ is Planck’s constant. The length window of motions studied depends upon
the accessible q range. Only motions that are accessible on the corresponding time
and length scale can be observed. Therefore the obtained mean square displacements
are instrument dependent. Motions studied can range from the pico second to the
nanosecond and often diﬀerent instruments are used to measure motions over diﬀerent
timescales (see Table 2.3).
2.4.3 Instruments used for incoherent neutron spectroscopy
The basic principle of neutron spectroscopy instruments is the measurement of scat-
tered neutron intensity as a function of both the energy transfer∆E and the scattering
vector q. In this thesis two diﬀerent types of instruments are used to achieve this goal,
time-of-ﬂight instruments and backscattering instruments. The basic principles are
similar,at reactor based neutron sources a monochromatic beam needs to be obtained
from the polychromatic stream of neutrons produced by the reactor. This is achieved
by the use of a monochromator, backscattering instruments often use a single crystal
that obtains a monochromatic beam using Bragg reﬂections. Time-of-ﬂight instru-
ments can also use single crystals but often multiple choppers are used to extract a
monochromatic beam. Time of ﬂight spectrometers chop the beam so that a pulsed
beam of neutrons with the same energy arrive simultaneously at the sample. It is
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known at what time the neutrons arrive at the sample, the scattered intensity is
then measured as a function of time. If a neutron gains energy from the sample it’s
speed will increase and arrive ﬁrst at the detector, followed by neutrons that did not
exchange energy with the sample and ﬁnally by neutrons that lose energy to the sam-
ple. The energy resolution reached by a time of ﬂight spectrometer is based on the
energy bandwidth of the incident beam, and ranges from around 5 eV to 200 eV. The
principle underlying this type of instrument is explained in detail elsewhere [159].
Backscattering on the other hand uses the principle of Bragg reﬂection to obtain a
higher energy resolution. The underlying principle of backscattering is described in
detail elsewhere [160]. Brieﬂy, if a neutron beam is reﬂected by a crystal close to a
90 degree angle the resulting reﬂected beam will have a very small energy dispersion,
∆E. The neutron beam that has undergone Bragg reﬂection is then scattered by the
sample towards analyser plates which reﬂect the beam under close to backscattering
conditions towards neutron detectors. A typical layout of a backscattering instrument
is shown in Figure 2.14. This allows a backscattering instrument to reach much lower
energy resolutions from around 1 eV upto 8 eV. Due to the small energy bandwidth
backscattering spectroscopy typically has lower counting statistics than similar time
of ﬂight instruments, however lower energy resolutions can be reached. By using a
combination of diﬀerent instruments with diﬀerent energy resolutions it is therefore
possible to cover several orders of magnitude in energy and time resolution (see Ta-
ble 2.3). The decreased counting statistics obtained by backscattering instruments
mean that large amounts of sample are required (typically around 100 mg), this com-
bined with the low sample quantity typically available for protein samples (micro to
milligrams) means that often only the elastic incoherent measurement is performed.
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Figure 2.14: Schematic drawing of a typical neutron backscattering instrument. Image
taken from www.ill.eu/othersites/BS-review/
2.5 Dynamic light scattering theory
Dynamic light scattering refers to the measurement of the ﬂuctuation in intensity
of scattered light over time. The change in intensity is interpreted and related to
the Brownian motions of the scattered particles.This interpretation analyses the scat-
tering intensity ﬂuctuations by using correlation functions. The results of such an
Table 2.3: Resolution and timescale reached by different neutron spectrometers at the
Institut Laue Langevin. BS = backscattering and TOF = time of flight instruments.
Instrument Type Resolution Timescale
IN16 BS 0.9µeV ≈ 1 Nanosecond
IN13 BS 8µeV ≈ 100 Picoseconds
IN6 TOF 50µeV ≈ 20 Picoseconds
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experiment provides information about the hydrodynamic radius of the scattered
particle in solution. Where the hydrodynamic radius is the radius of a hard sphere
that diﬀuses at the same rate as the sample.
All information about the diﬀusion of a particle through a solvent can be described by
the dynamic structure factor (Fs, (qτ)). The dynamic structure factor is the Fourier
Transform of the van Hove self-correlation function (Gs(r, t)).
Fs(q, τ) =
∫
Gs(r, τ)exp(iqr)dr (2.33)
And the Van Hove correlation function is:
Gs(r, τ) = 〈n(0, t)n(r, t+ τ)〉V,T (2.34)
Where n(r, t) is the amount of scattering particles diﬀusion with Brownian motion,
within a volume centred on r at time t. For dilute solutions Gs(r, τ) is the probability
of ﬁnding a particle at time t+τ at position r if the particle was previously at position
O. For dynamic light scattering measurements only diﬀerence vector, r,−0, and time
diﬀerence τ are used for interpreting results. Therefore the measurement is relative
diﬀusion of the particle over time.
The Brownian motion of a protein in solution can be described by a random walk,
where the van Het Hove self correlation function depends only upon the distance. to
give:
Gs(r, τ) =
[
2π
3
δR(τ)2
][ 3
2
]
exp
(
−2 ·
3r(τ)2
2 < δR(τ)2 >
)
(2.35)
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Where δR(τ)2 is the square of the Brownian motion that the particle undergoes in
time τ . The random movement of the particle through the solvent can be described
by
δR(τ)2 = 6Dsτ (2.36)
Where Ds is known as the self diﬀusion coeﬃcient.
During a dynamic light scattering measurement the Fourier transforms of the van
Hove correlation function (Gs(r, τ) is measured. The Fourier transform gives the
dynamic structure factor:
Fs(q, τ) = exp
(
−Dsq
2τ
)
(2.37)
Once the self diﬀusion coeﬃcient (D2) has been measured it is possible to determine
the hydrodynamic radius of the scatterer by using the Stokes-Einstein relationship:
Ds =
kT
f
=
kT
6πηRH
(2.38)
Where RH is the hydrodynamic radius, or the radius of a sphere equal to the size of
the scattering particle, which undergoes the same Brownian motion.
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Chapter 3
The dynamic footprint of
sequestration in the molecular
fluctuations of osteopontin
Experimental work presented in the following chapter has been submitted for
peer review and publication:
• Lenton, S., Nylander, T., Holt, C., Seydel, T., Haertlein, M. Teixeira, S,
and Zaccai, G. The dynamic footprint of sequestration in the molecular
fluctuations of osteopontin
Abstract
Different length fragments of osteopontin are known to adopt unfolded conformations in
solution. In milk the highly phosphorylated OPN1-149 phosphopeptide represents the largest
species. Previous studies by light scattering and SAXS have shown that the OPN1-149
fragment can sequester amorphous calcium phosphate and form a type of calcium phosphate
nanocluster. The sequestration of calcium phosphate by unfolded proteins is fundamental to
the stabilisation of biofluids supersaturated with respect to hydroxyapatite. The unfolded
state of osteopontin is thought to be a prerequisite for this activity. Here the effects of
sequestration on the molecular fluctuations of OPN1-149 are quantified on the nanosecond-
angstrom resolution by elastic incoherent neutron scattering. The molecular fluctuations of
the free phosphopeptide are found to represent a highly flexible protein. Upon sequestration
of calcium phosphate, stiffening of osteopontin is reflected in molecular fluctuations more
closely resembling those characteristic of globular proteins. The results bring insight into the
modulation of the activity of osteopontin and phosphopeptides with a role in the control of
biomineralisation. The quantification of the effects provides a handle for future comparisons
and classification of molecular fluctuations.
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3.1 Introduction
Osteopontin (OPN) has been called “a molecule for all seasons” because it partic-
ipates in numerous cellular functions including cell adhesion, signalling, migration,
and survival, in addition to roles in immunomodulation and biomineralisation [161].
The ability of a single protein to participate in multiple cellular functions is in part
because in vivo OPN is heavily modiﬁed by post translational enzymes, resulting in
a range of OPN peptides with diﬀerent amino acid lengths and diﬀerent functional
groups attached [86, 99]. OPN belongs to the family of Small Integrin-Binding Lig-
and, N-linked Glycoproteins (SIBLINGs) [162]. The SIBLINGs are a sub-group of a
larger, paralogous group of secreted proteins to which the caseins also belong. A key
characteristic of the SIBLINGs is their high degree of phosphorylation and the eﬀect
this has on the function of individual members. For example OPN is highly phos-
phorylated in the Golgi apparatus by the FAM20C golgi kinase, and then secreted
[96]. Mutations that inhibit the golgi kinase from phosphorylating OPN leads to a
bone disease known as Raine syndrome [85, 96, 163]. The secreted phosphorylated
OPN protein is present in all bioﬂuids where it has been sought. The role of OPN
in bioﬂuids is to prevent the precipitation of high levels of calcium phosphate [10].
This is achieved by sequestration of calcium phosphate by OPN leading to the forma-
tion of so called calcium phosphate nanoclusters (CPNs). Sequestration of calcium
phosphate by OPN phosphopeptides is phosphorylation dependent, and the formed
CPN are core shell structures containing a core of calcium phosphate surrounded by
an OPN shell. In bovine milk the highly phosphorylated OPN is processed prote-
olytically between 157-158 by the plasmin protease. This fragment is referred to in
the literature as OPN1-149 for historical purposes. The OPN1-149 phosphopeptide
contains regions which are highly phosphorylated through which it sequesters calcium
phosphate.
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The recombinant expression of OPN for experimental study is complicated due to the
presence of signiﬁcant and functionally important post-translational modiﬁcations in
the native protein. The length of the full OPN chain makes NMR assignments in the
native protein somewhat diﬃcult and has required work with labelled but (to-date)
unphosphorylated and unglycosylated recombinant material. Due to these limitations
only limited characterisations on several diﬀerent, usually short, OPN fragments has
been completed. Fisher et al . determined, using 1-D 1H NMR and transverse re-
laxation times, that the solution structure of native OPN was consistent with that
of an intrinsically disordered protein (IDP) [84]. The performed NMR experiments
were limited and only obtained information which showed that the studied fragment
was non globular in solution. More recently Kurzbach et al . used more advanced
NMR techniques to show that OPN displays compact and extended conformations
in solution and interconverts between these conformations through cooperative phase
transitions [101]. Further structural insights were obtained by the experiments of
Kurzbach et al ., however these experiments were based on a limited OPN fragment
due to problems with protein expression [164]. Yamaguchi et al . have shown that
a recombinantly produced fragment of mouse OPN exhibits transient long-range in-
tramolecular interaction between its N- and C-terminal regions that can shield the
central part of the chain from integrin interactions [165]. These experiments show
that diﬀerent OPN peptides behave diﬀerently but all share a common non globular
structure. However all of the listed experiments performed on OPN lack any kind of
post-translational modiﬁcations found in vivo, which have been shown to be funda-
mental for OPN function. A structural study of the previously mentioned OPN1-149
isolated from a bovine source has been completed using SAXS. The results from this
study indicated that bovine OPN1-149 adopts an unfolded conformation in solution,
however analysis of the data reported in this paper was limited to only model inde-
pendent methods [45]. From the results it was hypothesised that the adaptation of
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an unfolded conformation was vital for OPN1-149 to sequester calcium phosphate in
a stable CPN [45].
The literature therefore provides broad evidence that several OPN phosphopep-
tides are proteins which lack secondary structure elements, known as intrinsically
disordered proteins (IDPs). IDPs are a unique family of macromolecules that are
capable of fulﬁlling many biological functions despite entirely or partially lacking a
unique 3D structure (for recent reviews see, for example, Habchi et al . and Oldﬁeld
Dunker [106, 166, 167]). A disordered conformation is thought to convey several
functional beneﬁts [106, 166, 167]. For example, IDPs are able to adapt to diﬀerent
environments and interact rapidly with one or more partners. A possible combination
of intrinsic disorder with a high degree of controllable post-translational modiﬁcation
is why a single protein such as OPN can regulate so many cellular functions [102].
Several proteins have been identiﬁed as able to sequester calcium phosphate in a simi-
lar manner to OPN1-149. Apart from a high degree of phosphorylation all recognised
proteins adopt a largely or completely unfolded structure [23]. A key advantage of
adopting an unfolded conformation is the ability to achieve a high density of packing
of sequestering phosphopeptide chains on the core surface and thereby maximising
the free energy of sequestration by the shell [72]. It has been suggested that an-
other advantage of adopting an IDP conformation is the higher ﬂexibility aﬀorded
to an IDP [23]. This would allow IDPs such as OPN1-149 to sample a large area
of conformational space and rapidly sequester calcium phosphate prior to a nuclei
of calcium phosphate forming [67, 41]. Despite signiﬁcant advances in NMR and
other techniques, relatively little experimental evidence is available regarding this in-
creased ﬂexibility of IDPs. Therefore a full characterisation of OPN1-149 requires not
only information about the structure but also it’s ﬂexibility in solution. The ﬂexible
behaviour of proteins covers several orders of magnitude in timescale ranging from
electronic re-arrangements on the femto second scale to protein folding on the order
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of seconds or minutes (Figure 3.1) [168, 169]. The atomic thermal ﬂuctuations of
a protein can be related to the shape of the potential energy well within which the
protein moves [158]. Elastic incoherent neutron scattering has been extensively used
to study the molecular ﬂuctuations of globular proteins [170, 171].
Figure 3.1: Protein motions over periods corresponding to several orders of magnitude in
time, ranging from the vibration of hydrogen atoms to protein folding events. image taken
from [172].
In more recent years this technique has been used to study intrinsically disordered
proteins, including casein and Tau protein [157, 173]. The disordered Tau protein
was studied by elastic incoherent neutron scattering and was shown to be more ﬂex-
ible compared to a folded protein of similar molecular mass [157]. Similar results
were obtained for a β casein phosphopeptide by inelastic neutron scattering which
also showed behaviour of a highly ﬂexible protein [173]. The results indicate that in
general disordered proteins are more ﬂexible compared to globular proteins of similar
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molecular weight. A high degree of ﬂexibility is thought to be vital for the multi-
functional ability that many IDPs show. However so far no dynamical studies have
been completed on IDP in diﬀerent bound states and the eﬀects of being bound to a
partner on protein dynamics is not well explored.
In this study elastic incoherent neutron scattering is used to investigate the temper-
ature dependent protein dynamics of bovine OPN1-149. The eﬀects of sequestration
on the molecular dynamics are also investigated. Due to the distribution of hydrogen
in protein samples elastic incoherent neutron scattering provides information on the
displacement of hydrogen atoms and the side-chains to which they are attached, which
is used as a measure of protein ﬂexibility. The length scale studied is on the order of
Ångstroms and the timescales range from nano to pico second depending on instru-
mental resolution [156]. The results obtained indicate a high ﬂexibility of OPN1-149
which is reduced upon sequestration of calcium phosphate. The structural counter-
part of the dynamics study is presented in the form of small-angle X-ray scattering
(SAXS), which shows that the unfolded protein adopts a heterogeneous ensemble of
structures in solution. The structural and dynamics data is then combined to show
that OPN1-149 can rapidly sample large areas of conformational space and this is
related to the protein function in vivo.
3.2 Materials and methods
3.2.1 Bioinformatic structure predictions
Structural disorder tendency of OPN1-149 was predicted by IUPred [174]. The ac-
curacy of this predictor is high at around 80-90 % [174]. The predictor uses only the
amino acid sequence of OPN1-149 and returns a score that ascribes the possibility of
structural disorder on a per residue level [174]. A score given above 0.5 means the
region is likely to adopt a disordered conformation. Further analysis was completed
58
by plotting the mean net charge of the sequence against the hydrophobicity deter-
mined by the Kyte-Doolittle hydrophobicity scale, using the online PONDR server
[175]. The online PONDR server also adds the position of a reference set of globular
and intrinsically disordered proteins for comparison, with a boundary determined by
Uversky et al . [175].
3.2.2 Preparation of native bovine OPN1-149
Native bovine osteopontin (OPNmix) was kindly provided as a fraction of osteopontin
puriﬁed from bovine milk by the method of Sørensen et al by Dr C Holt (Glasgow
University) [99]. From the OPNmix the OPN1-149 peptide was puriﬁed to homogene-
ity by size exclusion chromatography (SEC) as described by Holt et al [45]. In brief,
osteopontin fragments were separated by size on a 120 ml volume column containing
a Superdex 75 (G.E. Healthcare) stationary phase, connected to a Biologic dual ﬂow
puriﬁcation system (Bio-Rad). Size exclusion was performed at room temperature,
the column was equilibrated with 2 column volumes of elution buﬀer (50 mM phos-
phate, pH 7.0, 300 mM NaCl, 0.02% NaN3) at a ﬂow rate of 0.3 ml/min. 100 mg
of OPNmix was then dissolved in the same elution buﬀer and loaded onto the col-
umn at a rate of 0.3 ml/min. Elution from the column was constantly monitored by
U.V. absorption at λ = 280 nm, fractions were collected on volumes of 1 ml, elution
was stopped after 2 column volumes of elution buﬀer. Two main elution peaks were
observed, aliquots were taken from the eluted fractions and analysed by SDS-PAGE .
N-terminal sequencing was used to conﬁrm the identify of OPN1-149 in the indicated
peak. Fractions deemed to be homogeneous by SDS-PAGE analysis were pooled, ex-
tensively dialyzed against water, ﬂash frozen and lyopholized until dry as determined
by weighing. The resulting dry OPN1-149 protein was stored in a desiccator over
phosphorus pentoxide at room temperature and used as required.
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3.2.3 Formation of calcium phosphate nanoclusters stabilised
by OPN1-149
Calcium phosphate nanoclusters were formed using the mixing method described
previously by Holt [45]. In the presence of an excess of osteopontin the pH of a
solution was raised slowly by addition of calcium phosphates salts of diﬀerent basicity
(mono, di and trisodium phosphate), whilst continuously mixing, until a pH of 7.4
was reached.
3.2.4 Circular dichroism experiments
Circular dichroism (CD) spectra were obtained on a J-720 spectrometer (JASCO) at
0.5 mg/mL (50 mM phosphate pH 7.4 , 150 mM NaCl). The sample environment was
kept at 20 ◦C; the spectrum was recorded between 190 nm and 250 nm accumulating
data over 3 runs with a band width of 1 nm. The raw data was normalised for protein
concentration and the number of amino acid residues. Secondary structure content
was analysed using the Dichroweb analysis server [176], using a reference data set
which contains the spectra of denatured proteins [177].
3.2.5 Small-angle X-ray scattering experiments
Small angle X-ray scattering experiments were performed at the I1911-SAXS beam-
line at the MAX II ring of the MAX IV laboratory (Lund, Sweden) [178]. Prior
to the measurements, the samples were exhaustively dialyzed against buﬀer (50 mM
phosphate pH 7.4 , 150 mM NaCl), centrifuged and ﬁltered (0.22 µm Sartorius syringe
ﬁlter), after which the concentration was determined by U.V. absorption at 280 nm.
Three OPN1-149 concentrations (1.5, 3 and 5 mg/ml) were measured and compared
to rule out concentration dependent eﬀects. Temperature controlled measurements
(20 ◦C) were performed in a 1 mm capillary. Scattering intensities were recorded using
a 2D sensitive detector. The sample to detector distance was 1.45m with an incident
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radiation wavelength (λ) of 0.91 Å, providing an accessible q-range of 0.01-0.4 Å−1,
where q = 4π ∗ sinθ/λ and 2θ is the scattering angle. 6 frames were recorded for
10 seconds per frame; each frame was inspected for signs of radiation damage before
averaging. Corresponding buﬀers from dialysis were measured before and after each
sample, using the same measurement settings and the resulting curve subtracted from
sample scattering.
3.2.6 Small-angle X-ray scattering data analysis
Scattering envelopes of OPN1-149 were obtained using two diﬀerent ab intio ap-
proaches: dummy atom and dummy residue modelling from the DAMMIF [149] and
GASBOR [179] software, respectively. The DAMMIF assembly of closely packed
dummy atoms are packed within a sphere which has a diameter equal to the Dmax,
determined by the indirect Fourier transform with the GNOM software [147]. Us-
ing simulated annealing the software searches for a conformation within the deﬁned
sphere that matches the experimental data. This approach will ﬁnd diﬀerent solu-
tions that ﬁt the data [180], therefore 20 independent DAMMIF computations were
performed. The models were then averaged using DAMAVER [149]. A ﬁltered ﬁnal
model was produced by removing low occupancy space. The ﬂexibility of OPN 1-149
was further analysed using the ensemble optimisation method EOM from the ATSAS
package [146]. EOM exploits a genetic algorithm to create a large heterogeneous en-
semble of models based on the amino acid sequence. A pool of 10 000 conformers was
created, from which an ensemble of 20 structures were picked by minimisation of the
discrepancy between the calculated scattering proﬁle and the experimental scattering
curve. Analysis of the resulting data provided information on the size distribution of
the protein and the 20 protein conformers that most accurately represent the ensemble
as a whole.
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3.2.7 Bioinformatic flexibility predictions
Predictions of OPN 1-149, tau and maltose binding protein (MBP) backbone ﬂexibil-
ity were also made using the Dynamine predictor with the corresponding amino acid
sequences [181]. Tau was chosen for comparison to an IDP, while the MBP provides
a comparison to a globular protein of a similar size (both taken from Gallat et al .)
[157]. The predictor functions by comparing sequence information with a database of
recorded NMR spectra. It predicts an average S2 value for every residue in a given
sequence, where S2 describes how restricted the movement of the atomic bond N-H
protein backbone vector is with respect to the molecular reference frame. A value of
1 reﬂects complete order in a stable conformation, while a value of 0 means random
bond vector movement (highly dynamic). Values of S2 predicted using DynaMine
are on an absolute scale, allowing for comparison between predictions for diﬀerent
proteins. Values of S2 less than 0.8 are considered to indicate a ﬂexible region [181].
3.2.8 Elastic incoherent neutron scattering experiments
Lyophilized powders (150 mg) of OPN 1-149 and OPN CPN were re-hydrated in a
desiccator over pure D2O until a level of 0.44 grams of D2O per gram of protein
was reached, as determined by weighing. Samples were then sealed with indium wire
within a ﬂat aluminium sample holder. Powder samples were chosen so that global
motions (diﬀusion and rotation of the entire molecule which are signiﬁcant in the
experimental resolution windows chosen) are suppressed on the chosen time scale,
while the humidity ensures a functional sample environment.
EINS experiments were carried out on the backscattering IN16 spectrometer at the In-
stitut Laue-Langevin (ILL, France). An instrumental resolution of 0.9 µeV (full width
half maximum) was used corresponding to motions occurring on the 1 ns timescale.
The wavelength of the incident neutron beam was 6.27 Å, corresponding to a mea-
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sured q-range of 0.02-1.9 Å−1. Each sample was inserted into an orange ILL cryo-
stat at room temperature before decreasing to 11K. The sample was held at a 135
◦angle with respect to the incident neutron beam. Elastically scattered neutrons were
continuously counted whilst raising the temperature from 11K to 300K at a rate of
0.2K/min. The samples were probed for crystalline ice formation using the diﬀraction
setting on IN16. No Bragg peaks were observed. The elastically scattered neutrons
of the empty cell I(empty.T )(q) were also recorded in a similar manner for subtraction
of sample holder eﬀects. The elastic contributions from the sample scattering were
then obtained according to the formula
Isample.T (q) =
Itotal.T (q)− t ∗ Iempty.T (q)
Itotal.T (q)− t ∗ Iempty.T (q)
(3.1)
3.2.9 EINS data analysis
Taking only incoherent scattering into account, the inelastic scattering law can be de-
scribed as a function of q and the frequency Ω (~Ω is the energy exchange experienced
by the sample):
S(q,Ω) =
1
2π
∫
I(q, t)exp(−iΩt)dt (3.2)
The intermediate scattering function is
I(q, t) =
∫
∞
−∞
g(r, t)exp(iq · r)d3r (3.3)
For N hydrogen atoms in position R, the Van Hove auto correlation function g(r, t)
can be described as:
g(r, t) =
1
N
〈
N∑
l=1
δ {r +R(0)−R(t)}
〉
(3.4)
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Where δ is a Dirac δ function, R(0) and R(t) are the position vectors for atomic
motions with no preferential orientation and no time dependence on the instrumental
resolution complying with:
q2
〈
u2
〉
≤ 2 (3.5)
Where u2 is the mean squared displacement (MSD). The elastic intensity can then
be approximated by applying the Gaussian approximation, analogous to the Guinier
approximation used for SAS, where the shape described by the motion of the particle
is: 〈
u2
〉
= 2R2g (3.6)
The elastic scattering intensity is approximated by:
Isample.T (q) = exp
(
−q2 < u2 >
6
)
(3.7)
The atomic MSDs were extracted from the normalised data using the program LAMP
provided by the ILL, from a linear ﬁt of the q dependency on the elastic intensity
described by the Gaussian approximation shown in equation 3.7.
3.3 Results
3.3.1 Purification of OPN1-149
Native bovine osteopontin is secreted as a 276 amino acid protein at relatively high
concentrations in most bodily ﬂuids [182]. In bovine milk osteopontin is cleaved
by plasmin and other milk proteases between the residues: Lys145-Ser146, Arg147-
Ser148, Lys149-Lys150, Phe151-Arg152, Arg152-Arg153, and Arg153-Ser154 [183].
The resulting osteopontin peptides contain an average of 150 amino acids, initially this
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group of osteopontin peptide fragments was thought to contain only a single fragment
cleaved between residue 149 and 150, termed OPN1-149 [45]. Although incorrect, for
readability the historical name OPN1-149 is used in this thesis to describe this group
of similarly sized peptides. The desired OPN1-149 peptide was puriﬁed from OPNmix
by single step size exclusion chromatography. The elution trace was monitored by
U.V. absorption as a function of retention time and is shown in Figure 3.2. Two
major peaks were obtained as previously observed during puriﬁcation of OPN1-149
from OPNmix [45]. The second peak has previously been identiﬁed as the fraction
containing OPN1-149 [45], which was conﬁrmed by mass spectrometry analysis.
Figure 3.2: U.V. at trace 280 nm of the elution from the S75 column after loading with
OPNmix. The second larger peak was consequently identified as OPN1-149 .
3.3.2 Primary sequence analysis
Many computational tools have been developed to predict the propensity of a cer-
tain amino acid sequence to adopt a disordered structure. One of the more simple
techniques relies on the fact that, in general, IDPs tend to contain a high proportion
of amino acids with a high negative net charge and low hydropathy [175]. A high
net charge inhibits the hydrophobic collapse by charge-charge repulsion and a low
hydrophobicity prevents the hydrophobic collapse of the amino acid chain [175, 184].
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A plot of the normalised net charge against the normalised hydropathy, both of which
are calculated from the amino acid sequence, yields the charge-hydropathy plot. This
charge-hydropathy plot contains a well deﬁned boundary which separates proteins
with a disordered tendency from globular proteins [175, 184]. The amino acid se-
quence of OPN1-149 was analysed by this technique and compared with a reference
set of IDPs and globular proteins. The resulting plot is shown in Figure 3.3 where
the boundary between globular and disordered proteins is indicated. The amino acid
properties of OPN1-149 show a low mean scaled hydropathy combined with a high net
charge. These properties place OPN1-149 well within the charge-hydropathy region
expected for intrinsically disordered proteins.
Figure 3.3: A comparison of the mean net charge and mean hydropathy for a set of 275
globular (red circles) and disordered (Blue circles) proteins taken from Uversky et al . [175].
The boundary between order and disorder is indicated by a black line. The calculated
properties of OPN1-149 is indicated by a green triangle, and lies well within the disordered
region.
Predictions of the amount of secondary structure elements within the OPN1-149
chain were undertaken using the residue based disorder predictor IUPred [174]. The
resulting proﬁle produced by IUPred is shown in Figure 3.4, the disorder boundary
is indicated by a dashed line, anything above this value is considered disordered.
The analysis by IUPred predicts that OPN1-149 is almost completely disordered and
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according to the prediction there is only one small region which has the possibility
of forming globular like regions such as alpha helices and beta sheets. These results
emphasise the charge-hydropathy plot analysis that OPN1-149 has an amino acid
contents characteristic of those found in intrinsically disordered proteins. Considering
the predicted IDP structure of OPN1-149, and what is known about other OPN
fragments, several biophysical techniques where chosen to further characterise the
protein structure.
Figure 3.4: Disorder profiles predicted of OPN1-149 by the IUPred method , a dashed
blue line shows the value above which the region is considered disordered [174].
3.3.3 OPN1-149 displays biophysical properties of a non glob-
ular protein
Circular dichroism spectroscopy was used to investigate the presence of local sec-
ondary structure elements in OPN1-149. The CD spectrum of OPN1-149 is shown
in Figure 3.5 A. The observed spectrum is typical of a protein lacking in secondary
structure elements, such as alpha-helix and beta-sheet, and has the appearance of
a spectrum caused mostly by disordered protein structure. Further deconvolution
analysis of the CD spectra with a comparison against a reference database indicates
that the protein has a secondary structure content consisting of 8% alpha helices,
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20% beta-sheet and 72% unordered or random coil structure. The analysis of sec-
ondary structure elements within OPN1-149 by circular dichroism indicates that the
protein is lacking in well deﬁned secondary structure elements, and agrees with the
predictions made by the amino acid analysis.
Figure 3.5: Biophyiscal characterisation of OPN1-149 (A): Circular dichroism spectra
collected for OPN1-149 at 1mg/ml shows a lack of secondary structure elements. (B)
Analytical size exclusion chromatography indicates that OPN1-149 migrates down a SEC
column at a much higher molecular weight compared to the calculated MW. (C) OPN1-149
also exhibits unusual migration on a SDS PAGE gel, indicative of an intrinsically disordered
protein.
The molecular mass at which OPN 1-149 migrates down the SEC column was obtained
by calibrating a column with a set of globular proteins and measuring their retention
time (Figure 3.5 B). This analysis yields an apparent molecular mass of ≈ 44 kDa
for OPN1-149, which is considerably larger then the theoretical molecular mass of
≈ 18 kDa based on the amino acid sequence (Figure 3.5 B). A ratio of 2.2 to 2.8
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times the apparent molecular mass compared to the theoretical molecular mass is
characteristic of disordered proteins [185]. The experimentally determined ratio for
OPN1-149 is 2.4, as expected for an IDP. The diﬀerence in expected and observed
molecular mass is caused by the inability of extended conformations to enter the pores
within the stationary phase of the column. This apparent disagreement in observed
and expected molecular weight is consistent with SDS-PAGE results, as typically is
observed for IDPs [119] . Aberrant migration of IDPs on SDS-PAGE gels is caused
by the eﬀects of SDS binding to the characteristically negatively charged proteins.
The combined biophysical evidence strongly supports a disordered protein structure
for OPN1-149 in solution.
3.3.4 Structural characterisation by SAXS
Experiments were performed at three diﬀerent concentrations of OPN1-149 (1.5, 3
and 5 mg/ml) to rule out concentration dependent eﬀects. The data were plotted as
Guinier plots from which the radius of gyration (RG) was determined from a linear ﬁt,
shown in Figure 3.6. Within error there is no observed eﬀect of concentration on the
RG, indicating no inter or intra particle eﬀects. Therefore concentration dependent
eﬀects which are detrimental to the resulting data can be ruled out. The highest
concentration measured (5 mg/ml) had the highest signal to noise ratio and was used
for all subsequent data analysis.
The RG of OPN1-149 derived from the Guinier plot was 3.88 ± 0.26 nm. Predictions
on the RG of disordered proteins based on the amino acid chain length can be made
by plotting the Flory equation (Figure 3.7B) [186]. The observed RG’s are consistent
with an unfolded protein in solution and scale well with values obtained for other
disordered proteins. [157, 187, 188]. Further model independent evidence of the
disordered nature of OPN1-149 can be observed in the Kratky plot (Figure 3.7 C).
For a folded protein a bell shaped curve with a deﬁned maximum would be expected
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Figure 3.6: Guinier plot of three different concentrations of OPN1-149 collected by SAXS
A) 5 mg/ml B) 3 mg/ml and C) 1.5 mg/ml. The radius of gyration was recovered from
the slope of the linear fit for each concentration
instead the Kratky plot plateaus at high q. The disordered state of OPN 1-149 is
also corroborated by the asymmetric shape of the P(r) distribution, calculated by the
indirect Fourier transform method Figure 3.8 [189]. The P(r) distribution function
yields a RG of 3.92 ± 0.06 nm this value is calculated in real space and agrees well
with the value obtained from the Guinier method. The P(r) distribution also provides
information on the maximum inter particle distance Dmax determined to be 12 nm.
Overall the model independent parameters obtained by small-angle X-ray scattering
suggest a disordered and elongated shape of OPN 1-149 in solution.
3.3.5 SAXS data modelling by ab initio methods
Overall molecular envelopes of OPN1-149 in solution were obtained by two ab initio
approaches, namely DAMMIN and GASBOR. Both modelling approaches use the
P(r) calculated from the SAXS data using the indirect Fourier-transform method
implemented in GNOM (Figure 3.8). DAMMIN was used to reconstitute scattering
envelopes based on the P(r) function. Because the method does not yield unique
solution [149, 180], the method was repeated 20 times. A selection of ﬁve of the
models are shown in green in Figure 3.9, although they each showed slightly diﬀerent
conformations they all displayed a characteristic elongated shape. The normalised
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Figure 3.7: A) Guinier plot from which the radius of gyration and I(0) was determined to
be 3.882 ± 0.26 nm . B) RG expected for folded proteins and disordered proteins based on
protein chain length. Profile of IDP was predicted by the Flory equation. The RG of OPN1-
149 is indicated by the cross, and lies within the region expected for disordered proteins. C)
Kratky plot of OPN1-149 SAXS data show characteristics of disordered proteins. D) Fit of
the model produced by DAMMIF (red line) to the experimental data points (black dots) (χ
= 1.241.
spatial discrepancies (NSDs), a measure of the similarity between diﬀerent DAMMIN
models was between 0.94 and 1.05 which is considered acceptable for this speciﬁc
modelling approach [190]. The selected collection of 20 models were averaged to
produce the model shown in purple in Figure 3.9.
Using the software DAMFILT, low occupancy areas were removed yielding the ﬁnal
DAMMIF model shown in Figure 3.10. The resulting structure shows an elongated
particle, and is similar to structures obtained for other disordered proteins. The
low resolution molecular reconstruction of this representation only shows that the
conformation of this protein is extended in solution. The resolution obtained by such
modelling techniques does not yield information on any secondary structure elements
present, however it does provide information on the average structure of the protein
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Figure 3.8: The distance distribution function (P(r)) calculated for OPN1-149. The p(r)
function shows a large Dmax at 13 nm and an asymmetric shape characteristic of IDPs.
Calculation of p(r) also yields a radius of gyration of 3.92 ± 0.06 nm
adopted in solution. In the case of OPN1-149 the models support the previously
obtained evidence that the protein is non globular in solution. Furthermore from the
models it can be seen that the protein samples a large area of conformational space.
These results follow the lines of the general features obtained for other intrinsically
unstructured proteins including ab initio SAXS models available in the literature
[187].
Ab initio modelling using the dummy residue approach incorporated within the GAS-
BOR software provides qualitatively similar results (Figure 3.11). The computed
models provide a good ﬁt to the data, with GASBOR models having slightly higher
χ values compared to the DAMMIF models (Figure 3.12). This is expected as the
dummy residue approach represents a more realistic description of the diﬀerent con-
formers present in a solution of a disordered protein. Further, the scattering envelopes
obtained by ab initio techniques agree with obtained model independent data from
the Kratky plot and the radii of gyration obtained from the p(r) distribution and the
Guinier plot that OPN1-149 behaves as an IDP in solution.
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Figure 3.9: The average model produced by averaging 20 individual DAMMIN runs (pur-
ple) and 5 examples of individual models produced by the DAMMIF software (Green)
Figure 3.10: Final OPN1-149 model produced by DAMMIF after averaging and filtering
excess density
3.3.6 Flexibility analysis by EOM
In solution IDPs consist of a heterogeneous distribution of diﬀerent conformers, rang-
ing from Gaussian chains to more compact folded conformations. SAXS measures
the form factor of a sample, but for IDPs the ﬂuctuations between form factors are
much higher than the SAXS time resolution. To extend the information attainable for
OPN 1-149, the SAXS data were analysed using the ensemble optimisation method
(EOM). The representative ensembles selected by the method to ﬁt the data give in-
formation about the preferable conformations of OPN1-149 in solution. The selected
EOM ensemble of 20 structures generated for OPN 1-149 produced a good ﬁt to the
experimental data with χ of 1.31 (Figure 3.13 A).
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Figure 3.11: Dummy residue model of OPN1-149 produced by GASBOR
Figure 3.12: Fit of the calculated GASBOR model to the scattering curve, χ = 1.84
Several runs were repeated and yielded a reproducible ensembles shown in Figure 3.13
B + C. The best ﬁt ensemble shows a somewhat bimodal although wide ranging dis-
tribution of the RG Figure 3.13 B. The distribution of the radii peak at higher values
than the random pool, indicative of a preference to a somewhat open or extended
conformation. The peak for lower RG however also indicated that the protein exists
in a more compact state. This representation of compact and extended structures in
solution is also observed in the Dmax distribution Figure 3.13 C, which shows that
the maximum interparticle distance of OPN1-149 ranging from 75 Å up to almost
200 Å. The blue line in Figure 3.13 is the random pool generated assuming a random
coil structure. In both the Dmax and RG distribution of the generated pool there is a
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Figure 3.13: EOM analysis of OPN1-149 (A) Fit of the selected ensemble (Red line)
against experimental data (Black dots) (χ = 1.133). B RG distribution from the selected
ensemble (red) and that corresponding to the pool (blue). C Dmax distribution from the
selected ensemble (red) and that corresponding to the pool (blue).
smaller peak in these regions. OPN1-149 can therefore sample not only the random
coil areas but also more extended structures. The models generated by the EOM
method can also be investigated visually. Figure 3.14 shows an example of a com-
pact and extended model from the produced pool. The extended model is visually
quite similar to the models produced by GASBOR and DAMMIN. The analysis of
SAXS data by EOM provides information about the range of conformations adopted
including the more compact conformations that OPN1-149 samples in solution. The
results from EOM therefore conﬁrm that OPN1-149 is a disordered protein in solu-
tion, capable of sampling a large area of conformational space in by adopting compact
and extended conformations. The compact model shown in green corresponds to one
of the models present in the peak of the random coil distribution shown in blue in
Figure 3.13.
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Figure 3.14: Experimentally determined elongated and compact structures of OPN1-149,
determined by the EOM method
3.3.7 Characterisation of formed CPN
Dynamic light scattering and small-angle neutron scattering measurements were per-
formed to assess the extent of CPN formation and the solution monodispersity prior
to EINS experiments. The DLS results Figure 3.15 A show two main distributions of
particle sizes. The hydrodynamic radii of both peaks were determined by the Stokes-
Einstein equation yielding hydrodynamic radii of 2.1 nm and 19 nm respectively.
These observed hydrodynamic radii correspond with the values expected for both
the excess of OPN1-149 peptide and the formed calcium phosphate nanoclusters, as
previously measured.
The samples were then further analysed by SANS in order to obtain information
about the radius of gyration. The radius of gyration was extracted from the Guinier
plot obtained from SANS in H2O for points that satisﬁed qRG<1.3 (Figure 3.15). The
obtained RG of 20.5 ± 0.5 nm, in close agreement with previously obtained results by
SAXS which gave an RG of 21.9 nm, and in agreement with the hydrodynamic radius
obtained by DLS measurements. [45, 10]. Some diﬀerences in the value of the radius
of gyration are to be expected between small-angle neutron scattering and small-angle
X-ray scattering because scattering depends on diﬀerent physical properties (neutron
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Figure 3.15: A) DLS data of OPN1-149 CPN shows 2 major species in the solution.
The larger peak corresponds to the formed CPN with a Rh of 19 nm and the smaller peak
corresponds to excess protein in solution with a Rh of 2.1 nm. Guinier approximation of
OPN1-149 CPN measured by SANS, yields an RG of 20.5 ±0.5 nm
scattering length density or electron density, respectively). The results conﬁrm the
ability of OPN1-149 to form novel calcium phosphate nanoclusters with a larger
radii of gyration then those observed for CPN formed by other proteins such as the
caseins. The results from DLS also indicate a single species forming rather then a
wide distribution of sizes.
3.3.8 Osteopontin dynamics and the effects of calcium phos-
phate sequestration.
EINS data were recorded as a function of temperature against the angular depen-
dency of scattering intensity, known as a ﬁxed window EINS temperature scan. A
Gaussian ﬁt was applied to the data at low q from which MSDs were extracted from
the slope of the straight line. An example of the Gaussian ﬁt is shown for several
diﬀerent temperatures in Figure 3.16. At higher temperatures the linear dependency
of the scattered intensity with q deviates more, caused by large amplitude motions.
However at q values satisfying the condition in equation 3.5 the Gaussian approxima-
tion provides a satisfactory ﬁt at higher temperatures q. From the linear ﬁt the MSD
was extracted for each temperature point, for both samples. The resulting data was
plotted as a MSD against temperature, shown in Figure 3.17.
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Figure 3.16: Elastic scattering intensity as a function of q measured for OPN1-149 shown
for three temperatures, showing the linear fit from which the MSD is obtained.
The results obtained for both free OPN and OPN CPN respectively show typical
two well model behaviour, previously observed in other hydrated protein samples
examined by EINS [191]. Identical MSDs were obtained at temperatures below 240
K, where atoms are trapped in a low harmonic well. At higher temperatures both
the OPN1-149 and OPN CPN start to sample the harmonic and anharmonic wells
causing a rapid increase in measured MSDs values. At higher temperatures the MSD
of OPN 1-149 is higher than that of OPN CPN, indicative of a higher ﬂexibility of free
OPN1-149. When comparing CPN-forming phosphopeptide dynamics, however, the
number and distribution of clustered regions of phosphorylated residues (phosphate
centres; PC) must be kept in mind. OPN1-149 interacts with the inorganic core of
the CPN through phosphorylated regions, which act like anchor points to calcium
phosphate, restricting the chain displacements.
The associated eﬀective force constants (<k’>) were extracted from the data above
260K (Table 3.1). The eﬀective force constant of OPN1-149 was determined to be
0.083 ± 0.009 which is in close agreement with the <k’> of Tau protein determined
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Figure 3.17: Disorder profiles predicted for hOPN1-157 and OPN1-149 by the IUPred
method, a dashed red line shows the value above which the region is considered disordered
[174].
to be 0.096 by Gallat et al . [157]. The EINS measurement from which this value
was obtained are identical to the conditions used in this study. Tau protein is also
an IDP, and the determined value of <k’> was compared to that obtained for MBP
a folded protein of similar molecular mass. The determined eﬀective force constant
of MBP was almost twice as large as that determined for Tau Table 3.1 indicative of
a stiﬀer protein. The eﬀective force constant of OPN1-149 is almost twice as large
compared to that obtained for OPN CPN. The observed increase in the eﬀective
force constant indicates that OPN1-149 becomes more resilient upon sequestration of
calcium phosphate, which is combined with a decrease in ﬂexibility. This is consistent
with the crowded environment in the CPN, where the 3 PCs further anchor the
protein chain. Furthermore table 1 shows that the resilience of hydrated osteopontin
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Table 3.1: Values of the effective force constants (<k’>), obtained from the EINS temper-
ature scans on IN16B. Values of Tau and MBP were taken from Gallat et al . [157]
Hydrated powder sample <k’> (N/m)
OPN1-149 0.083± 0.009
CPN 0.156± 0.0190
Tau 0.096
MBP 0.185
is in close agreement with previously measured force constants of the disordered Tau
protein. The ﬂexibility of OPN CPN is somewhat reduced yet it is still larger then
that observed in globular proteins. Therefore the peptides on the nanocluster shell
are still able to occupy a comparably larger conformational space, compared to folded
counterparts.
3.4 Discussion
Here a detailed description of the structure and dynamics of OPN1-149 is presented.
Analysis of the amino acid sequence showed that OPN1-149 had several of the key
characteristics of disordered proteins, including a high net negative charge and an
excess of amino acid residues which have a low structural propensity [174]. Circu-
lar dichroism analysis showed a low propensity for secondary structure elements in
OPN1-149, and other biophysical techniques indicated IDP characteristics of OPN1-
149. This result is in close agreement with structural characterisation of other OPN
fragments isolated from recombinant and natural sources. Using SAXS in combina-
tion with EOM analysis the wide range of conformations adopted by OPN1-149 in
solution where determined, ranging from compact to more extended conformations.
Similar compact and extended structures have previously been observed by NMR
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in a diﬀerent OPN fragment originating from Quail. Our results build on this data
and provide low resolution structural models for the diﬀerent conformations found in
OPN1-149. Adopting a wide range of conformations in solution is a key principle of
IDP function, allowing for rapid recognition and weak binding to multiple diﬀerent
partners. In the case of OPN1-149 if the protein is phosphorylated it is capable of
sequestering calcium phosphate through highly phosphorylated regions. It has previ-
ously been determined that sequestration of calcium phosphate by OPN1-149 leads
to the formation of calcium phosphate nanoclusters. It is now known that this se-
questration of calcium phosphate is one of the key biological functions of OPN1-149
and similar proteins in biological ﬂuids. In this study the ability of OPN1-149 to form
monodisperse calcium phosphate nanoclusters was determined by DLS.
The EINS temperature scan was veriﬁed by the transitions observed in all hydrated
protein powders studied at 240K. At lower temperatures contributions to the dynam-
ics only arise from solid like vibrational motions. From the data at higher temper-
atures information about the resilience of the protein was obtained. This resilience
is related to the softness of the protein, with a lower value corresponding to a more
ﬂexible protein. The resilience of OPN1-149 is lower then those found for globular
proteins on the pico-second timescale. This information can be combined with the
distribution of models obtained by the EOM SAXS data analysis, to show that in so-
lution OPN1-149 is rapidly sampling a large area of conformational space. In the case
of OPN1-149 it can be rationalised that sampling large areas of conformation space
could allow the protein to quickly respond to local ﬂuctuations in calcium phosphate
concentration, allowing it to sequester excess calcium phosphate prior to nucleation.
This rapid sampling of conformational space by IDPs such as Tau and OPN1-149
could be the reason that many proteins that control biomineralisation are IDPs.
Upon sequestration of calcium phosphate by OPN1-149 <k’> decreases signiﬁcantly,
and the ﬂexibility of the protein is more accurately represented by that of a globular
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protein. This result shows that the speciﬁc dynamical and conformational properties
of IDP not only depends on their amino acid composition or structure in solution but
that the protein environment also has to be considered. This train of thought can
be extended to the conditions experienced within the cellular environment or even in
biological ﬂuids which are often considerably more crowded then the conditions used
to study proteins in the laboratory. For example disordered proteins can undergo
disorder to order transition upon binding with their partners but can also retain sub-
stantial conformational ﬂexibilities as shown here for OPN CPN. Given that previous
work showed that the ﬂexibility of OPN increases upon binding to heparin, structural
and dynamical changes are strongly dependant on the molecular partner [192]. For
both calcium phosphate and heparin, the order or disorder induced is not described
by formation of secondary structural elements but rather OPN peptide occupation
of conformational space. Such behaviour of IPDs has previously been simulated by
computational studies, which showed that under crowding conditions the calculated
RG of unfolded proteins decrease, without induction of structural elements [173].
3.5 Conclusion
Several diﬀerent biophysical characterisations showed that OPN1-149 behaves as an
IDP in solution. This result was conﬁrmed by solution SAXS studies and ab initio
modelling. By using the ensemble optimisation method further information about the
ensemble of OPN1-149 in solution was obtained. In solution the protein can adopt a
large amount of diﬀerent conformations, ranging from compact to highly extended. By
combining the structural ensemble data and the data obtained by EINS it was shown
that OPN1-149 more rapidly samples diﬀerent conformations compared to globular
proteins. And that these transient conformations can range from quite compact to
highly extended. The ability of OPN1-149 to sequester calcium phosphate leading to
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the formation of calcium phosphate nanoclusters was conﬁrmed by DLS and SANS.
Allowing the peptide to regulate bioﬂuids supersaturated with respect to hydroxya-
patite. The ability to sample large areas of conformational space could be vital in
the process of sequestering excess calcium phosphate prior to irreversible nucleation
and crystal growth. Data is also presented that shows an increase in the resilience of
OPN1-149 upon formation of calcium phosphate nanoclusters and is similar to the
resilience found in globular proteins. This increase in resilience could be caused by the
tight packing of OPN1-149 around the particle core and could be of beneﬁt for fur-
ther CPN interactions [193]. This increase in resilience has important insights for the
dynamics of intrinsically disordered proteins. Most structural studies of intrinsically
disordered proteins are on monodisperse dilute samples in solution. The conditions
under which biophysical experiments are performed make it diﬃcult to understand
the impact of binding partners and cellular conditions on protein dynamics and struc-
ture. It is for example well known that IDPs are more eﬀected by the crowded protein
conditions found in the cell, leading to adoption of more compact states.The complex
conditions found in the cell and biological ﬂuids could therefore also eﬀect the dy-
namics of other intrinsically disordered proteins, not only in terms of induced folding
but also in restriction of conformational space sampling. Recent neutron scatter-
ing experiments on highly concentrated globular protein solutions representing those
found in cellular conditions show that that sidechain rotations are reduced at high
crowding concentrations. Given their unique structural features, disordered proteins
may respond to these factors diﬀerently, especially in terms of compaction.
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Chapter 4
Calcium phosphate nanoclusters
stabilised by osteopontin contain a
core of amorphous calcium phosphate
sequestered within a protein shell
Experimental work presented in the following chapter has been peer reviewed
and published:
• Holt, C., Lenton, S., Nylander, T., Sørensen, E. S., Teixeira, S. C.
M. (2014). Mineralisation of soft and hard tissues and the stability of
biofluids. Journal of structural biology, 185(3), 383-396.
Abstract
In vertebrates insufficient availability of calcium and phosphate ions in biofluids leads to
loss of density in mineralised tissue. Consequently concentrations of calcium and phosphate
ions are above their respective levels of saturation. The same biofluids often permeate soft
tissue without causing ectopic calcification. Several proteins have been shown to allow soft
and hard tissue to coexist by sequestering calcium phosphate within a calcium phosphate
nanocluster (CPN), thereby stabilising saturated biofluids. Osteopontin (OPN) is an ex-
ample of a protein able to form CPN. The CPN stabilised by OPN are larger then those
formed by other proteins. Here we present a detailed characterisation of the CPN formed
by OPN proteins. Using small-angle neutron scattering we determine that the formed CPN
have a core-shell type structure. Using neutron diffraction a distinct lack of crystallinity
is observed within the core, indicating an amorphous structure of the sequestered calcium
phosphate. The biological implications of the findings are discussed in context of the role of
OPN in biomineralisation.
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4.1 Introduction
In vertebrates mineralised tissue consists of a protein matrix within which crystalline
calcium phosphate is deposited. Insuﬃcient availability of calcium and phosphate
ions in biological ﬂuids that are in contact with mineralised tissue can lead to the loss
of mineral density [9]. Consequently most bioﬂuids contain calcium and phosphate
ions above their soluble concentrations [194, 12]. At physiological pH a solution sat-
urated with calcium and phosphate ions is expected to precipitate out of solution
[14]. The precipitation and consequent formation of crystalline material is a thermo-
dynamically driven process [74]. The process is initiated by the formation of a short
lived amorphous calcium phosphate (ACP) phase, which is metastable at best, the
fresh precipitate of ACP is then transformed through a number of transient calcium
phosphate phases, before the ﬁnal most stable phase of crystalline hydroxyapatite
(HA) is formed [17, 195, 196]. In vertebrates HA is the mineral phase found in most
mineralised tissue such as bone and tooth [4]. It would therefore be expected that
bioﬂuids would readily precipitate HA and readily mineralise soft tissue with which
they are in contact. However precipitation of calcium phosphate in bioﬂuids is not
spontaneous and degenerate ectopic calciﬁcation is a relatively rare occurrence [1].
Several phosphorylated proteins have been shown to inhibit the precipitation of cal-
cium phosphate from solution [23]. These proteins inhibit precipitation of calcium
phosphate by forming equilibrium complexes, a vital requirement for the formation
of such complexes is the presence of phosphate centres. A phosphate centre (PC) is
deﬁned as a short acidic subsequence within which at least three or more residues are
phosphorylated [10]. If these phosphate centres are present in stoichiometric excess
over the amount of initial precipitate of amorphous calcium phosphate the solution
remains stable and no precipitate is formed [74]. The stability is aﬀorded through
the reaction of the phosphate centres with the formed precipitate of amorphous cal-
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cium phosphate which leads to formation of calcium phosphate nanocluster (CPN)
[74]. It is thought that calcium phosphate nanoclusters contain a core of amorphous
calcium phosphate surrounded by a peptide shell [45]. The sequestration of calcium
phosphate by PC containing peptides completely inhibits the maturation of the cal-
cium phosphate and the core reaches equilibrium with the solution. In bovine milk
the PC containing β-casein is responsible for stabilising the high concentrations of
calcium phosphate through formation of CPN. The CPN formed by β-casein contains
an amorphous core of calcium phosphate surrounded by a protein shell [67, 73]. Os-
teopontin (OPN) is another PC containing peptide found in bovine milk formed by
the cleavage of full length OPN by the secreted plasmin protease, OPN1-149 contains
three phosphate centres [45, 64, 197].
Table 4.1: Identified PC sequences formed by phosphorylation of secreted phosphoproteins
by Golgi Kinase and Casein Kinase 2, with phosphorylated sites shown in bold. Table
adapted from Holt et al . [72]
.
Protein Swiss-prot No PC sequence
OPN P31096 6 - TSSGSSEEKQ - 15
Casein P045656 19 - SSSSSSSEER - 28
Fetuin-A P02765 307 - SLGSPSGEVS - 316
SANS experiments performed on the CPN stabilised by the single PC containing β-
casein showed that the nanocluster can be described by a core shell model with a core
radius of 2.30 ± 0.05 nm and a total radius of 4.04 ± 0.15 nm. SAXS experiments
on OPN1-149 CPN showed a much larger radius of around 20 nm with a predicted
core radius of 12.5 nm. However the SAXS results do not provide direct evidence
of this core-shell structure, instead the core-shell model is imposed on the data [72].
The larger radius of the core was thought to be mainly due to hydration and the
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increased sequestering ability of the OPN1-149 peptide aﬀorded by a higher degree of
phosphorylation [72]. The increased ability to sequester calcium phosphate is thought
to be due to the higher concentration of hydrophobic sequences around the phosphate
centre together. However, as of yet, there is no experimental evidence that the core
of OPN1-149 CPN is amorphous, the larger core radius could also be due to crystal
growth within the core.
4.1.1 Amorphous phases of calcium phosphate
Structures lacking in any medium or short range order are more closely related to the
structures of liquid phases then those of crystalline material. They are named amor-
phous phases, from the Greek amorphos meaning without form or shapeless. The
structures are highly irregular such that the concept of a reference crystal lattice is
nonsensical. Instead an amorphous phase is more accurately described by a distribu-
tion of diﬀerent structures, or ideally a perfectly random structure [198]. Amorphous
calcium phosphate phases are the ﬁrst phases of calcium phosphate to form from a
supersaturated solution above pH 7. The formation of amorphous calcium phopshate
is thermodynamically driven, however the formed amorphous structure is intrinsically
unstable or metastable at best. The initial phase of ACP is spontaneously converted
to more stable crystalline calcium phosphate phases. The transient nature of amor-
phous phases has been observed by electron diﬀraction patterns where over time the
formation of a crystalline phase was observed originating from an amorphous diﬀrac-
tion pattern [199].
4.1.2 Crystalline phases of calcium phosphate
Crystalline solids are characterised by their regular, periodic atomic arrangement in
three dimensional space. Periodic arrangement in structures can be described over
diﬀerent length scales. The crystalline state of diﬀerent phases of calcium phosphate
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can be described over the Ångstrom length scale (see Table 4.2). This length scale cor-
responds to shortest length scale used to describe biological material which typically
lies around the order of Ångstroms which roughly corresponds to the intermolecular
bond length. Nearly all liquids and solids can be said to contain order over these
short length scales, so called short-range order. Crystalline solids contain structural
order over much longer length scales, so called medium range order and also long-
range order. The length scales of the three diﬀerent scales of order have been deﬁned
in literature, Short-range consists of 2-5 Å, medium range order of 5-20 Å and long
range order exceeds 20 Å [200, 201].
Table 4.2: Crystallographic data of different calcium phosphate phases. [202] MCPM =
monocalcium phosphate monohydrate, MCPA = monocalcium phosphate anhydrate, DCPD
= dicalcium phosphate dihydrate, OCP = octacalcium phosphate, α-TCP = α-tricalcium
phosphate, β-TCP = β-tricalcium phosphate.
Compound Space Group Unit cell parameters (Å)
MCPM Triclinic a = 5.3, b = 11.9, c = 6.5
MCPA Triclinic a = 7.6, b = 8.3, c = 5.6
DCPD Monoclinic a = 5.8, b = 15.2, c = 6.2
OCP Triclinic a = 19.6, b = 9.5, c = 6.8
α-TCP Monoclinic a = 12.9, b = 27.3, c = 15.2
β-TCP Rhombohedral a = b = 10.4, c = 6.9
Hydroxyapatite Monoclinic a = 9.8, b = 2a, c = 6.9
It is this repetitiveness which is detected and detailed by the manner in which
radiation is scattered by a crystalline sample. It is therefore possible to obtain infor-
mation about the structure of the scattering crystal by investigation of the diﬀraction.
In order to study structural features using radiation the incident beam has to probe
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distances on the order of the periodicity, which for calcium phosphate phases on the
the Ångstrom scale (see Table 4.2). Both X-rays and neutrons can be obtained on
this order of magnitude. For X-rays the wavelength of the radiation is tuned using
collimator’s whereas for neutrons the corresponding wavelength is obtained by regu-
lating the temperature of the neutron beam, for example by interaction with D2O.
X-ray diﬀraction has several beneﬁts over neutron diﬀraction including, easier access
to beam-time, faster data collection and smaller sample sizes. The interaction of high
energy X-rays with soft matter such as protein and crystalline material can induce ra-
diation damage in the sample. In some cases synchrotron radiation is known to alter
the structure of the studied sample in both proteins and crystalline latices. Neutrons
require much longer measurement times and larger samples, but the interaction of
neutrons with the atomic nucleus is non destructive meaning that samples are not
damaged. Diﬀraction studies using neutrons also allow the experimenter to take use
contrast variation. This technique exploits the interaction of neutrons with diﬀerent
isotopes thereby allowing the match out of parts of the sample with diﬀerent scatter-
ing length densities. Using this technique for example it is possible to study only the
core of a calcium phosphate nanocluster without observing contributions from the
protein shell.
In this chapter a combination of small-angle neutron scattering with contrast
variation and static light scattering is used to show that OPN1-149-CPN formed
in supersaturated solutions of calcium phospate are core shell particles. The core is
then characterised using a combination of neutron diﬀraction and FT-IR spectroscopy.
The implications of the results obtained are then discussed in terms of the biological
function of OPN1-149 and OPN1-149-CPN.
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4.2 Materials and methods
4.2.1 Protein purification and preparation
In milk OPN undergoes proteolytic processing by several diﬀerent proteases, leading
to a mixture (OPNmix) of diﬀerent phosphopeptides [183]. For this study, naturally
occurring OPNmix was isolated from bovine milk as previously described and used
without further puriﬁcation [45]. The principal components are N-terminal peptides
ending between residues 145 and 153 of the mature protein sequence [197]. Previously
this group of N-terminal peptides was considered equivalent to OPN 1-149. We have
kept this nomenclature here for the sake of simplicity and continuity. Puriﬁcation of
OPN1-149 from OPNmix was completed per the method of Holt et al . [72]. From
the OPNmix the OPN1-149 peptide was puriﬁed to homogeneity by size exclusion
chromatography (SEC) as described by Holt et al [45]. In brief, osteopontin frag-
ments were separated by size on a 120 ml volume column containing a Superdex 75
(G.E. Healthcare) stationary phase, connected to a Biologic dual ﬂow puriﬁcation
system (Bio-Rad). Size exclusion was performed at room temperature, the column
was equilibrated with 2 column volumes of elution buﬀer (50 mM phosphate, pH 7.0,
300 mM NaCl, 0.02% NaN3) at a ﬂow rate of 0.3 ml/min. 100 mg of OPNmix was
then dissolved in the same elution buﬀer and loaded onto the column at a rate of 0.3
ml/min. Elution from the column was constantly monitored by U.V. absorption at
λ = 280 nm, fractions were collected on volumes of 1 ml, elution was stopped after 2
column volumes of elution buﬀer.
4.2.2 Formation of calcium phosphate nanoclusters
OPNmix and OPN1-149 CPN were prepared by the simple mixing method to give ﬁnal
concentrations of 22 mM calcium, 20 mM inorganic phosphate, an ionic strength of
63 mM and pH 7.0. The nanocluster equilibrium has a free calcium ion concentration
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of 0.5 mM and, on average, each peptide is attached to calcium phosphate through
only one of its 3 phosphate centres. Samples were allowed to equilibrate for at least
14 days prior to centrifugation. Two hydrated samples were produced from solutions
of 10 ml of 30 mg/ml OPNmix CPN using 39% D2O (contrast match point of the
peptide) or 100% D2O.
4.2.3 Static light scattering experiments
Experiments were performed on a CGS-3 Compact Goniometer System (ALV, Lan-
gen, Germany) using a 22 mW Helium-Neon laser operating at 632.8 nm. To prevent
multiple scattering the sample was diluted 50 fold with a buﬀer that matched the
ultraﬁltrate to maintain sample integrity. Prior to measurement, the sample and di-
lution buﬀer were ﬁltered through a Sartorius syringe ﬁlter of 0.2 µm porosity into a
QS cylindrical cell with an optical path length of 8 mm (Hellma, Mullheim, Germany).
Measurements were made at scattering angles between 30◦ and 150◦ in intervals of 10◦
at a temperature of 24◦C. After subtracting the dilution buﬀer scattering, the radius
of gyration (RG) of the OPNmix nanoclusters in 0 % and 39 % D2O was recovered
from the slope of the Guinier plot.
4.2.4 Small-angle neutron scattering experiments
Neutron scattering measurements were made at 24 ◦C on the small-angle neutron
diﬀractometer D33 [152] at the Institut Laue-Langevin, Grenoble. Prior to each
measurement, samples containing 30 mg/ml OPNmix were ﬁltered through a 0.2
µm Sartorius syringe ﬁlter into Hellma quartz cells of 1 mm optical path length.
Scattering curves were recorded using a ﬁxed incident neutron wavelength of 0.6 nm
and wavelength spread
(
∆λ
λ
)
of 10 %. A Guinier plot was made of the small-angle
neutron scattering in the scattering wave vector (q) range 0.00408 - 0.01281 Å. Data
satisfying the condition q·RG≤ 1 were ﬁtted to a straight line to recover the value of
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the radius of gyration.
4.2.5 Model calculations
The core-shell model used originates from the work of Holt et al . [67]. Total scattering
measured P arises from the diﬀerence between excess scattering of the core and shell
P1 and P2 above the scattering of the solvent Ps.
P = P1 + P2 + PS (4.1)
The non solvent scattering material consists of contributions from the core and shell
which have radii R1 and R2, respectively. According to Holt et al . [67] the RG for a
core-shell particle is given by:
R2G =
(
3
5
)
·
(
[(P2 − PS)R
5
2 + (P1 − PS)R
5
1]
[(P2 − PS)R32 + (P1 − PS)R
3
1]
)
(4.2)
For a neutron scattering experiment the scattering length densities of the core and
shell contributions can be calculated, and depend upon the concentration of D2O, β,
in the solvent. Assuming full exchange of the buﬀer
Ps = −0.562 + 6.962β (4.3)
P1 = 2.019 + 4.043β (4.4)
P2 = 1.901 + 1.011β (4.5)
From which it can be calculated that P1 = PS at β = 0.882, P2 = PS at β = 0.413
and P1 = P2 at β = −0.039.
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4.2.6 Preparation of micellar calcium phosphate
The preparation of micellar calcium phosphate from the casein micelle of bovine milk
followed the method described by Holt et al . [203]. Casein micelles were recovered
from 40 ml of commercial skimmed milk by centrifugation at 60,000 g for one hour, the
resulting supernatant was disposed and the pellet re-suspended in the same volume of
milk. Sodium azide was added to the resulting solution to a ﬁnal concentration of 1.5
mM. The solution was left to stir for 24 hours at 4◦C until the solution was fully re-
dispersed. 100 mg of proteinase K was added to the solution and placed in a Visking
dialysis tube. The resulting solution was then dialyzed for 24 hours against 2 litres
of skimmed milk also containing 1.5 mM sodium azide at 4◦C. The resulting solution
in the dialysis bag cleared. Casein micelles where then recovered by centrifugation
(85,000 g, 16 hours at 8◦C) which yielded a clear brown pellet. Previous work has
shown that the pellet comprises the micellar calcium phosphate and associated casein
phosphopeptides resistant to digestion by the proteolytic enzyme [203, 204].
4.2.7 Preparation of calcium phosphate samples
Amorphous calcium phosphate was prepared using a modiﬁed method of Holt et al .,
by including the tryptic digest of β-casein, β-casein 1-25, which inhibits the matu-
ration of the formed amorphous calcium phosphate [10, 205]. Brieﬂy, 500 ml of a
phosphate solution was mixed with 500 ml of a calcium solution at room tempera-
ture. The phosphate solution contained 100 mM NaH2PO4 and 100 mM Na2HPO4,
the calcium solution contained 4 mM CaCl2, 135 mM NaCl, 14 mM MgCl2 and 10
mg of the bovine casein tryptic digest β-casein 1-25. The pH of the resulting solution
was adjusted and maintained to 7 by addition of NaOH whilst stirring. The solution
was ﬁltered through a 0.44 µm Sartorius membrane after 60 minutes of stirring, the
obtained solid was then freeze dried and kept over silica powder overnight and ﬁnally
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stored at -20◦C. Dicalcium phosphate dihydrate (DCPD) was prepared according to
a previously published protocol. In brief, 0.825 g of KH2PO4 and 3 g Na2HPO4, to
which 200 ml of a solution containing 4 g of CaCl2· 2H2O was added whilst stirring
. The solution was left to stir at room temperature for 60 minutes resulting in the
formation of a precipitate. The solid was recovered by ﬁltration through a 0.44 µm
Sartorius membrane and washed several times with de-ionised water. The obtained
solid was left to dry overnight on silica gel before storage at -20◦C.
4.2.8 Simulated neutron and X-ray diffraction patterns
The detection of crystalline material within a sample depends upon many parame-
ters including the number, purity and size of crystalline material present as well as
instrumental parameters which are often quite complex. Many of these diﬀerent pa-
rameters are taken into account in the FullProf suite thereby allowing for an accurate
prediction of neutron scattering by diﬀerent crystalline material [206]. Diﬀraction
patterns were calculated for diﬀerent crystalline sizes of HA and DCPD, within a
range corresponding to the sizes present in diﬀerent calcium phosphate nanoclusters.
Neutron and X-ray diﬀraction patterns where also predicted using the Inorganic Crys-
tal Structure Database (ICSD-for WWW) hosted at the Institut Laue-Langevin [207].
4.2.9 FT-IR experiments
FT-IR analysis was performed with a Bruker VERTEX 70 (Rheinstetten, Germany)
infrared spectrometer equipped with a Platinum ATR device. Data was recorded
with a resolution of 2 cm−1 in the range 4000 - 400 cm−1, with a total of 32 scans.
The spectra were recorded and stored using spectroscopic software (OPUS, Bruker
Inc.).
94
4.2.10 X-ray diffraction experiments
X-ray diﬀraction data were collected using a GeniX Cu high ﬂux generator (1.5418
Å), average ﬂux for this conﬁguration was 400x106 photons.s−1, and recorded on
a Mar345 detector with exposure times of 20 minutes per sample. Each dried or
hydrated sample was mounted in a glass capillary of 0.5 mm diameter (beam size at
focus 200x200 µm2 with a divergence of 5 mrad).
4.2.11 Neutron diffraction experiments
Diﬀraction measurements were collected at the D16 diﬀractometer at the Institut
Laue-Langevin, Grenoble France [208]. Data were recorded over the q range of 0.01-
2.5 Å−1 by rotation of the detector around the sample position. Where q is the
scattering wave vector described by q = (4π/λ)sinθ where λ is the wavelength of the
incident neutron beam in this case 4.76 Å(∆λ/λ = 10%). Measurements were made
corresponding to a 2θ range of 30 - 115◦ at this range the D16 instrumental neutron
diﬀraction peak broadening corresponds to a maximum of 0.83◦ at the wider angles
(where 0.5◦ is the maximum beam bandwidth in the range). Diﬀraction was recorded
on a millimetre resolution large area 3He detector (MILAND, 320 × 320mm2). The
incident beam had a diameter of 3mm, the divergence was calculated from the image
of a attenuated beam and determined to be 0.33◦. During data collection the incident
ﬂux of neutrons on the sample was 1×106 neutrons cm−2s−1. Samples were deposited
in sample containers with a 5mm path-length. Empty cell scattering was recorded
and subtracted from the sample scattering pattern. Data was collected on OPNmix-
CPN samples prepared in H2O, 100% D2O and 41% D2O. The samples were pelleted
after 3 weeks of formation to allow them to reach equilibrium size [45]. Diﬀraction
measurements were repeated 4 weeks later, no changes in diﬀraction were observed.
While the hydrated samples were pelleted to obtain a higher concentration within
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the beam the dry powdered samples were deposited in the sample container without
compaction. Data was collected at room temperature with exposure time of 120 min-
utes per sample. Data reduction was carried out using the Large Array Manipulation
Programme (LAMP) of the ILL.
4.3 Results
4.3.1 Match-point of OPN1-149
The match-point of OPN1-149 was calculated to be around 40% D2O. This was
veriﬁed experimentally by measurement of the protein in buﬀer containing 40% D2O,
shown in Figure 4.1
Figure 4.1: Kratky plot of OPN1-149 measured in 100% D2O (green circles) and 40% D2O
(red circles). In the 40% D2O there is no scattering above noise, verifying that OPN1-149
is matched out.
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4.3.2 CPN stabilised by OPN have a core-shell structure
The formation of calcium phosphate nanoclusters by OPNmix, in both 0% and 39%
D2O, was observed in the Guinier plot of the static light scattering data. The RG was
determined from the slope of a straight line ﬁt for OPNmix-CPN in 0% and 39% D2O,
to be 24.5 ± 0.3 nm and 24.5 ± 0.48 nm respectively. The results indicate that the
increased levels of D2O do not aﬀect the overall size of the formed CPN and that the
CPN can still form even under higher percentages of D2O. The RG determined from
the SANS for OPNmix-CPN in 0% D2O was 19.5 ± 0.36 nm, which compares well
with the RG of 20.5 ± 0.1 nm, previously determined by small-angle X-ray scattering
[45]. The slight diﬀerences observed between the presented light scattering and small-
angle neutron scattering data are expected, because for each method the scattering
depends on a range of physical properties. The small-angle neutron scattering data
in 39% D2O, close to the protein match-point, yielded a lower RG of 17.5 ± 0.51
nm, conﬁrming that the nanoclusters have a core-shell structure. The data was then
modelled according to the core-shell structure model (See quation:4.2), from which
the core and shell radii can be calculated from the experimentally determined RG. In
0% D2O the radius of the whole calcium phosphate nanocluster is then 25.2 ± 0.44
nm and the radius of the core determined from the 39% D2O sample is 22.6 ± 0.68
nm, corresponding to a shell thickness of 2.6 nm (Table 4.3).
Further studies were completed using puriﬁed OPN1-149 for which a more accurate
calculation of the core shell model can be completed. The Guinier plot of the SANS
data of OPN1-149-CPN is shown in Figure 4.3. The RG obtained for the 0% D2O
and 39% D2O sample was 18.1 ± 0.29 nm and 19.5 ± 0.36 nm, respectively. The
core-shell model calculation was also applied to the the data and is shown in table
Table 4.3. From the model a shell thickness of 2 nm is obtained, slightly smaller
compared to the shell thickness of OPNmix-CPN. The Kratky plot of both the 0
% and 39 % OPN1-149-CPN is shown in Figure 4.4. Both Kratky plots show a well
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Figure 4.2: A) Guinier plot of SANS from OPNmix-CPN in 39% and 0% D2O B)A
Guinier plot of Elastic light scattering data from OPNmix-CPN in 39% and 0%
D2O. The radius of gyration was recovered from the fit of a straight line to the points.
deﬁned maximum, which is at lower q for the non matched out sample, corresponding
to a larger particle. This type of behaviour where the core is smaller then the whole
particle corresponds to the core-shell mode.
Figure 4.3: Guinier plot of the small-angle neutron scattering data from OPN1-149 CPN
in 0 % and 39% D2O. The obtained RG where 18.1±0.29 nm and 16.5±0.60 nm respectively.
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Table 4.3: Radius of gyration obtained for OPNmix and OPN1-149 CPN by SANS. Core
RG measurements were performed at the match point of protein (41% D2O). CPN RG
measurements were obtained from SANS measurements in 0% D2O. The calculations of the
Core and shell radius are based on the model presented in equation 4.2. All units are nm
unless stated otherwise
.
Core RG Core radius CPN RG CPN radius
OPNmix 17.5 ± 0.51 22.6 19.5 ± 0.36 25.1
OPN1-149 16.5 ± 0.60 21.4 18.1 ± 0.29 23.4
4.3.3 Characterisation of calcium phosphate phases
In order to conﬁrm successful synthesis of the control samples, ACP and DCPD, were
initially characterised by FT-IR. The experimentally determined FTIR spectra of the
control samples are shown in Figure 4.5 and are in close agreement with previous
experimental observations [209, 210]. The structure of DCPD is indicated by broad
bands centred around 2850 cm−1 corresponding to the hydrogen phosphate anions is
present in the spectra [211]. A pair of doublets can be observed around 3480 cm−1 and
3200 cm−1 caused by the water stretching mode. Neither of these peaks are observed
in the ACP or dry CPN sample (Figure 4.5). The characteristic water bending mode
at 1649 cm and it’s subsidiary peak at 1730cm −1, indicative of DCPD are also
present. The expected lifting of the degeneracy of the broad phosphate asymmetric
stretch (1100 cm−1) for crystalline calcium orthophosphates, due to site symmetry of
factor group splitting is observed in the DCPD sample but is not present in either the
ACP or CPN spectra. The measured spectra of ACP is also in close agreement with
previously published results for ACP prepared in a similar manner (Figure 4.5) [212].
A large part of the measured spectra is obscured by the presence of water, speciﬁcally
in the region ranging from 2500-3650 cm−1. The strong peak observed at around
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Figure 4.4: Kratky plot of the small-angle neutron scattering data from OPN1-149 nan-
oclusters. Filled circles shows OPN1-149 CPN in 39% D2O and empty circles shows OPN1-
149 CPN in 0% D2O
850 cm−1 is caused by the stretching mode of protonated phosphate groups, which is
absent in the dry CPN sample (Figure 4.5) this is probably due to it being obscured by
other absorption bands as previously observed in FTIR of CPN samples [73]. The FT-
IR results therefore indicate formation of an amorphous phase of calcium phosphate
and successfully synthesis of DCPD. Moreover the dried OPN-CPN sample shows a
FT-IR spectrum similar to those obtained for amorphous calcium phosphate.
4.3.4 Calculation of neutron and X-ray diffraction patterns
Neutron diﬀraction patterns were simulated over the q-range measured on D16 for
diﬀerent calcium phosphate phases (Figure 4.7). All calcium phosphate phases simu-
lated show diﬀraction under the measurement conditions used on D16. The simulated
neutron diﬀraction patterns of DCPD and HA for diﬀerent possible crystalite sizes
are also shown in Figure 4.7. The crystallite sizes were chosen to cover a range from
the dimension equivalent to just one or two stacked unit cells, up to a size that would
occupy the full diameter of the core of CPN. DCPD and HA were chosen as represen-
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Figure 4.5: FT-IR spectra recorded for the synthesised ACP, DCPD and the dried CPN
samples. The dried CPN samples show a similar absorbance as ACP, lacking any of the
characteristic crystalline peaks as observed for DCPD between 850 and 1250 cm−1
tative potential structures that crystallise in small unit cells. If pure HA crystallites
were present (Figure 4.7b), and given that the experiments carried out allowed for
data to be collected up to a 2θ of 115◦, the simulations suggest that crystallites of
18.9 Å- large enough to include two or more unit cells stacked in the ’b’ or ’c’ unit
cell edge directions - would cause a broad peak centred at ~34◦. A second broad
peak would be outside the experimental range but a tail would cause intensities to
increase signiﬁcantly with the scattering angle from a 2θ of 60◦. A similar proﬁle
would already be expected for a 13.8 Å crystallite, which can contain two unit cells
stacked along the ’c’ direction and would ﬁll 2% of the casein CPN core, or only 3%
of the OPN core. For DCPD, the simulations suggest that experimental resolution
would not allow resolution of the presence of crystallites formed by up to 3 unit cells
stacked in the ’a’ direction, nor any made of a single monoclinic unit cell (as shown
by the broad intensity proﬁle for 5.8 Å or 15.2 Å). Crystallites of DCPD larger than
15.2 Å would however be resolved through the presence of at least two distinct peaks
within the experimental range observed.
101
Figure 4.6: Neutron diffraction patterns for different calcium phosphate phases calculated
under conditions measured on D16 at the Institut Laue-Langevin. The diffraction patterns
are based on the crystal structures of anhydrous calcium phosphate, tri-calcium phosphate,
hexagonal HAP, DCPD and OCP. All calcium phosphate phases are expected to diffract
within the range measured on D16
4.3.5 Neutron diffraction control measurements
Known phases of calcium phosphates were measured on the D16 diﬀractometer as
control measurements. Figure 4.8 A, shows the diﬀraction pattern recorded on a
control sample of DCPD. The measured diﬀraction pattern is noisy, however it is
possible to discern the two major diﬀraction peaks caused by DCPD crystalline ma-
terial. Only peaks 15 times above the standard deviation were considered signiﬁcant.
The measured peaks agree well with the position from the simulated data, and indi-
cate that it is possible to detect crystalline phases of calcium phosphate on the D16
diﬀractometer.
Figure 4.8 B shows measurements completed on the synthesised amorphous calcium
phosphate, previously characterised by FT-IR. The synthesised amorphous phase
stabilised by magnesium was also measured and showed no clear Bragg diﬀraction,
as would be expected for a sample lacking in crystalline order. Upon hydration of
102
Figure 4.7: Simulations of neutron diffraction patterns expected at D16 using the sample
measurement conditions. Patterns for Hydroxyapatite (top) assumed a pure hexagonal
crystal with the unit cell: a = b = 9.432, c = 6.881 (Å). DCPD was also assumed to
take the form of a pure crystalite with the unit cell: a = 5.812, b = 15.18, c = 6.239 (Å).
CPN stabilised by OPN have the largest core diameter of 350Å whereas CPN stabilised by
β casein have a core of 48 Å, corresponding to the predicted sizes indicated.
the amorphous phase crystallinity is introduced to the system, which has a diﬀrac-
tion pattern similar to that observed in DCPD, indicating a transformation from an
amorphous to crystalline phase Figure 4.8 B.
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Figure 4.8: (a) Simulated and experimental neutron diffraction pattern of DCPD. Exper-
imental data was collected on D16 at the ILL. Sharp Bragg peaks are observed as expected
at 2θ = 36.3◦ and 2θ = 67.8◦, closely matching the simulated diffraction pattern. (b) Mat-
uration of ACP as observed by neutron diffraction. The dry sample lacks any sharp Bragg
peaks however after being left in a hydrated, or a atmosphere sharp peaks corresponding to
DCPD appear as the ACP matures. Evidence that hydrated ACP does indeed eventually
form DCPD, or a more crystalline phase.
4.3.6 Neutron and X-ray scattering indicate a lack of crys-
tallinity within the OPN-CPN
Neutron diﬀraction measurements were carried out on several OPN-CPN samples, in-
cluding a dry sample, a matched out sample, and a sample in 100% D2O(Figure 4.9A).
Initially it was thought that the peptide may form ﬁbres or other ordered structures
which would interfere with the measured diﬀraction pattern. In 41% D2O these con-
tributions are hidden because this is the match-point of protein. However none of the
measured samples showed any Bragg diﬀraction by neutron scattering.
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Figure 4.9: (A) Neutron diffraction measurements collected on D16 for different samples
containing calcium phosphate nanoclusters. The observed patterns are similar to those
collected for dry ACP, and no unambiguously diffraction rings can be detected. (B) X-ray
diffraction patterns for the same samples as shown in (A), covering a lower 2θ range. At
this range no Bragg peaks are observed for either sample.
The same samples were also measured by X-ray scattering in order to detect any Bragg
diﬀraction at lower values of 2θ Figure 4.9 B. Once again the diﬀraction pattern is
featureless and corresponds well with the neutron diﬀraction data and in agreement
with the data obtained by FT-IR.
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4.4 Discussion
4.4.1 OPN forms core shell CPN
Previously the formation of CPN after sequestration of calcium phosphate by OPN1-
149 was observed by SAXS, Holt et al . [45] modelled a core-shell structure to the
collected SAXS data. Using small-angle neutron scattering with contrast variation it
is possible to hide contributions of the shell from the scattering, which is not possible
by SAXS. Here we report SANS data with contributions from the shell hidden using
contrast variation. Our results yield a similar size of the CPN stabilised by OPN1-
149 23.4 nm, compared to the result of Holt et al . of 21.2 nm [45]. Further more we
also obtain information about the size of the core and whole CPN (Table 4.3). For
OPN1-149 CPN we obtain a shell thickness of 2 nm which compares well with the
model obtained by Holt et al . which yields a shell thickness of 1.6 nm [67]. The shell
thickness of OPN1-149 CPN is 2 nm, slightly smaller compared to the shell thickness
of OPNmix-CPN of 2.5 nm. This is probably due to presence of un-cleaved OPN
fragments in the OPNmix [213]. Previously it was shown that CPN stabilised by
β-casein have a radius of 4.04 nm [67]. This radius is much smaller compared to our
results. Using SANS it was determined that the core of a β-casein-CPN has a radius
of 2.3 nm, yielding a shell thickness of 1.7 nm. The shell thickness of OPN1-149
CPN is only slightly larger at 2 nm. If we consider the length of the amino acid
sequence β-casein consists of only 42 amino acids compared to the 149 amino acid
residues of OPN1-149. The similarity of the shell thickness can be understood once
it is considered that OPN1-149 contains 3 phosphate centres through which it can
interact with the core, compared to only one phosphate centre present on β-casein
[67, 213]. The core of β-casein-CPN is considerably smaller then the core of OPN1-
149-CPN, 2.305 nm and 21.4 nm respectively. That the core radius is signiﬁcantly
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larger for OPN CPN can be explained by the apparent increased sequestration ability
of this peptide. Previously it was determined that the core of OPN1-149 is more
basic compared to that found in β-casein-CPN [67]. Holt et al . proposed that the
increased size of the core of OPN1-149-CPN is probably due to the decreased surface
area of OPN1-149 phosphate centres compared to those found in β-casein. This
would allow more phosphate centres to interact and hence stabilise a larger area of
calcium phosphate in the core. The decreased surface area per phosphate centre is
dependent upon the properties of the phosphate centre in the protein. Therefore the
power of sequestration depends upon several diﬀerent factors not least the extent
of phosphorylation in the phosphate centre but also the ﬂanking regions alongside
each phosphate centre. This greater ability to sequester calcium phosphate can be
explained by the higher negative charge amino acid residues present in osteopontin
compared to casein. Even though the phosphate centres are roughly similar the
peptide as a whole is more electronegative, favouring the interaction with calcium
phosphate. The higher net negative charge increases the aﬃnity of the PC and aids
in the act of sequestration.
4.4.2 The core of CPN
The calcium phosphate core of β-casein-CPN has been studied using a range of tech-
niques. X-ray absorption experiments yielded X-ray radial distribution functions
similar to those found in biological and synthetic amorphous calcium phosphates
[214, 215, 216]. Other biophysical methods have also been used to determine any or-
der on several length-scales in calcium phosphate associated with the casein micelle.
High resolution electron diﬀraction did not observe any periodic lattice spacing ruling
out the presence of medium and long range order (15 Å plus) [217]. The presence of
short and medium range order in the inorganic part of the casein micelle has been
studied by extended X-ray ﬁne absorption ﬁne structure (EXAFS). EXAFS absorp-
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tion spectra of the β-casein-CPN sample and a control sample of amorphous calcium
phosphate were modelled and ACP provided a good match for the spectra obtained
for the β-casein-CPN. The results further rule out the eﬀects of medium range or-
der, concluding that β-casein-CPN has only short-range order in the crystalline phase
[69]. Other structures for the inorganic CPN calcium phosphate have been proposed
including a structure consisting of 9 unit cells of DCPD in the form of a tetrahydra
[218]. This proposition is not based on any experimental evidence, furthermore only
monoclinic of DCPD has been observed, which has to lower symmetry to form a
tetrahydra structure [219]. Other workers proposed that the micellar calcium phos-
phate contains order over the medium range scale in the form of single Ca9(PO4)6
units with a 0.95 nm diameter [220]. Order over the medium range length scale has
been ruled out by several extensive EXAFS studies [221, 69].
Both the X-ray and neutron scattering data obtained for OPN1-149-CPN presented
here did not show any diﬀraction, indicating a lack of structural order in the sam-
ple. Using match-out neutron diﬀraction contributions from the protein shell were
hidden. No diﬀraction patterns were observed. According to the neutron diﬀraction
simulations of diﬀerent crystalline size it should be possible to observe crystalline ma-
terial equivalent to the core size of OPN-CPN. We can conclude that the core has an
amorphous structure over the long and medium range. With no well deﬁned crystal
packing.
4.4.3 Implications of an amorphous phase
Amorphous phases are inherently metastable at best, formation of a crystalline phase
is thermodynamically desirable due to the negative energy of formation of the crys-
talline lattice. The supersaturation level of a ﬂuid can be calculated with respect
to diﬀerent crystalline phases. Holt et al . have completed this calculation on sev-
eral biological ﬂuids with respect to diﬀerent calcium phosphate phases shown in
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(Figure 4.10) [10].
Figure 4.10: Compositional variation and Log(saturation indices) in ultrafiltrates of bovine
milk, human blood and stimulated saliva taken from Holt et al . [10]
.
The calculation is based on concentrations of calcium and phosphate taken from real
biological ﬂuids. The calculated saturated is shown assuming diﬀerent structures of
calcium phosphate in the bioﬂuid [10]. The calculation shows that milk, blood and
saliva are all supersaturated with respect to the thermodynamically stable hydroxya-
patite. However if the structure of calcium phosphate is assumed to be amorphous the
saturation index lies below 0 for all three bioﬂuid [10]. That the core of OPN1-149-
CPN is amorphous agrees well with the thermodynamic description of nanocluster
formation [72]. Resulting in the stabilisation of bioﬂuids supersaturated with respect
to hydroxyapatite by sequestration of amorphous calcium phosphate within CPN. In
vertebrates the mineralisation process proceeds via the deposition of mineral within
an organic matrix [222]. Often the organic matrix consists of protein such as collagen.
Although the exact process is not well understood several theories are under devel-
opment [222, 223]. Most of these theories share in common that they require calcium
phosphate precursor is an amorphous phase so that the properly ordered hard mineral
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can grow [222, 224]. This is because the maturation of calcium phosphate into it’s
lower energy crystalline phases is an irreversible process. An amorphous phase there-
fore allows for more control over crystal growth and the resulting properties of the
mineralised tissue [223]. The amorphous nature of calcium phosphate within OPN-
CPN is indicative of the possibility that OPN-CPN are of general importance, not
only as an inhibitor of mineralisation in biological ﬂuid but also that they can act as a
stable reservoir of amorphous calcium phosphate, allowing mineral phases to grow at
the expensive of the calcium phosphate present within the core [10]. This corresponds
with several independent observations of OPN peptides. Including the up-regulation
of protein expression upon an increase in calcium concentration in diﬀerent biological
ﬂuids, up-regulation upon trauma to bone and other mineralised tissues as well as
the observed concentration of osteopontin on the mineral front of bone and teeth
[225, 226, 227]. The amorphous phase precipitates ﬁrst during biomineralisation and
acts as the precursor for consequent mineral formation. OPN-CPN and similar CPN
found in vivo may therefore not only stabilise bioﬂuids supersaturated with respect
to HA but also provide bio-available calcium phosphate in the form of ACP. This
behaviour has been observed in vitro where an OPN-CPN containing solution was
shown to remineralise an artiﬁcial collagen ﬁbril, forming ordered HA from the amor-
phous calcium phosphate present in the CPN [61]. Calcium phosphate nanoclusters
stabilised by β-casein have also been shown to be able to remineralise tooth enamel
when included within a chewing gum [228]. Several potential applications for such
a technology have been imagined including the creation of mimetic bioﬂuids which
more accurately represent the ion concentrations found in vivo. Remineralisation of
collagen and enamel scaﬀolds [61, 228] as well as increasing bio-availability of low sol-
ubility compounds [229]. Therefore the observations that diﬀerent peptides can form
diﬀerent size CPN whilst maintaining an amorphous core is vital for the development
of artiﬁcial peptides. The characterisation presented here is a ﬁrst step in creating
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artiﬁcial phosphate centre containing peptides. By engineering the peptide and more
speciﬁcally the amino acids present in the phosphate centre diﬀerent peptides with
diﬀerent size CPN can be formed, with potential applications in drug delivery and
remineralisation of protein scaﬀolds in vivo.
4.5 Conclusion
It has been shown that nanoclusters stabilised by OPN1-149 and OPNmix have a
core-shell structure, the formed core is larger then the core of CPN stabilised by β-
casein, with a similar shell thickness. The diﬀerence in size is due to the increased
sequestration ability of OPN1-149, caused by the PC and ﬂanking amino acids. The
reported diﬀraction studies observed no crystalline material in the core of OPN-CPN
despite the larger radius. That the core is amorphous is in agreement with the the-
ory of nanocluster formation and stabilisation of bioﬂuids. Furthermore, amorphous
calcium phosphate is biologically available and given the abundance of OPN in the
extracellular matrix CPN formed by OPN peptides may play an important role in
maintaining and growing mineralised tissue. There are several possible applications of
the science described in this chapter, and an understanding of the size and structure of
CPN is a requirement for future biotechnological developments. Possible applications
include, bio-mimetic materials for the repair of damaged bone and re-mineralisation
of teeth, artiﬁcial bioﬂuids that remain stable over long periods of time and for the
development of growth medium in tissue engineering applications that can support
the growth of mineralised tissues.
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Chapter 5
Effects of phosphorylation on
hOPN1-157 structure and dynamics
A manuscript containing the experimental findings presented in this chapter is
under preparation:
• Lenton, S., Nylander, T., Holt, C., Haertlein, M., Zaccai, G. and Teix-
eira, S. Structure and dynamics of the human Osteopontin protein and
the effects of phosphorylation.
Abstract
In humans osteopontin is known to play important roles in mineralisation, cellular signalling
and inflammation. The function of osteopontin in many of these processes is highly depen-
dent upon the location and amount of post-translational modifications of osteopontin. In
the control of mineralisation phosphorylation is of particular importance for determining
osteopontin structure. Phosphorylated amino acid residues alter the way in which the pro-
tein interacts with mineral interfaces and facilitates the sequestration of amorphous calcium
phosphate in solutions supersaturated with respect to hydroxypapatite. In this chapter the
structure, and effects of phosphorylation thereon, of human osteopontin is characterised
using small-angle X-ray scattering. Information about the effects of phosphorylation on
protein dynamics is obtained by elastic incoherent neutron scattering. The results demon-
strate that human osteopontin is a disordered protein that does not gain structural features
upon phosphorylation. Elastic incoherent neutron scattering indicates that the resilience of
the protein on the nano to pico second timescale is independent of phosphorylation. Finally
the importance of phosphorylation with respect to the role of osteopontin in the control of
biomineralisation is discussed in terms of the results obtained.
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5.1 Introduction
Several proteins that are involved in bone growth and mineral regulation undergo sig-
niﬁcant amounts of phosphorylation including osteopontin (OPN), bone sialoprotein
and Fetuin A [66, 230, 59]. OPN is a highly conserved multifunctional protein ex-
pressed in many mineralised tissues, soft tissues and biological ﬂuids [89, 161]. OPN
is a member of the SIBLING (small integrin-binding ligand, N-linked glycoprotein)
family of proteins, it binds integrin through a short Arg-Gly-Asp sequence [84]. In
mammals OPN is a versatile protein that is highly modiﬁed by post translational mod-
iﬁcations. Post-translational modiﬁcation (PTM) of proteins is an important, often
reversible, biochemical event involved in the regulation of various cellular functions
[231, 124]. There exists over 300 diﬀerent types of modiﬁcations regulated by PTM
enzymes, from the introduction of phosphate groups to the cleavage of the amino acid
chain, for a recent review see Witze et al . [125]. PTMs signiﬁcantly increase the range
of chemically diﬀerent amino acids from 20 to 140 and thereby signiﬁcantly diversify
both the structure and function of proteins after translation [124, 35]. OPN is found
in high levels in milk of diﬀerent species, typically in a highly phosphorylated state
[99, 86]. For example human breast milk contains around 100 - 300 mg/mL OPN
corresponding to 1-2 % wt/wt of the total protein concentration [232]. Other human
bioﬂuids including urine and blood also contain signiﬁcant concentrations of OPN [81].
High levels of OPN are also found on the matrix of mineralised tissue including bone
and teeth [84]. OPN plays an extensive role in the formation and regulation of miner-
alisation, and is also associated with several diﬀerent pathologies including inﬂamma-
tion and cancer [233, 234, 90, 91]. The Kinase responsible for phosphorylating several
residues of OOPN in humans has recently been identiﬁed as the FAM20C Golgi Ki-
nase [97, 96]. In globular proteins phosphorylation can alter the conformational space
occupied by the amino acid residues, causing for example the opening of a binding
113
pocket allowing for substrate access [235]. Other post-translational modiﬁcations are
not reﬂected in the conformation of the protein but instead alter functional changes in
protein-protein or protein-substrate interactions [126]. Due to the lack of secondary
and tertiary structure in intrinsically disordered protein the latter type of regulation
by post-translational modiﬁcation is considered more important. The function of
IDPs such as osteopontin are widely regulated by many types of post-translational
modiﬁcations, the reversible nature of many post-translational modiﬁcations enable
IDP to adopt both diﬀerent functional and conformational states in a rapid manner
[236, 237]. A sub-class of intrinsically disordered proteins, known as hub proteins,
convey many roles in vivo. Hub proteins require a large amount of ﬂexibility at either
a local or global level and therefore they have a propensity to contain intrinsically
disordered regions or are fully disordered [131]. On average mammalian proteins un-
dergo at least three post-translational modiﬁcations [238]. Proteins that undergo a
large amount of post-translational modiﬁcations have a tendency to be intrinsically
disordered [120, 122, 121]. This is due to the increased accessibility of disordered re-
gions to enzymes that undertake post-translational modiﬁcations [121, 239, 240, 241].
The reversible nature of many post-translational modiﬁcations and the wide preva-
lence in intrinsically disordered proteins PTM are thought to allow IDPs to undertake
their often multifunctional role in vivo. [124, 238]. Phosphorylation is one of the most
common post-translational modiﬁcations found in intrinsically disordered proteins, in
eukaryotes at least a third of intrinsically disordered proteins are post-translationally
phosphorylated [242, 238, 243]. Due to the inherent quantity and amount of phos-
phorylation found in vivo the study of the eﬀects of phosphorylation on IDPs such
as OPN1-157 is vital to fully understand the regulation and eﬀects of PTMs on the
protein structure and function.
As previously mentioned one of the most important aspects of PTMs is their abil-
ity to modulate protein structure, as is often observed in globular proteins [236]. In
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intrinsically disordered proteins and intrinsically disordered protein regions several
examples exist where phosphorylation of amino acid residues induces folding in, caus-
ing so called disorder to order transitions [244, 245]. For example the intrinsically
disordered tau protein is largely processed by kinase enzymes. Upon phosphorylation
of speciﬁc threonine and serine residue the tau protein remained globally intrinsically
disordered but some local structure becomes ordered, including the stabilisation of
an α helix [246, 247, 248]. Induction of secondary and tertiary structure elements
in IDPs by PTMs is, however, uncommon. Instead, modiﬁcations of IDPs by PTMs
often modify protein-protein and protein-substrate interactions instead.
Experimental evidence of the eﬀects of phosphorylation on protein-substrate in-
teraction have been observed for the casein class of proteins. Whilst phosphorylated
caseins can sequester amorphous calcium phosphate, unphosphorylated caseins can
not [79]. This is due to the charge-charge interaction that stabilises the amorphous
phase [79]. Similarly it is also known that phosphorylation is required for OPN
to sequester amorphous calcium phosphate thereby forming calcium phosphate nan-
oclusters [45]. Certain fragments of OPN can inhibit the growth of calcium phosphate
mineral phases by binding to the surface, the binding and hence inhibition of mineral
growth is also phosphorylation dependent [59, 249, 94, 250].
So far no studies on the eﬀects of phosphorylation on the dynamics of intrinsically
disordered proteins have been completed. Even if the average conformational space
occupied by a protein is not eﬀected the ﬂexibility of a protein may be. This is
especially the case for intrinsically disordered protein where the protein exists as an
ensemble of structures. Therefore the characterisation of both structure and dynamics
is important for a full understanding of the eﬀects of protein phosphorylation. IDPs
are often involved in the development of diﬀerent diseases [251]. Aggregates of Tau
protein found on the brains of alzheimer patients are found in a hyperphosphorylated
state although the relationship between protein phosphorylation and plaque formation
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is not well understood [246, 252].
In bovine milk the OPN fragment OPN1-149 is easily isolated, and is the result
of cleavage by the plasmin protein. The analogous peptide in humans is hOPN1-157.
The sequences similarity between human and bovine OPN is high for the cleavage
fragments (Figure 5.1). In this chapter the eﬀects of phosphorylation on this novel
fragment of human osteopontin, believed to play an important role in biomineralisa-
tion, is studied. The hOPN1-157 protein is produced using recombinant methods and
produced in phosphorylated form by co-expression with casein kinase. The structure
of the protein is characterised by a range of biophysical techniques. Information about
the conformational ensemble present in solution is obtained by small-angle X-ray scat-
tering using the ensemble optimisation method. The dynamics of the protein in both
phosphorylated and unphosphorylated states are examined in the hydrated powder
state by elastic incoherent neutron scattering. The results show that hOPN1-157 is a
disordered protein independent of phosphorylation state which samples a large area of
conformational space. On the pico-second timescale no eﬀects of phosphorylation are
observed, however it is shown that formation of CPN is phosphorylation dependent.
Figure 5.1: Amino acid sequence alignment of human OPN1-157 (Uniprot: P10451) and
bovine OPN1-149 (Uniprot: P31096) osteopontin fragments. The alignment was performed
using clustalW [253], residues highlighted in red are conserved amino acids.
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5.2 Materials and methods
5.2.1 Bioinformatics
PONDR predictions where made using the VL-XT and VSL2 algorithms on the hOPN
sequence. Detailed descriptions of the diﬀerences between these algorithms can be
found elsewhere [175, 254, 255, 256]. Charge-Hydropathy analysis was completed
using the PONDR server (www.pondr.com), which included charge hydropathy cal-
culation for known folded and unfolded proteins [175].
5.2.2 Over-expression and purification of human osteoptontin
Recombinant over-expression of phosphorylated hOPN1-157 in E.coli was based on
the co-expression system developed by Clegg and Holt [79]. The method relies on the
simultaneous co-expression of two diﬀerent vectors with a low and high copy number,
expressing a protein kinase and substrate protein respectively. The hOPN1-157 gene
containing a 6 histidine tag on the N-terminus (527 base pairs) was inserted into the
pET 28a(+) vector. The chosen expression vector carries genes which encode for
ampicillin resistance and a T7 promoter. Plasmid containing the gene encoding for
the casein kinase (CK2α) was kindly provided by Dr R. Clegg (Glasgow University) on
a pACYC-Duet vector (Novagen). In the pACYC-Duet 1 vector protein expression
is also controlled by a T7 promoter, the vector also contains a gene encoding for
chloramphenicol resistance. This plasmid maintains a lower copy number in E.coli
compared to the pET 28(+) plasmid. By combining two diﬀerent antibiotic resistance
genes the suppression of non transformed bacterial cells is maintained by the addition
of both chloramphenicol and ampicillin, allowing for tighter control of the expression
system.
The host organism used for recombinant protein over-expression was BL21-DE3. This
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strain of E.coli incorporates elements from the T7 bacteriophage, and includes the
DE3 lysogen which carries the gene encoding for T7 RNA polymerase. The expression
of DE3 lysogen is under the control of a lacUV promoter, thereby allowing for induc-
tion of the T7 polymerase and consequent protein over-expression on both plasmids
via the addition of isopropyl β-D-1-thiogalactopryanoside (IPTG).
The pET28 plasmid containing the hOPN gene was introduced into chemically
competent BL21-DE3 E.coli cells by heat shock. The transformed bacteria were prop-
agated on plates in the presence of ampicillin to select for pET28 induced ampicillin
resistance and and were incubated overnight at 37◦C. Colonies from the overnight
plates were used to inoculate 10 ml Luria-Bertani (LB) medium containing amp-
cicillin, which was left to grow overnight at 37◦C [257]. 500 ml of LB containing
ampicillin was inoculated with 5 % V/V of the overnight cultures. The cells were
grown at 37◦C with vigorous stirring until the culture had reached mid-exponential
phase at an optical density (OD) at λ = 600 nm of 0.7. Transcription of the OPN1-
157 gene from the plasmid encoded T7 promoter in pET28 was then induced by
addition of IPTG to a ﬁnal concentration of 1 mM. Cells where grown for a further
3 hours at 37◦C to allow OPN1-157 production, after which the bacteria were har-
vested by centrifugation (10.000 g, 20 minutes) the resulting cell pellet was stored at
-22◦C until puriﬁcation. In order to achieve in vivo phosphorylation the pET28 plas-
mid containing the hOPN1-157 gene and a PaCYC-Duet vector containing the casein
kinase were simultaneously introduced into chemically competent BL21-DE3. The
pACYC duet contains a gene expressing for chloramphenicol resistance. The trans-
formed bacteria were propagated on LB containing plates in the presence of both
ampicillin and chloramphenicol to select for bacteria transformed with both vectors.
The rest of the preparation was identical to the unphosphorylated preparation, with
the inclusion of chloramphenicol at every step of bacterial growth. Aliquots taken
before induction and after induction were stained with coomasie blue and resolved on
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a 12% SDS-PAGE gel. A western blot was performed by transferring aliquots onto
a polyvinylidene ﬂuoride (PVDF) membrane. The membrane was blocked with 5%
(w/v) bovine serum albumin in tris buﬀered saline (50 mM Tris-Cl, pH 7.5, 150 mM
NaCl) and probed with a Monoclonal anti-polyHistidine antibody produced in mouse
(Sigma) for 90 minutes at room temperature. Blots were developed by addition of
goat anti-mouse alkaline phosphatase antibody (Sigma), and visualised by addition of
an alkaline phosphatase substrate. The frozen cell pellet was re-suspended in ice cold
lysis buﬀer (20 mM tris, 0.5 M NaCl, pH 8) (10 ml per gram of cell paste) containing
EDTA free protease inhibitors (Roche), cells were lysed by sonication on ice. Insoluble
material was released from the lysate by centrifuging at 14,000 g for 30 minutes. The
cleared protein extract was then loaded onto a HisTrap 5 ml nickle aﬃnity column
(G.E. Healthcare) using an Akta Prime system. The column was washed with lysis
buﬀer containing 25 mM imidazole to release weakly bound proteins (1 ml/minute,
30 minutes). The His-tagged protein was eluted by increasing imidazole concentra-
tion in the buﬀer from 50 mM to 250 mM, whilst constantly collecting fractions of 1
ml. The fractions were analysed by SDS-PAGE and consequently transferred onto a
polyvinylidene ﬂuoride (PVDF) membrane which was developed as before. Samples
containing the expressed fraction were further puriﬁed by analytical size exclusion
chromatography. 250 µg of each sample in buﬀer containing 50 mM phosphate, 300
mM NaCl, 0.02% NaN3 at pH 7), were loaded onto a Superdex 75 pg 10/300 GL
column (GE Healthcare) connected to a Bio-rad system (Bio-rad). The column was
calibrated using molecular weight standards from Bio-rad (Bio-rad) dissolved in the
sample buﬀer. The elution from the column was monitored by U.V. absorption at
280 nm, and fractions of 0.5 ml collected. The fractions were analysed by SDS-PAGE
for purity, samples containing the expressed protein were pooled, and extensively dia-
lyzed against H2O and consequently freeze dried and stored in a desiccator containing
phosphopentoxide. Successful expression of the puriﬁed protein was further conﬁrmed
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by N-terminal sequencing of the ﬁrst 5 amino acids.
5.2.3 Mass spectrometry analysis
Samples were dialysed against a buﬀer containing 20 mM tris pH 8, 250 mM NaCl and
concentrated to 0.8 mg/ml ( 50 nMol). 4 µL of the sample diluted to 5µM in 0.03 %
TFA were injected for analysis. Loaded samples were desalted using a Zorbax 300sb-
C8 (Agilent technologies) on-line protein trap for 3 minutes with a ﬂow rate of 100 µ
l/min of 0.03% TFA. The sample was then eluted at 50 µL/min with 5% acetonitrile.
The desalted samples were analysed on a 6210 LC-TOF mass spectrometer interfaced
with an LC pump system (Agilent Technologies).
5.2.4 Proteinase K sensitivity assay
Proteolytic sensitivity analysis of hOPN1-157 in the phosphorlyated and unphospho-
rylated state and a control of myoglobin were completed by the method of Denning
et al . [258]. Brieﬂy, 5 µg of each protein was incubated with 100 ng of proteinase K
(Sigma) at 37 ◦C controlled by a water bath. Aliquots of each sample were taken at
the indicated time points, the reaction was stopped by boiling the aliquots in SDS
loading buﬀer. The samples where then loaded onto a 12 % SDS-PAGE gel run at 150
V for 50 minutes, with molecular Pagerule plus prestained protein ladder (Fermentas,
USA).
5.2.5 1D HET-SOFAST NMR
NMR spectra were measured at the NMR facility at the Institut de Biologie Struc-
turale (Grenoble, France). All NMR experiments were performed at a protein con-
centration of 150 µM in a buﬀer of 50 mM phosphate, 200 mM NaCl, at pH 7. NMR
experiments were performed at room temperature on a Varian 600 MHz spectrometer
(Agilent technologies, USA), as described by Schanda et al. [259].
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5.2.6 FPLC-SAXS Experiment
Measurements were performed using an on-line high pressure liquid chromatography
(FPLC) system (Viscotek GPCmax, Malvern intstruments) directly attached to the
sample capillary on the BM29 Bio-SAXS beamline at the European Synchrotron
Radiation Facility (Grenoble, France). A 2.4 ml Superdex 200 Increase 5/150 GL
column (G.E. Healthcare) was attached; prior to each run the column was equilibrated
with 2 column volumes of the corresponding buﬀer. Sample volumes of 100 µl (5
mg/ml) were directly loaded onto the column using the FPLC system, at a ﬂow rate
of 0.1 ml per minute at room temperature. Elution from the column was measured
by U.V. absorption at 280 nm−1 . X-ray scattering data was continuously collected
on the column elution at a wavelength of 0.99 Å using a sample-to-detector distance
of 2.81 m corresponding to a measured q range of 0.08 - 4 nm−1. Small angle X-ray
scattering data was collected at the rate of 1 frame every 2 seconds leading to the
collection of roughly 1000 frames for the whole run. Primary data reduction leading
to radially integrated, calibrated and normalised one dimensional scattering proﬁles
was completed by the EDNA software pipeline [260]. Frames were compared manually
and investigated for radiation damage, non damaged frames were averaged, and buﬀer
frames were averaged for background subtraction. Calibration of the superdex 200
(GE Healthcare) column was completed using the same method with molecular weight
standards from Bio-Rad.
5.2.7 FPLC-SAXS data analysis
Model independent
The experimental radius of gyration, RG, and the forward scattering intensity, I0,
were calculated from data at low q values in the range of qRG< 1.3, using the Guinier
approximation: lnI(q) = Ln(I(0)) − R2Gq
2/3. The pair distribution function p(r)
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in real space was calculated by indirect Fourier transform using GNOM from the
ATSAS software package [147]. Analysis of the p(r) function allowed the estimation
of the maximum inter-particle distance (Dmax) as well as RG and I0. The Kratky plot
(q2I against q) provides further model independent information about the scattering
particle. Globular particles typically show a well deﬁned maximum when plotted in
this way whereas for a disordered protein the Kratky plot should plateau at high
values of q.
Ensemble Optimisation Method (EOM)
Flexible proteins are best described by an ensemble of structures rather than one well
deﬁned structure as is the case for most globular proteins. The ensemble optimisation
method (EOM) software was used which takes into account protein ﬂexibility by
allowing the co-existence of several diﬀerent conformational isomers in the scattering
solution. Using the EOM software a pool of 10,000 random models based on the
amino acid sequence of the hOPN1-157 protein were generated. A genetic algorithm
was then employed in order to narrow the pool down to 50 models that best ﬁtted the
scattering curve which were then selected for further analysis. The RG and Dmax of
these 50 models were plotted as a histogram and 5 models were selected to represent
the ensemble.
5.2.8 Elastic incoherent neutron scattering experiments
Neutron scattering experiments on phosphorylated and unphosphorylated hOPN D2O
hydrated powder sample were carried out on the IRIS spectrometer at the ISIS spal-
lation neutron source, Chilton, UK. By exploiting the Pyrolitic Graphite PG(002)
analyser conﬁguration and the Beryllium ﬁlter, the covered momentum transfer range
was between 0.3 and 1.8 1 with an energy resolution of 17 µeV (corresponding to a 50-
ps time scale). Each sample contained 100 mg of protein powder with 0.44 g D2O/g
protein held in a ﬂat aluminium cell with internal spacing of 0.3 mm. The sample was
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placed at an angle of 135◦ with respect to the incident beam. A elastic temperature
scan was performed by continuously counting the scattered neutrons whilst increasing
the temperature at a rate of 1 K/min from 10 K to 310 K. The MSD were obtained
from the analysis of the integrated intensity over a frequency window corresponding
to instrumental resolution around the elastic peak.
5.2.9 Dynamic Light Scattering experiments
Samples (5 mg/ml) were prepared in phosphate buﬀer as per the method of Holt.
Samples were measured on a Malvern Zetasizer instrument with an incident wave-
length of 633 nm. At least 10 consecutive measurements of the correlation time of the
scattered light intensity were performed and averaged for each sample. The data were
ﬁtted according to the algorithm present in the Malvern analysis software. Brieﬂy
the correlation function (G(t)) was ﬁtted to the equation
G(t) = B + A2−2q
2
Dt (5.1)
Where B is the baseline measurement, A is the amplitude, q is the scattering vector,
t is the delay time and D is the diﬀusion coeﬃcient. The hydrodynamic radius of the
particle (Rh) is inversely proportional to the diﬀusion coeﬃcient D and the solvent
viscosity η as per the Stokes-Einstein equation
RH =
kBT
6πηD
(5.2)
Such that the radius of hydration (RH) can be determined experimentally.
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5.3 Results
5.3.1 Amino acid composition analysis of hOPN1-157
OPN belongs to the Small integrin binding-ligand n-linked glycoproteins (SIBLING)
family of proteins, known to have degrees of structural disorder [84]. The hOPN1-
157 fragment studied here is signiﬁcantly shorter and lacks several of the binding and
interaction domains present in full length OPN. This raises the question as to whether
the resulting fragment retains intrinsically disordered features or obtains secondary
structural elements. Amino acid analysis of the hOPN1-157 protein was completed
using several diﬀerent computational techniques, that focus on predicting intrinsic
disorder. The Uversky plot analyses protein sequences based on their charge and
hydropathy. A combination of low overall hydrophobicity and a large net charge are
key characteristics of IDP responsible for preventing the hydrophobic collapse into
a globular structure. As a result they generally occupy diﬀerent region to globular
proteins in charge-hydrophobicity plots [184]. A plot of the mean net charges and
hydrophobicities of hOPN1-157 and a set of reference proteins is shown in Figure 5.2.
A boundary is observed between reference proteins known to be globular and those
that are intrinsically disordered. The distance of hOPN1-157 from the folded unfolded
boundary is shown in the ﬁgure, and the protein lies well within the intrinsically
disordered region. The charge-hydrophobicity analysis of hOPN1-157 indicates that
the chemical properties of hOPN1-157 are similar to those found in IDPs.
PONDR is one of the most reliable and consistently used predictors of disorder in
proteins [254]. Analysis by the PONDR predictor using the VSL2 and VLXT algo-
rithm provides information about the propensity of folding on diﬀerent regions of the
protein. According to the PONDR predictions the hOPN1-157 sequence is mainly
disordered, and is lacking any kind of secondary structure elements (Figure 5.3). The
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Figure 5.2: Comparison of the mean net charge and the mean hydrophobicity indicated
for a set of folded proteins (blue circles) and intrinsically disordered proteins (red circles)
data taken from Uversky et al . [175]. The boundary between natively folded and unfolded
proteins is indicated by a solid black line. hOPN1-157 (Green diamond) lies within the
region expected of a unfolded protein.
predictions made by PONDR are in close agreement with the position of hOPN1-157
in the charge-hydropathy plot which also indicated a disordered structure.
5.3.2 Production, purification and phosphorylation of hOPN1-
157
Expression of of hOPN1-157 was monitored after induction with IPTG by SDS PAGE
analysis. Cells where lysed three hours after induction and the protein was identiﬁed
in the cell lysate which was used for further protein puriﬁcation. The ﬁrst step of
puriﬁcation was completed by the aﬃnity of the his-tagged recombinant protein to a
nickel column, eluted fractions were pooled and loaded onto a size exclusion column
in order to remove any contaminating species. The collected fractions were then
analysed by SDS-page gel as shown in Figure 5.4, the analysis indicates the successful
puriﬁcation of a single species. The identity of the puriﬁed species was conﬁrmed by
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Figure 5.3: Sequence based structural analysis of hOPN1-157using PONDR.
The prediction of hOPN1-157 disorder tendency using two different prediction algorithms.
Solid line shows the VSL2 algorithm and the dashed line shows the VLXT algorithm. Scores
above 0.5 are considered disordered regions (indicated by the red line).
Western blot analysis with antibody speciﬁc of the 6 histidine tag, which is not
present in any E.coli proteins (Figure 5.4). In order to further conﬁrm the identiﬁed
puriﬁed protein the N-terminal 5 residues were sequenced and correctly identiﬁed
as those expected for hOPN1-157. A combination of N-terminal sequencing, SDS-
PAGE gel and Western blot indicate successful production, isolation and puriﬁcation
of recombinant hOPN1-157.
Protein phosphorylation involves the addition of phosphate groups to speciﬁc protein
side chains, and hence the extent of phosphorylation can be identiﬁed by measuring
the mass of the protein. In order to determine whether the recombinant expression
system produced phosphorylated protein both the HIS tagged proteins were analysed
by electron spray ionisation (ESI) mass spectrometry. Unphosphorylated hOPN1-157
showed one species corresponding to the expected molecular mass of the protein in
an unphosphorylated state, as would be expected due to the lack of kinase enzymes
within E.coli. The de-convoluted mass spectrum of phosphorylated hOPN1-157 con-
tained several major species corresponding to diﬀerent levels of phosphorylation (Ta-
ble 5.1). The levels of phosphorylation appear to be non speciﬁc and correspond to
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Figure 5.4: Left: SDS-PAGE of hOPN1-157 after size exclusion chromatography. Right:
corresponding Western Blot against 6HIS antibody. Molecular masses are indicated in kDa.
levels higher then expected by the inclusion of a single phosphate centre. .
5.3.3 Biophysical characterisation of hOPN1-157
To further investigate the aforementioned predictions experimentally a combination of
limited proteolysis, SDS-PAGE gel migration, 1-D HET-SOFAST NMR and analyti-
cal size exclusion chromatography (SEC) was used. Intrinsically disordered proteins
exhibit larger hydrodynamic radii compared to globular proteins of the same molec-
ular weight [119]. This is caused by their low compactness in solution. Analytical gel
ﬁltration was used to calculate the apparent molecular mass of hOPN1-157 according
to its migration on a SEC column. The apparent molecular mass can be calculated by
measuring the retention time of proteins with a known molecular weight. In this case
a reference set of globular proteins was used. In order to determine the eﬀects of phos-
phorylation on the hydrodynamic radius both phosphorylated and unphosphorylated
hOPN1-157 were analysed by this technique. The results are shown in Figure 5.5
A. The retention time of hOPN1-157 is phosphorylation independent, indicating no
signiﬁcant changes in the radius of hydration upon phosphorylation. Based on the
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Table 5.1: Species observed by MALDI-TOF measurements of phosphorylated hOPN1-157
and the corresponding number of phosphorylated residues.
Observed mass (Da) Phosporylated residues
18356.00 3
18435.89 4
18515.86 5
18596.03 6
18675.88 7
18756.04 8
18835.82 9
18915.79 10
elution volume observed for hOPN11-157 the apparent molecular mass was calculated
to be 59kDa, which is independent of phosphorylation state and larger then the mass
determined by mass spectrometry, and the mass expected based on the amino acid
sequence. Migration at a higher apparent molecular weight on a size exclusion column
is a typical property of IDP [119].
It is known that intrinsically disordered proteins typically migrate on SDS-PAGE gels
at higher molecular masses due to their lack of a hydrophobic core, which leads to
binding of SDS in an atypical manner leading to reduced mobility by electrophore-
sis. The migration of both phosphorylated and un phosphorylated hOPN1-157 on
a 12 % SDS-PAGE gel was investigated (Figure 5.5 B). A reference set of globular
proteins was used to determine the apparent molecular mass. In a similar manner
to the analytical SEC results there seems to be no eﬀect of phosphorlyation on the
apparent molecular mass. However the apparent molecular mass at which hOPN1-
157 migrates (37 kDa) is much higher then the expected molecular mass. Once again
this is another key characteristic of intrinsically disordered proteins, and further indi-
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Figure 5.5: (A) Analytical size exclusion chromatography indicates a single peak which
is the same for phosphorylated and unphosphorylated hOPN1-157 (green and red curves
respectively). Both samples eluted at a higher molecular weight then would be expected for
folded proteins. Molecular weight standards are indicated by the blue curve and consist of a
set of globular reference proteins. (B) Both phosphorylated and unphosphorylated samples
migrate at the same rate on a SDS-PAGE gel, at a higher apparent mass then expected
cates a disordered structure of hOPN1-157 [245]. Due to their low compactness and
lack of secondary structure, disordered proteins are more susceptible to proteolysis
compared to globular proteins, where residues are inaccessible because for example
they are buried in the hydrophobic core [119]. The susceptibility to proteolysis is
therefore often used to identify and characterise IDP and disordered protein regions
[261]. In certain cases phosphorylation has shown to inhibit the degradation of IDP
by protease enzymes [262]. To asses the extent of intrinsic disorder in hOPN1-157
the puriﬁed protein was exposed in the phosphorylated and unphosphorylated state
and myoglobin, a reference protein of similar molecular mass, to low concentrations of
proteinase K. In low concentrations and short periods of time proteinase K is capable
of rapidly digesting disordered regions, but not globular regions [258]. The ability of
proteinase K to digest hOPN1-157 in both the phosphorylated and unphosphorylated
state and the reference myoglobin is shown in Figure 5.6.
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Figure 5.6: Proteinase K induced limited proteolysis at 37 ◦C of (A) Phosphorylated
hOPN1-157 (B) Unphosporylated hOPN1-157 (C) myoglobin. Exposure time for each lane
is indicated at the top in minutes.
The intensities of the diﬀerent bands directly correspond to protein concentration.
For both phosphorylated and unphosphorylated hOPN1-157 the intensity decreases
rapidly so that after several minutes the protein is heavily digested. Myoglobin on
the other hand does not undergo digestion on the same timescale. After 2 hour incu-
bation with protease K both hOPN1-157 samples are fully digested as are the smaller
fragments, the myoglobin sample still shows a single band at the correct molecular
mass indicating that the protein wasn’t digested to the same extent as either hOPN1-
157 proteins. After two hours all bands in the hOPN1-157 samples disappear indicate
that there is an almost total lack of order in any region of the structure. The high rate
of degradation of hOPN1-157 compared to the globular myoglobin protein indicates
that hOPN1-157 is heavily exposed to the solvent, independent of phosphorylation
state, and hence in both the phosphorylated and unphosphorylated state hOPN1-157
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is an IDP. These results agree with the previously presented prediction of intrinsic
protein disorder and the high levels of phosphorylation detected within the protein.
Using 1-D HET-SOFAST NMR it is possible to get an estimate of the degree of
folding within a protein, and hence an indication about the extent of protein ﬂexi-
bility. Samples of both phosphorylated and unphosphorylated hOPN1-157 were fur-
ther analysed using this technique, which yields a quantitative parameter known as
λNOE. Phosphorylated and unphosphorylated hOPN1-157 displayed λNOE of 0.84
and 0.77, respectively (Figure 5.7). The measured λNOE for both samples lie within
the region expected of disordered proteins (Figure 5.7), and lies far away from those
expected for globular proteins. Furthermore the spectra show an almost total lack of
any folded secondary structure elements. There is a slight change in λNOE observed
upon phosphorylation of the protein which could correspond to a reduction of mo-
bility upon phosphorylation, however the ﬁgure still lies well within the intrinsically
disordered region. The above mentioned biophysical analysis provide strong evidence
that the hOPN1-157 adopts a nonglobular conformation in solution, which is not
phosphorylation dependent.
Figure 5.7: One dimensional 1H NMR spectra of the reference and saturated intensities of
phosphorylated (left) and unphosphorylated hOPN1-157 (right). The corresponding λ NOE
are indicated for both samples.
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5.3.4 Structural analysis by FPLC-SAXS
The U.V. traces of the elution from the online FPLC experiments of hOPN1-157
in the phosphorylated and unphosphorylated state are shown in Figure 5.8. Both
samples migrate at the same rate observed in the preparation step Figure 5.5 and the
retention time is independent of phosphorylation state.
Figure 5.8: Hydrodynamic characterisation of phosphorylated (red) and unphosphory-
lated hOPN (blue) by analytical size exclusion chromatography, both proteins migrate at a
mW corresponding to 59kDa. Inset: Calibration curve using molecular weight standards,
indicated by blue dots, Thyroglobulin (670kDa),y-globulin (158kDa), Ovalbumin (44kDa),
Myoglobin(17kDa), Vitamin B12(1.35kDa), elution volume of the measured samples are
indicated by the green dot.
During the online FPLC-SAXS experiments elution from the column was constantly
measured by SAXS. Elution of protein was identiﬁed by the U.V. absorption. The
EDNA pipeline automatically calculated the RG and I(0) from the Guinier plot, the
results of this are shown in Figure 5.9. The eluted peak corresponds to the peak as
measured by U.V. absorption at 280 nm (Figure 5.8). Each frame was then inspected
manually for radiation damage and quality of data, for both samples multiple frames
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where picked and averaged, providing the ﬁnal data set. The averaged frames are
shown in Figure 5.10 for both samples, the error in radii of gyration is relatively large
due to the short exposure of each individual frame. Upon averaging the individual
frames (shown in Figure 5.10) the error in data is reduced. Frames from the beginning
and end of the elution peak were compared by overlaying the scattering curves. Buﬀer
for background frames containing only buﬀer were averaged and subtracted from
peaks containing protein sample.
Figure 5.9: Trace of I(0) (blue) and RG (Red). for (A) unphosphorylated hOPN1-157 and
(B) phosphorylated hOPN1-157, frames as determined by the Guinier plot of the measured
FPLC-SAXS. With an exposure time of 2 seconds per frame whilst flowing through a quartz
capillary.
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Figure 5.10: The radius of gyration determined for each frame by the Guinier plot with the
error shown in blue bars. For (A) Unphosphorylated hOPN1-157 and (B) Phosphorylated
hOPN1-157. For both samples all frames where averaged to provide the final data set.
The RG determined from the Guinier plots and calculated from the p(r) distributions
are shown in Table 5.2 and graphically in Figure 5.11 . The determined RG are
similar between phosphorylated and unphosphorylated hOPN1-157. The expected
RG of an IDP can be calculated based on the amino acid length of a protein using the
Flory equation, as can the RG expected for globular proteins [263]. The calculated
RG for globular and IDP are shown in Figure 5.11 C. hOPN1-157 in phosphorylated
state and unphosphorylated state lie within the region expected for IDPs, consistent
with a highly ﬂexible structur. The calculated p(r) distributions of phosphorylated
and unphosphorylated hOPN1-157 are shown in Figure 5.11 D. The distributions are
similar and the asymmetrical shape observed in both samples is consistent with that
expected for IDPs. From the p(r) distribution the RG were also obtained in real-space,
and lie in close agreement with those obtained from the Guinier plot (Table 5.2). The
Guinier plot was also used to determine the forward scattering intensity at q = 0,
which is dependent upon protein concentration. This value was used to produce a
normalised Kratky plot for both samples shown in Figure 5.11E. For both samples the
shape of the Kratky plots are identical, with a plateau at high q which corresponds
to Gaussian chain, behaviour characteristic of IDPs and ﬂexible proteins [264].
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Figure 5.11: Guinier plots of phosphorylated (A) and unphosphorylated (B) hOPN1-157.
The RG and I(0) were recovered from the fit of the straight line where q·RG < 1.3 . (C)
Comparison of the experimentally determined RG of phosphorylated (red diamond) and un-
phosphorylated (Green diamond) with those expected for a disordered protein according to
the Flory equation (red dash lines) and the RG of a globular protein with the same molecular
mass. (D) The p(r) distribution of phosphorylated and unphosphorylated hOPN1-157. (E)
Normalized Kratky plot of phosphorylated hOPN1-157 (Red line) and unphosphorylated
hOPN1-157 (Blue line).
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Table 5.2: SAXS parameters of hOPN1-157 in the unphosphorylated and phosphorylated
state
.
Phosphorylated Unphosphorylated
RG-Guinier 39.0 ± 0.59 Å 37.6 ± 0.60 Å
RG-p(r) 39.8 ± 0.20 Å 39.4 ± 0.26 Å
Dmax-p(r) 129.4 Å 130.6 Å
SAXS data is often interpreted to obtain information about the size and shape of
a protein. Model independent parameters obtained include the shape of the Kratky
plot, the p(r) distribution and the RG. In the case of SAXS the experimentally deter-
mined RG is a size estimate averaged over all conformations in solution, and therefore
for proteins with transient structure which display a large range of conformations
it is not a very accurate description of the protein in solution. Using the ensemble
optimisation method (EOM) a more detailed description of the heterogeneous con-
formations present in solution can be obtained. The RG and Dmax were obtained
for the ensemble that best represents the diﬀerent ﬂexible conformations present in
solution for both phosphorylated and unphosphorylated hOPN1-157 (Figure 5.12).
The resulting ensemble ﬁts the SAXS data well (Figure 5.12 C and D). Both proteins
are represented by a broad ensemble of structures with a RG ranging from 30 Å up
to approximately 50 Å (Figure 5.12 A and B). A similar distribution of sizes is re-
ﬂedted in the distribution of Dmax ranging from 90 Å to 130 Å . The obtained size
distributions are similar for both phosphorylated and unphosphorylated hOPN1-157,
indicating that the protein occupies a similar set of transient structures which are not
greatly aﬀected by extensive protein phosphorylation. The obtained distribution of
sizes can be compared to an ensemble randomly generated based on the amino acid
sequence of the protein. This ensemble is shown as a black line in Figure 5.12A and
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B. The distributions of hOPN1-157 are broadly similar to the random ensemble and
it samples nearly all the same conformations. The random pool sample conforma-
tions at higher values of Dmax and RG compared to the experimental data, indicating
that hOPN1-157 possibly is not as extended as a completely random structure. This
tendency does not appear to be aﬀected by phosphorylation of hOPN1-157.
Figure 5.12: Ensemble optimisation analysis of the FPLC-SAXS profile measured for
hOPN in the phosphorylated and unphosphorylated state. (A) RG distribution of the
samples and the random ensemble (black line) (phosphorylated hOPN1-157 blue line, un-
phosphorylated hOPN1-157 red line). (B) Dmax distribution shown for phosphorylated
hOPN1-157 blue line, unphosphorylated hOPN1-157 red line and the pool of random struc-
tures black line. (C) Fit of the selected pool to the hOPN1-157 phosohporylated scattering
curve (χ2 = 1.090) (D) Fit of the selected pool to the unphosphorylated hOPN1-157 scat-
tering curve χ2 = 1.064).
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5.3.5 Effects of phosphorylation on protein dynamics
The mean squared displacement (MSD) of the samples were determined on the nano-
second timescale using elastic incoherent neutron scattering on the IRIS instrument
at ISIS. The MSDs were extracted as a function of temperature and are shown in
Figure 5.13. The large incoherent scattering cross section of hydrogen dominates the
scattering by the hydrated sample. Therefore the obtained MSDs can be related to
the average movement of hydrogen which are spread across the sidechains of hOPN1-
157. According to the obtained results there does not seem to be a signiﬁcant eﬀect
of phosphorylation upon the MSD on the nano second timescale.
Figure 5.13: MSDs of phosphorylated (Red circles) and unphosphorylated (Blue circles)
hOPN1-157. Error bar is shown at the highest temperature and decreases with decreasing
temperature. Data was measured on the IRIS spectrometer at ISIS
A break in the increase of the MSD at around 200 K can be seen for both samples. This
has been observed in several hydrated protein powders studied by neutron scattesring
and is called the glass transition temperature [265]. The glass transition temperature
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can be interpreted in terms of the two well model, below the transition temperature
the atoms do not have enough energy to sample all structural ﬂuctuations and only
samples the lower energy well, the atoms are harmonic [266]. At temperatures above
the glass transition the atoms within the sample have enough energy to sample all
structural conﬁgurations, the atoms become anharmonic [266]. This anharmonic
transition is present in both samples at similar points. At temperatures above the
glass transition no signiﬁcant diﬀerences are observed in the measured MSDs. The
results indicated that on the nano-second timescale the motions of hOPN1-157 are
not inﬂuenced by the state of phosphorylation of the protein.
5.4 Discussion
The hOPN1-157 protein was readily expressed by the host organism with a yield
of around 10 mg per litre of culture for both the phosphorylated and unphosphory-
lated form. By inclusion of both the hOPN1-157 vector and the vector containing
CK2α in the same bacteria, expression of phosphorylated hOPN1-157 was achieved.
The hOPN1-157 vector contained 3 serines in a row placed within the recognition
sequence of CK2α. Mass spectrometric analysis of the puriﬁed hOPN1-157 protein
showed however that phosphorylation of hOPN1-157 by CK2α was non speciﬁc. In-
stead of phosphorylation of only the desired 3 residues several other side chains were
also phosphorylated to some degree. 1 D HET-SOFAST NMR provides a method
to semi-quantitatively asses the structural compactness and heterogeneity of proteins
in solution. The measurements performed on hOPN1-157 in the phosphorylated and
unphosphorylated state and λNOE values were calculated to be 0.84 and 0.77 re-
spectively, indicative of highly ﬂexible proteins in solution. The results obtained by
NMR were highly similar to those previously observed for another OPN fragment
[84]. The structural studies that followed indicated that hOPN1-157 has a disordered
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and highly ﬂexible structure. The nonspeciﬁc phosphorylation observed in the re-
combinant hOPN 1-157 can be understood by a distinct lack of structural elements.
The intrinsic ﬂexibility of the hOPN1-157 peptide allows for wider recognition by
kinases due to the increased exposure of the protein chain to solvent. Indeed this
was observed by the sensitivity of hOPN1-157 by proteinase K, which was higher
then that observed in the globular myoglobin protein (see Figure 5.6). Recently it
has been observed that the kinase used in this study (CK2α) is not as speciﬁc as
previously thought. Previously it was thought that CK2α recognised a speciﬁc motif
our study shows that this is not the case. It may instead be that the speciﬁc motif
increases aﬃnity to CK2α and increases the rate of phosphorylaton. In the case of
OPN1-157 the increased exposure of all the sidechains due to intrinsic disorder results
in phosphorylation of multiple residues outside of the CK2α recognition sequence.
Calculation of the apparent molecular mass of the protein by both SDS-PAGE and an-
alytical SEC yielded a much higher molecular weight then would be expected based on
the amino acid sequence (Figure 5.5). According to the amino acid analysis hOPN1-
157 contains a high degree of negatively charged amino acids, compared to globular
proteins Figure 5.2. The aberrant migration of hOPN1-157 by SDS-PAGE is due to
this high content of negatively charged amino acids which inhibit the binding of SDS
and in doing so reduces the migration of the protein on the gel. This behaviour is
typical of proteins that adopt an intrinsically disordered conformation as observed for
a number of IDPs [267, 193, 263]. Analytical size exclusion chromatography provides
a estimate of the molecular mass depending on the hydrodynamic radius of the sam-
ple. For hOPN1-157 the calibrated chromatogram indicates that the protein elutes
at a molecular mass which corresponds to that of a globular protein of a much higher
weight. Uversky explained the diﬀerence in the theoretical molecular mass and that
observed by analytical SEC as due to the larger hydrodynamic radii of intrinsically
disordered proteins compared to globular proteins.
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In order to obtain good quality data by small-angle X-ray scattering, particularly
for visualising small conformational changes in heterogeneous structures, sample of
high purity lacking in aggregates is important. Protein aggregation is common at
high concentrations but the formation of aggregates is not necessarily concentration
dependent [268]. SAXS data analysis can lead to false interpretations if the sam-
ple contains only a small amount of aggregate. Error introduced by measurement
of aggregates particularly aﬀects data at low resolution and is typically observed in
the Guinier region, thereby inﬂuencing the model independent determined radius of
gyration and I(0) [148]. To overcome the problem of protein aggregation and in order
to determine even small changes in the RG online FPLC-SAXS has been developed
at several SAXS beamlines [269, 270, 150]. Measurement of the protein or a com-
plex of proteins immediately after size exclusion puriﬁcation improves the sample
homogeneity and increases the quality of data. Several experiments have been per-
formed that have identiﬁed small changes in the size of the macro-molecule by the
FPLC-SAXS method [270, 271]. FPLC-SAXS is therefore ideally suited for proteins
which display heterogeneous conformations allowing the separation of diﬀerent struc-
tural conformers based on their size and migration rate through the size exclusion
column. This technique is therefore ideally suited to investigate whether the broad
band eluting for hOPN1-157 from a SEC column is due to diﬀerent conformations or
purely the structural inhomogeneity caused by hOPN1-157. The measured RG was
consistent across all frames measured during the FPLC-SAXS experiment indicative
of only a singular species, the frames were therefore averaged to provide the ﬁnal
data. Model independent data analysis of the FPLC-SAXS data by means of the
Kratky and Guinier plot indicate that hOPN1-157 adopts an unfolded conformation
in both phosphorylated and unphosphorylated states. The ensemble optimisation
method was used to characterise the heterogeneous ensemble of structures present
in solution. The generated ensemble of both phosphorylated and unphosphorylated
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hOPN1-157 displays a highly extended and ﬂexible structure which is identical for
both. From the selected ensemble of structures it can be observed that in solution
hOPN1-157 adopts a wide range of conformations from more compact structures to
highly extended conformations. The result is in agreement with both the 1D-HET-
SOFAST NMR and the model independent SAXS data. Interestingly the ensemble
of heterogeneous structures cannot be separated out by FPLC SAXS, indicating that
the protein is a heterogeneous ensemble of structures that is transient in solution.
From the SAXS data information can be obtained about the structural char-
acteristics; however this data does not yield any information about the dynamical
properties of the protein in solution. In order to assess the eﬀects of phosphorylation
on the picosecond timescale we studied the mean squared displacements of the sam-
ples using elastic incoherent neutron scattering on IRIS at ISIS. From both the data
the mean square displacements were calculated as a function of temperature. The
results shown in Figure 5.13 indicate no signiﬁcant change in protein dynamics upon
phosphorylation of hOPN1-157 on the picosecond timescale.
The experimental evidence presented here indicates no signiﬁcant alteration in ei-
ther protein structure or dynamics on the timescales measured upon phosphorylation
of the protein. Phosphorlyation of hOPN does not aﬀect structure or dynamics but
in other osteopontin fragments phosphorylation does aﬀect function; of primary im-
portance is the altered electrostatic eﬀects of the protein which are greatly altered by
phosphorylation [59]. The size of the core of a calcium phosphate nanocluster depends
on the sequestering power of the peptide [79]. In the case of CPN formation, phospho-
rylation is required to provide suﬃcient sequestering power to the phosphate centres
aﬀording suﬃcient free energy for sequestration. The importance of phosphorylation
in hOPN1-157 is therefore not structural or dynamical but rather phosphorylation
alters the electrostatic properties of the protein. Multiple phosphorylation of the
protein in regions previously deﬁned as phosphate centers leads to the formation of a
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so called net charge or mean ﬁeld [272]. The disordered state of hOPN1-157 in solu-
tion and the resulting rapid interconversion (observed by EINS) through a multitude
of transient conformations means that the protein does not present discrete charges
through the individual phosphorylated amino acids but rather a mean electrostatic
ﬁeld, which represents the sum of all the charges in the phosphate centre, is presented
[272, 273] . It has previously also been suggested that the adoption of an intrinsi-
cally disordered conformation is a requirement for calcium phosphate sequestration
because it allows the protein to be concentrated to a high degree on the core surface
of a calcium phosphate nanocluster [23]. This combination of properties between
the mean ﬁeld and the ability to pack densely on the core of a calcium phosphate
nanocluster may be the most important properties of OPN in terms of sequestration
rather than the exact conformations adopted in solution. The unfolded conformation
of hOPN1-157 may not only be important for the act of sequestration but also to
allow the protein to undertake its multifunctional roles in vivo. As observed here, by
the susceptibility of proteinase K and the high degree of phosphorylation of hOPN1-
157 by CK2α, a disordered conformation allows easier access to amino acid residues
by enzymes which undertake post-translational modiﬁcations. In the case of CPN
formation regulation of the mean electrostatic ﬁeld and hence protein interaction can
be more rapidly controlled as well as post-translational modiﬁcations that regulate
other functions in vivo.
5.5 Conclusion
hOPN1-157 samples a transient ensemble of conformations in solution independent of
phosphorylation state. The rate at which this ensemble is sampled is also not eﬀected
by the phosphorylated state of the protein. The nonspeciﬁc phosphorylation observed
in the recombinant hOPN1-157 can be understood by structural elements. Firstly the
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intrinsic ﬂexibility of the hOPN1-157 peptide allows for wider recognition not only by
kinases but also by other enzymes which undertake post-translational modiﬁcation
due to the increased exposure of the protein chain to solvent. Secondly nonspeciﬁc
phosphorylation of hOPN by CK2α could be due to the apparent non-speciﬁcity of
the CK2A enzyme itself, which has been proposed to phosphorylate and regulate
a wide range of biological processes. This high propensity to interact with other
proteins could explain how intrinsically disordered proteins can participate in many
diﬀerent cellular processes. The combination of disorder and regions which contain
a high amount of phosphorylation allows OPN1-157 to present a mean electrostatic
ﬁeld. It is through the mean charge of the electrostatic ﬁeld that OPN peptides can
sequester amorphous calcium phosphate and pack densely around the core leading to
the formation of CPN.
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Chapter 6
Summary & conclusions
The main results from this work related to osteopontin phosphor-peptides and the cal-
cium phosphate nanoclusters formed upon sequestration of calcium phosphate. The
key mechanism of calcium phosphate sequestration requires phosphate centres within
the sequestering protein. Formation of calcium phosphate nanoclusters leads to the
stabilisation of bioﬂuids and allows the concentration of calcium and phosphate ions
to exceed their saturation level. It is believed that the calcium phosphate nanoclus-
ters also provide a biologically available source of calcium phosphate for the growth
of mineralised tissue in vivo.
In this work several techniques were used to study the structure of OPN1-149 iso-
lated from bovine milk. Biophysical characterisation showed that OPN1-149 displays
features of a disordered protein. Consequently SAXS was used to study the confor-
mation of OPN1-149 in solution. Model free interpretation of the SAXS data showed
properties consistent with those expected of intrinsically disordered protein. The data
were further interpreted using the ensemble optimisation method which showed that
OPN1-149 adopts a range of transient structures in solution ranging from extended to
compact. Elastic incoherent neutron scattering was then used to obtain information
about the rate at which the OPN1-149 peptide samples the heterogeneous confor-
mations present in solution. The mean force constant was extracted from a EINS
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temperature scan. Comparison of the obtained mean force constant with previous
results showed that the value obtained for OPN1-149 closely matches those observed
in another IDP. The resilience of OPN1-149 was also studied after sequestration of
calcium phosphate, the obtained force constant showed an increase in rigidity, show-
ing a diﬀerence in behaviour upon sequestration.
Formed OPN1-149-CPNs were studied using small-angle neutron scattering in com-
bination with contrast variation. Static light scattering showed no change in the size
of OPN1-149 CPN upon variation of D2O in the buﬀer. The size determined by
static light scattering closely matched the size previously obtained by SAXS which
are far larger than previously observed in any other CPN system. The match-point
of OPN1-149 was conﬁrmed. SANS studies of the formed CPN showed properties of
core-shell type particles. From the SANS data the radius of the core and shell were
calculated and the thickness of the shell obtained. The shell thickness was compara-
ble to those observed in other CPN. The core radius was, however, larger than those
observed in other CPN. The core structure was studied using a range of techniques
to rule out formation of crystalline material, including neutron and X-ray diﬀraction.
No crystallinity was observed. The increased size of the core and whole CPN particle
was therefore due to the increased power of sequestration of OPN1-149.
In order to elucidate the role of osteopontin in human a bioﬂuids, a recombinant E.coli
expression system was used to produce a phosphorylated human OPN fragment. The
system relied on two plasmids, one which expressed the protein and one which ex-
pressed CK2α. Mass spectrometry experiments of the phosphorylated protein showed
phosphorylation in a non speciﬁc manner. This was related to the intrinsic disorder
observed in the protein by SAXS and other biophysical techniques. Intrinsic disorder
in proteins leaves the protein more susceptible to solvent and hence interaction with
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other proteins. It is thought that this intrinsic disorder allows unfolded proteins such
as OPN to rapidly sequester excess calcium phosphate prior to precipitate formation.
The dynamics of hOPN1-157 were also studied using EINS, however no eﬀects of
phosphorylation were observed. Phosphorylation of hOPN1-157 has no detectable
eﬀect on the structure or dynamics of the protein, however introducing large phos-
phorylated areas on the protein does eﬀect the electrostatic properties. Thus it can be
concluded that phosphorylation regulates hOPN1-157 function merely by modifying
its electrostatic properties rather than its conformational properties.
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